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CHAPTER 1 
INTRODUCTION 
1.1. Historic aspects and sources of thyroid hormone 
The thyroid is an endocrine gland the function of which is under the direct 
control of thyroid stimulating hormone (thyrotropin, TSH). The secretion of the 
latter by the anterior pituitary is subject to neuroendocrine regulation involv-
ing the stimulatory action of thyrotropin releasing hormone (TRH; Fig. 1.1.) 
and the inhibitory actions of dopamine and somatostatin. 
HYPOTHALAMUS 
I 
TRH e 
THYROID HORMONE 
Fig. 1. 1. Hypothalamus-pituitary-thyroid axis. 
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Fig. 1.2. Structures of T4, ~ and rT3 • 
The thyroid "hormones" are iodinated amino acids (see Fig. 1.2.), which are 
synthesized by the follicular cells of the thyroid and influence many metabolic 
processes. These hormones also regulate TSH secretion through a direct action 
on the anterior pituitary (negative feedback control). 
The thyroid hormone thyroxine (3,3',5,5'-tetraiodothyronine, T4) has been 
crystallized by Kendall (1) in 1915 and the chemical structure of T4 was eluci-
dated by Harington (2) and Harington and Barger (3) in 1926 and 1927, respect-
; ve ly. 
In 1952 Gross and Pitt-Rivers (4) and Roche et al (5) discovered 3,3' ,5-
triiodothyronine (T3), which proved to be physiologically more potent and more 
rapid in onset of action than T4. Pitt-Rivers et al (6) showed that T4 can be 
deiodinated in vivo to T3 and this finding led to the proposal that T4 is the 
form in which thyroid hormone is secreted, while T3 is the form which is active 
in the tissues. However, conversion of T4 into T3 in man could not be demon-
strated by Lassiter and Stanbury (7). In 1970 Braverman et al (8) provided new 
evidence for the peripheral (extrathyroidal) conversion of T4 into T3• These 
investigators were able to demonstrate formation of T3 from T4 in athyreotic 
human subjects, in whom substitution therapy with T4 was the only possible 
source of T3. Peripheral monodeiodination of T4 in man has now been confirmed 
in many laboratories (9-14). 
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Another iodothyronine, 3,3',5'-triiodothyronine (reverse T3, rT3), has been 
identified in 1956 both in serum and thyroglobulin (an iodinated protein in the 
thyroid which stores thyroid hormones as peptide linked iodoamino acids) of the 
rat (15,16). It was only in 1974 that the natural existence of rT3 in human 
serum could be established using a radioimmunoassay (17). This compound has little 
or no metabolic activity (18) and is therefore currently regarded to be biologic-
ally inactive. rT3 can, comparable to T3, be generated peripherally from T4 in 
man (19-22). 
It is generally believed that the thyroid gland does not contribute import-
antly to circulating T3 and rT3 in normal humans, but that monodeiodination of 
T4 in extrathyroidal tissues is the major source of T3 and rT3 (19). The relative 
contributions of the peripheral deiodination to the daily production of T3 and 
rT3 are 80 and 94%, respectively (for reviews see 23-25). These figures have 
been calculated from the plasma concentrations, metabolic clearance rates and 
thyroidal secretion rates (which are assumed to be related to the proportion in 
which T3 and rT3 are present in thyroglobulin) of T4, T3 and rT3• On the other 
hand, i~ the rat the contribution of the peripheral deiodination of T4 to the 
total production of T3 has been estimated at 20% (26) and 32% (27). However, 
the results in the latter study are contradictory, because in this study the 
fractional conversion rate of T4 into T3 was reported to be approximately 30%. 
From this value and the production rates of T4 and T3, which are for the former 
2-3 times higher than for the latter, it can be calculated that at least 60% of 
circulating T3 is derived from peripheral deiodination of T4. Moreover, Abrams 
and Larsen (28) have calculated that two-thirds of the T3 utilized per day by 
the iodine-sufficient rat arises from T4. Finally, comparison of serum T3 levels 
in T4-substituted athyreotic rats with those in euthyroid animals yielded simil-
values (29). The above results point to a situation in the rat which is not dif-
ferent from the one in humans. 
1.2. Metabolism of thyroid hormone in humans 
The thyroid gland is, as far as presently known, the only source of T4• 
Only a small amount of T3 and a negligible amount of rT3 are also of thyroidal 
origin. Upon entering the blood, the iodothyronines bind strongly but reversibly 
to three serum proteinso Of these proteins thyroxine-binding globulin (TBG) has 
the highest affinity for T4 and T3 and carries more than 70% of thyroid hormone 
in serum. The other two transport proteins are thyroxine-binding prealbumin 
(TBPA) and albumin (30). TBPA binds 15-20% of circulating T4 and almost no T3• 
Albumin binds 5-10% of serum T4 and 25-30% of serum T3• About 0.02% of serum T4 
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and 0.2% of serum T3 circulate in a free, not protein bound form. The free 
moiety of thyroid hormone is the only form which can enter tissue cells. 
Thyroid hormone is translocated over the plasma membrane by a specific, energy-
dependent transport process as shown by in vitro studies (31,32). In the cell, 
thyroid hormone is bound to cytosolic protein but interaction with this protein 
is not a prerequisite for binding to the nucleus (33). The nucleus is supposed 
to be the main site of initiation of thyroid hormone action (34,35). Binding to 
a specific nuclear receptor leads to increased transcription rates and synthesis 
of proteins involved in the metabolic response to thyroid hormone. However, a 
mitochondrial route of thyroid hormone action cannot be ruled out (35,36). 
Recently, MUller and Seitz (37) provided evidence for a rapid action of T3 on 
intermediairy metabolism independent of "de novo" protein synthesis. They found 
that T3 at the supraphysiologic concentration of 10-
6 M rapidly stimulates 
hepatic glucose production by increasing amino acid uptake and ATP regeneration. 
It still remains a question whether T4 has intrinsic biological activity, be-
cause most, if not all, of its effect is brought about by transformation into 
T3• Therefore, T4 is regarded as a prohormone which becomes activated after 
conversion into T3• 
There are several pathways of T4 metabolism: a) deiodination, b) oxidat-
ive deamination, c) conjugation and d) ether bond cleavage (Fig. 1.3.). Deiodir.-
ation is the most important pathway of metabolism, accounting foratleast 60% 
of T4 turnover in humans. Roughly half seems to undergo initial monodeiodin-
ation in the phenolic ring to yield T3, while the remaining half is converted 
into rT3. Although similar amounts of T3 and rT3 are generated, deiodination 
of T4 is not a random process as has been suggested by Surks and Oppenheimer 
(38). In several situations (starvation, non-thyroidal disease) conversion of 
T4 into T3 is diminished, whereas conversion into rT3 does not change (25,39). 
As rT3 appears to be devoid of biological activity and T3 is the most active 
iodothyronine, modulation of the alternate pathways of T4 metabolism could 
provide an effective means for modifying the balance between activation and 
inactivation of T4• Both T3 and rT3 are subject to further deiodination, which 
ultimately leads to the formation of thyronine (T0) as illustrated in Figure 
1.4. The presence of 3,3'-diiodothyronine (3,3'-T2) in the thyroid gland and 
the serum of the rat was demonstrated originally in 1956 by Roche et al (16). 
Monodeiodination of T3 and rT3 into 3,3'-T2 and of rT3 into 3',5'-diiodothyro-
nine (3',5'-T2) in man has been demonstrated by several investigators (40-44). 
Recently, evidence was presented that 3,5-diiodothyronine (3,5-T2) is derived 
from T3 in normal humans (45). In vivo generation of 3'-monoiodothyronine (3'-
T1) from 3',5'-T2 and rT3 has also been found (46,47). Up to now, no evidence 
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Fig. 1.4. Se~uential 5-(~) and 5'-(~) deiodination of T4. 
has been presented for the production of 3-monoiodothyronine (3-T1) from 3,5-T2 
or 3,3'-T2 in humans. In vivo fot·mation of T0 from T4 has been suggested by Pitt-
man et al (48). Recently, excretion of T0 in the urine has been measured by a 
combination of gas chromatography and mass-fragmentography (49). The sequent-
ial deiodination of T4 in peripheral tissues is thought to be mediated by two 
enzyme activities, i.e. iodothyronine 5(or 3)*-deiodinase, which catalyzes de-
iodination of the tyrosyl ring and iodothyronine 5'(or 3')*-deiodinase, which 
catalyzes deiodination of the phenolic ring (50,51). 
*Positions 3 and 5 are equivalent as are positions 3' and 5'. 
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About 5-10% of T4 is metabolized via oxidative deamination of the alanine 
side chain to yield 3,3' ,5,5'-tetraiodothyroacetic acid (52). In normal humans 
10-25% and in rats a somewhat greater fraction of the daily disposal of T4 takes 
place through fecal excretion, mainly of glucuronyl- and sulfoconjugates (52). 
Hydrolysis of the ether bond is only a very minor pathway of T4 degradation. 
1.3. Scope of the present study 
It is well established that in man peripheral deiodination of T4 accounts 
for most of the biologically active T3 and virtually all of the inactive rT3• 
In several situations reciprocal changes in serum T3 and rT3 levels occur, which 
indicates that enzymatic deiodination is not an uncontrolled process. To get 
more insight into the regulation and mechanism of thyroid hormone metabolism, 
basic knowledge of the deiodinating enzyme(s) is necessary. Therefore, the aim 
of this study was to localize, purify and characterize the iodothyronine deio-
dinase(s). The availability of pure enzyme preparations will not only facilitate 
the elucidation of the molecular mechanism of thyroid hormone regulation, but 
also answer the question of whether one or two enzymes are involved in the de-
iodination of T4• 
In Chapter 2, in vitro observations of the enzymatic deiodination of iodo-
thyronines are described. In addition to a review of the literature, results 
from my own work are also included. The results of this work are discussed in 
relation to the findings by other investigators.In the following chapters, which 
are papers already published, my investigations of the enzymatic deiodination 
of several iodothyronines in rat liver preparations are described in detail. 
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CHAPTER2 
MONODEIODINATION OF IODOTHYRONINES - IN VITRO STUDIES 
2.1. Monodeiodination of thyroxine 
Soon after the discovery of T3 (4,5), conversion of T4 into T3 was demon-
strated in rat kidney slices by Albright et al (53). This deiodination reaction 
has now been demonstrated in many tissues and cell preparations, including cul-
tured human liver cells (54), isolated rat liver cells (55), rat liver homoge-
nate (55-60) and microsomes (55,57), cultured human kidney cells (54), rat kid-
ney homogenate (59,61,62) and isolated rat renal tubules (63), cultured human 
fibroblasts (64), human polymorphonuclear leukocytes (65,66), isolated perfused 
rat heart (67) and dog heart homogenate (68), homogenates of rat cerebellumand 
cerebral cortex (69,70), rat skeletal muscle homogenate (59,71) and perfused 
rat skeletal muscle (72), rat thyroid tissue (73,74), isolated human thyroid 
cells (75), human thyroid homogenate (76), rat thyroid particulate fraction 
(77), human and dog thyroid microsomes (78), rat pituitary homogenate (79,80) 
and human placenta and fetal membranes (81). 
Although conversion of T4 into rT3 is difficult to study in vitro, because 
rT3 is metabolized very rapidly to 3,3'-T2, this reaction has been demonstrated 
in dog liver microsomes (78), cytosol (82), homogenate (83-85) and microsomes 
of rat liver (86), isolated rat renal tubules (63), human polymorphonuclear 
leukocytes (66), dog heart homogenate (68) and cultured chick-embryo heartcells 
(87), rat cerebellar and cerebral cortical homogenates (69,70), monkey hepato-
carcinoma cells (88), rat thyroid particulate fraction (77), dog thyroid micro-
somes (78) and human placenta and fetal membranes (81,89). 
2.2. Monodeiodination of tri- and diiodothyronines 
The conversion of rT3 into 3,3'-T2 has been studied in rat pituitarytumour 
cells (90), rat liver homogenate (85,91-96) and microsomes (86), rat kidney 
homogenate (91,95), rat thyroid particulate fraction (77) and monkey hepatocar-
cinoma cells (97). 
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Monodeiodination of T3 into 3,3'-T2 was found to occur in rat liver homo-
genate (85,91-93) and microsomes (86), rat kidney homogenate (91), cultured 
chick-embryo heart cells (87), rat thyroid particulate fraction (77) and monkey 
hepatocarcinoma cells (88,97). 
Very interesting are the monkey hepatocarcinoma cells which, besides the 
above mentioned deiodinations, can at the same time convert rT3 into 3',5'-T2, 
3,3'-T2 and 3' ,5'-T2 into 3'-T1 and 3,5-T2 into 3-T1 (97). The generation of 
3'-T1 from 3',5'-T2 has also been found in rat liver microsomes (98-100) and 
cytosol (100) and in rat kidney microsomes and cytosol (100). Recently, the 
conversion of 3,3'-T2 into 3-T1 has been shown to occur in rat liver microsomes 
(99). Although production of 3,5-T2 from T3 seems to exist in normal humans 
(45), this reaction has not been demonstrated directly in vitro nor has metab-
olism to the completely deiodinated thyronine been observed. 
2.3. Nature of the deiodination process 
Factors modulating the deiodination reaction include the temperature and 
pH of incubation, and the concentration of substrate (25,56,59-61,66,83-86,92). 
The deiodination is stimulated by several thiols (mercapto compounds) such as 
dithiothreitol (OTT) and 2-mercaptoethanol (57,101), and by reduced glutathione 
(39, 96,101-103). However, several investigators found no or only small stimul-
atory effect of the latter compound (60,61,104 and D. Fekkes, unpublished ob-
servations). On the other hand, the sulphhydryl-oxidizing agent diamide, the 
sulphhyd~l-binding reagents N-ethylmaleimide, iodoacetic acid and mercuric 
chloride, and oxidized glutathione are potent inhibitors of the monodeiodinaDon 
(25,51). These characteristics suggest that the monodeiodinating activity is 
enzymatic in nature and that the presence of sulphhydryl groups is essential 
for the deiodination of the various iodothyronines. Probably, an essential 
cysteine residue is located in the active site of the enzyme. It has recently 
been established that thiols are cofactors in the deiodination reactions. These 
compounds act as the second substrate in the 5'-deiodination of T4 (105) and 
of rT3 (106). 
2.4. Localization of deiodinase activity 
The monodeiodinating activities have been observed in several tissues, 
such as liver, kidney, heart, leukocytes, fibroblasts, skeletal muscle, thyroid 
gland, pituitary, cerebral cortex, cerebellum and placenta (see Section 2.1. 
and 2.2.). Of these tissues, liver and kidney demonstrated the greatest deiodin-
ating capacity. 
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However, because of its large mass, muscle cannot be excluded as an important 
site for the deiodination of thyroid hormone. Rat spleen and intestines showed 
very low deiodinase activity (59,91,100), while lungs were devoid of activity 
(59,100). 
Subcellular fractionation studies have revealed different locations of the 
deiodinating activities in rat liver and kidney tissues (see Table 2.1.). 
Table 2.1. SUBCELLULAR LOCALIZATION OF IODOTHYRONINE DEIODINATING ACTIVITIES 
IN RAT LIVER AND KIDNEY 
Organ 
1 i ver 
1 iver 
kidney 
kidney 
liver 
1 i ver 
1 i ver 
1 i ver 
1 i ver 
1 i ver 
Activity Localization Reference 
T4+T3 microsomes Hesch et al, 1975 (55), Visser 
et al, 1976 (57), Cavalieri et 
al, 1977 (82) 
T4+rT3 cytosol Cavalieri et al, 1977 (82) 
T4+T3 plasma membrane and Chiraseveenuprapund et al 
mitochondria 1978 (61) 
T4+T3 plasma membrane Leonard and Rosenberg,1978 (52) 
T4+T3, plasma membrane Maciel et al, 1979 (107) 
rT3+3,3'-T2 
T4+T3 + rT3, endoplasmic reti- Fekkes et al, 1979 (108) 
rT3+T3+3,3'-T2 culum 
T4+T3 endoplasmic reti- Auf dem Brinke et al,1979 (109) 
culum 
T4+T3 
T4+rT3 
T4+T3 
microsomes 
microsomes 
endoplasmic reti-
culum 
Takaishi et al, 1979 (110) 
Auf dem Brinke et al, 1980(111) 
Saito et al, 1980 (112) 
liver T4+rT3, mitochondria and Sorimachi et al, 1980 (113) 
rT3+3,3'-T2 microsomes 
liver and 3',5'-T2+3'-T1 microsomes and 
kidney 
1 i ver 
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cytosol 
3',5'-T2+3'-T1, plasma membrane 
3,3'-T2+3-T1 
Smallridge et al, 1981 (100) 
Chopra, 1981 (99) 
Most investigators reported on a microsomal localization of the deiodinase act-
ivity. In some studies iodothyronine deiodinase activity was localized in the 
endoplasmic reticulum (108,109,112), whereas in others an association with the 
plasma membrane fraction was observed (99,107). However, close examination of 
the data in the latter reports do not support this conclusion. On the other hand, 
Chiraseveenuprapund et al (51) and Leonard and Rosenberg (52) showed that the 
kidney enzyme is associated with the plasma membrane. The above mentioned studies 
all show an association of the deiodinase activity with the particulate fraction 
of tissue homogenates. These results are disconcordant with those of Cavalieri 
et al (82) and Smallridge et al (100), who found deiodinating activity in cyto-
sol. Probably, contamination of cytosol with microsomal components is responsible 
for this observation (111). Existence of phenolic- as well as nonphenolic ring 
deiodinase activity has also been shown in particulate fractions of cultured 
monkey hepatocarcinoma cells (113), human placenta and chorion (81), rat thyroid 
homogenate (77), dog liver and thyroid homogenate (78) and human thyroid homo-
genate (78). 
2.5. Characteristics of the enzymatic deiodination in rat liver 
All deiodination reactions so far studied obey Michaelis-Menten kinetics. 
Many different Km - and especially Vmax values of the several deiodination react-
ions in rat liver have been reported. These discrepancies may be caused by the 
use of different crude enzyme preparations such as rat liver homogenate (contain-
ing soluble iodothyronine-binding proteins) or microsomes, and by studying the 
reactions at different pH values and cofactor concentrations. A summary of the 
apparent kinetic parameters of the deiodination reactions is shown in Table 2.2. 
Table 2. 2. RANGES OF APPARENT K1~ AND V MAX VALUES OF IODOTHYRONINE 5- AND 5 1 -
DEIODINASE-CATALYZED REACTIONS IN RAT LIVER PREPARATIONS 
Reaction Km (JlM) vmax (pmol/min per Reference 
mg of protein) 
T4....-T3 1-10 0.1-0.5 and 10-70 59,60,83,86,95,109,112, 
114,115 
T4....-rT3 0.1 and 2-5 13-24 82,86,114 
rT3....-3,3
1
-T2 0.01-0.3 0.2-0.4 and 340-830 60,86,91-93 
T3....-3,3
1
-T2 5-10 21-42 86,91 
3 I '5 I - T 2-+-3 I - T 1 0.01 and 0.1-0.8 and 150-170 99,100,Chapter 7 
0.2-0.8 
3,3 1 -T2....-3-T1 0.5 0.1 99 
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The apparent Km values of the 5'-deiodination of T4 and of the 5-deiodin-
ation of T4 and T3 vary between 1-10 ~M. Only Hoffken et al (114) found a dif-
ferent value for T4 (0.1 ~M) in the 5-deiodination to rT3. The apparent Km 
values for the 5'(3')-deiodinations of 3',5-T2 and 3,3'-T2 are, with the except-
ion of one study (100), in the range of 0.1-1 ~M. The lowest apparent Km values 
have been determined for the 5'-deiodination of rT3, viz. 0.01-0.3 ~M. However, 
all estimated values are expressed as the total substrate concentration and, 
therefore, only represent apparent Km values. Recently, Heinen et al (115) cal-
culated the real K value for the 5'-deiodination of T4 on the basis of free m -
instead of total T4 concentration to be 9.7 nM. This value is substantially 
lower than the apparent Km of 2.1 ~M, which was found by the same investigators 
after applying the total T4 concentration. However, the significance of these 
findings remains unclear as reactions were carried out with large amounts of 
microsomes without added cofactor. The large discrepancies in the estimated 
Vmax values, as shown in Table 2.2., are mainly caused by different cofactor 
concentrations in the incubation medium and not by a different ratio substrate/ 
microsomes. 
The pH-optima of the deiodination reactions have been determined by many 
investigators. The 5'-deiodination of T4 was found to be optimal at pH 6-7 
(59,82-86,92,109,116), whereas the 5-deiodination of T4 is most effective 
around pH 8 (82,85,86). However, earlier studies revealed an optimal pH for 
this latter reaction at pH 9 (83) and 9.5 (84). The reason for this discrepancy 
is the rapid degradation of rT3 into 3,3'-T2 between pH 5-8 (85,91-93), which 
was not taken into consideration by these investigators. The 5-deiodination of 
T3, which is analogous to the conversion of T4 into rT3 (both reactions are 
5-deiodinations), has also been shown to be optimal at pH 8 (85,86,91). However, 
Hoffken et al (93) and Gavin et al (116) found somewhat higher optimal values 
(pH 8.4). Optimal pH values for the 5'-deiodination of rT3, which is a similar 
type of reaction as the conversion of T4 into T3, have been reported to amount 
to 6.5 (85), 7.3 (93), 7.7 (116) and 8.0-8.5 (86,91,92,104). It has been shown 
that the pH-optimum for this reaction depends on the concentration of the sub-
strate (86,98). At low rT3 concentrations reaction rate is highest at pH 6-7, 
whereas at high concentrations optimal pH value is shifted towards pH 8. A 
similar dependence of the optimal pH on the substrate concentration also holds 
for the 5'-deiodination of 3' ,5'-T2 (98). A broad pH plateau (pH 4.9-7.6) and 
a narrower pH peak (pH 5.0-6.5) for this reaction have been found by Smallridge 
et al (100), whereas Chopra (99) reported on a maximal deiodination rate between 
pH 7.5-8.1 both for the 5' (3')-deiodination of 3',5'-T2 and 3,3'-T2. 
Despite differences in pH-optima and kinetic parameters of the several 
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deiodination reactions, evidence has been obtained that the 5'-deiodinations of 
both T4 and rT3 and 3',5'-T2 are catalyzed by a single enzyme, viz. iodothyro-
nine 5'-deiodinase (60,85,86,95,96,99,107,117). Thus, rT3 is a competitive in-
hibitor of the 5'-deiodination of T4 (59,60,115) and T4 is a competitive inhibi-
tor of the production of 3,3'-T3 from rT3 (60,86,96). Ki and Km values were 
found to be equal under various conditions. In only one study rT3 was found to 
be a noncompetitive inhibitor of the 5'-deiodination of T4 (83). In this study, 
degradation of rT3 was not taken into account when inhibition of T4 to T3 con-
version was investigated. 3',5'-T2 has been shown to be a competitive inhibitor 
of the 5'-deiodination of T4 (25) and of rT3 (Chapter 7). The conversion of 
3',5'-T2 into 3'-T1 is also inhibited competitively by rT3 (Chapter 7). On the 
other hand, Auf dem Brinke et al (109) suggested that three enzymes are involved 
in the 5'-deiodination of T4, while Smallridge et al (100) reported on a micro-
somal and a cytosolic enzyme mediating the conversion of 3',5'-T2 into 3'-T1• 
The 5-deiodinations of T4 and rT3 were initially thought to be mediated 
by a separate enzyme, viz. iodothyronine 5-deiodinase. Both reactions exhibit 
similar pH profiles (85) and the kinetic parameters of these deiodinations 
demonstrate a similar dependence on pH (86). However, 3,5-T2 also appears to be 
deiodinated by iodothyronine 5'-deiodinase (118, Chapters 7 and 9). In addition, 
T3 was found to be a competitive inhibitor of the 5'-deiodination of both rT3 
and 3',5-T2, while 3',5'-T2 competitively inhibits the 5-deiodination of T3• 
Values for Ki are identical with the respective~ values (Chapter 9). These 
data point strongly to a single enzyme catalyzing both the 5- and 5'-deiodination 
of all iodothyronines. This hypothesis is sustained by the finding that all de-
iodinating activities, involved in the production of 3,3'-T2 from T4 via T3 and 
rT3, are located in the endoplasmic reticulum of the rat liver cell (108). 
Moreover, it has not been possible to separate 5- and 5'-deiodinase activity in 
detergent solubilized microsomes (119). 
Several regulatory mechanisms in the deiodination process have been pro-
posed, such as changes in intracellular pH (84,114), changes in cofactor con-
centration (or the glutathione sulphhydryl-disulphide ratio) (39), substrate-
induction of the deiodinating enzymes (120), the concentration of the iodo-
thyronines themselves, the concentration of naturally occurring inhibitors 
(including iodothyronines) and changes in cellular uptake of T4 (32,121). It 
may be well that some of these mechanisms operate in concert resulting in the 
observed changes in thyroid hormone metabolism (decreased peripheral T3 pro-
duction and rT3 degradation leading to low serum T3 and high rT3 concentrat-
ions) induced by drugs and disease states. 
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2.6. Inhibitors of the deiodination reactions 
Many investigators have reported on dose-dependent inhibitions of the 
several deiodination reactions in rat liver homogenate or microsomes by a 
variety of agents. However, only in a few studies the type of inhibition has 
been described. Three types of inhibition may be distinguished: a) competitive, 
b) noncompetitive and c) uncompetitive inhibition. Competitive inhibition of 
the 5'-deiodination of T4 has been found by the iodothyronines rT3 (59,60,115) 
and 3',5'-T2 (25), by the radiographic contrast agent ipodic acid (25) and by 
salicylic acid (122). The conversion of rT3 into 3,3'-T2 is inhibited competi-
tively by T4 (60,86,96),_ ipodic acid (25) and salicylic acid (122), while ipodic 
acid also inhibits the 5-deiodination of T3 in a competitive fashion (25). In 
Chapter 7, competitive inhibition of the 5'-deiodination of both rT3 and 3',5'-
T2 by several iodothyronines and iodothyronine analogues, radiographic contrast 
agents, 8-anilino-1-naphthalene sulphonic acid and salicylic acid derivates is 
described. Furthermore, in Chapter 8 the competitive inhibition of rT3 5'-
deiodinase by phenolphthalein dyes is discussed. Some of these derivatives may 
be regarded as substrate analogues (both types of compounds contain a 3,5-
dihalogen-4-hydroxyphenyl group). In addition, Sorimachi and Robbins (123) re-
ported on a competitive inhibition by T4 of both the 5'-deiodination of rT3 
and the 5-deiodination of 3,5-T2 in monkey hepatocarcinoma cells, though with 
widely different Ki values. 
Noncompetitive inhibition of the conversion of T4 into T3 has been found 
by compounds which react more or less specifically with sulphhydryl groups, 
such as iodoacetic acid, diamide, N-ethylmaleimide and mercuric chloride (25). 
Iodoacetic acid has also been shown to inhibit production of 3,3'-T2 from both 
T3 and rT3 in a noncompetitive manner (91). 
The uncompetitive type of inhibition is achieved by reaction of compounds 
with an oxidized form of the essential sulphhydryl group of the deiodinase, 
which is generated upon reaction with substrate. An example of such an uncom-
petitive inhibitor is 6-propyl-2-thiouracil, a derivative of 2-thiouracil 
(124), which inhibits not only the 5'-deiodination of T4 (59,60,105) and rT3 
(60,91,106), but also the 5-deiodination of T3 (91). A similar mode of inhibit-
ion is exerted by sulfite (125). 
2.7. Mechanism of the reductive deiodination of iodothyronines 
Recent observations by Leonard and Rosenberg (105) and Visser (106) have 
given insight into the mechanism of action of iodothyronine 5'-deiodinase. 
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Thiols, such as DTT, stimulate 5'-deiodination of both T4 and rT3 (25,57,62,85, 
101), while 2-thiouracil inhibits these reactions uncompetitively with respect 
to substrate (59,60,91,105,106), but competitively with respect to DTT (105,106). 
A change in the cofactor (OTT) concentration results in a parallel displacement 
of the double reciprocal (Lineweaver-Burk) plots of the deiodination rate as a 
function of the substrate concentration (105,106).In presence of OTT, oxidized 
glutathione inhibits 5'-deiodination of rT3 uncompetitively with respect to 
substrate and competitively with respect to OTT (D. Fekkes and E.v.Overmeeren, 
unpublished observations). Based on the kinetics of stimulation by thiols and 
inhibition by 2-thiouracil, a ping-pong mechanism has been implied. According 
to the proposed model, the reductive deiodination of iodothyronines is envisaged 
as a transfer of an iodinium ion from the substrate to a sulphhydryl group of 
the enzyme leading to the formation of an enzyme-sulphenyl iodide (E-SI) com-
plex. The E-SI intermediate is subsequently reduced by thiol compounds (cofac-
tor) to free enzyme. Both phenolic and tyrosyl ring deiodination may occur via 
_such a mechanism. The reaction pathway may, therefore, be visualized as consist-
ing of two half-reactions: 
Tin (substrate) + E-SH (enzyme) 7 Tin_1 (product) + E-SI (intermediate) 
E-SI + 2 R-SH (cofactor) 7 E-SH + R-S-S-R + HI. 
The deiodinase is inhibited by derivatives of 2-thiouracil (X-SH) as these com-
pounds react with the ESI intermediate forming an enzyme-thiouracil mixed disul-
phide: 
E-SI + X-SH + E-S-S-X + HI 
A prediction of this model is that 2-thiouracil would only react with the de-
iodinase in the presence of substrate. This is true since binding of radioactive 
6-propyl-2-thiouracil to rat liver microsomes is specifically induced by iodo-
thyronines (126,127). Moreover, persistent and reversible inactivation of the 
enzyme by thiouracils requires the presence of substrate (105,118,127,128). 
2.8. Solubilization, characterization ond partial purification of iodothyronine 
deiodinases 
Enzymatic activity catalyzing the reductive 5'-deiodination of T4 and rT3 
has been solubilized from rat liver and kidney microsomes by treatment with 1% 
sodium cholate (119,129), 0.25% of the polyoxyethylene ether W-1 (119) or 0.1-
0.33% sodium deoxycholate (103,127,130,131). The structures of two of these 
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detergents are shown in figure 2.1 .. The 5-deiodinating activity has also been 
solubilized with these detergents from rat (119) as well as from beef liver 
microsomes (131). A review of published data concerning solubilization of iodo-
thyronine deiodinase activity is given in Table 2.3. In all studies, the con-
centration of detergent necessary for effective solubilization inhibits deiodin-
ase activity. Removal of detergent from the solubilized fraction results in 
restoration of activity and formation of enzymatically active aggregates (119, 
127 ,130,131). 
n = 10 (Brij 56) 
n = 20 (Brij 58) 
HO H OH 
0- [cH -CH -o] H 2 2 n 
W-1 ETHER 
(a 1-1.78 mixture of 
Brij 56 and Brij 58) 
COO-Na + 
SODIUM CHOLATE 
Fig. 2.1. Structures of W-1 ether and sodium cholate. 
Low concentration of deoxycholate such as 0.05%, which is too low for 
solubilization of phospholipid of biological membranes but sufficient to in-
duce reversible formation of membrane pores or openings in liver microsomes, 
releases protein from the lumen of microsomal vesicles (132). When 0.05% deoxy-
cholate is applied to microsomes, no solubilization of iodothyronine deiodinase 
activity is observed (110,131). Treatment of microsomes with the chelating 
agent EDTA, 150 mM Tris buffer pH 8.0 or various salt (KCl) concentrations also 
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Table 2.3. IODOTHYRONINE DEIODINASE ACTIVITY AFTER SOLUBILIZATION OF r~ICROS0~1ES 
origin of activity detergent recovery reference 
mi crosomes investigated (%) 
rat liver T4-+ T3 1% cholate 70 Kohrle et al, 1978 (129) 
rat liver T4-+ T3 0 .1255~ DOC 41 Takaishi et al, 1979 (110) 
rat liver T4 -+ T3 + rT3, 1% cholate and 50-60 Fekkes et al, 1980 (119) 
rT3-+ 3,3'-T2 0.25% W-1 ether 
rat kidney T4 -+ T3 0.2% DOC 60-70 Leonard and Rosenberg, 
1980 (127) 
rat 1 iver T4-+ T3 0.1% DOC 30 Imai et al, 1980 (103) 
beef liver T4 -+ T3 + rT3 0.33% DOC 78 Kohrle et al, 1980 (131) 
rat kidney T4 -+ T3' 0.2% DOC 55-75 Leonard and Rosenberg, 
rT3 ->-3,3'-T2 1981, (130) 
DOC =deoxycholate 
does not solubilize any deiodinase activity (119,131). These findings strongly 
suggest that the enzyme is neither enclosed in the luminal cavity nor adsorbed 
to the outer side of the microsomal vesicles. It is therefore concluded that 
the iodothyronine deiodinating enzyme in both rat and beef liver microsomes is 
an integral (intrinsic) membrane protein. The same conclusion has been drawn 
for the renal enzyme (131).Deiodinases are accessible to the attack of proteo-
lytic enzymes without making microsomal vesicles permeable by 0.05% deoxycholate 
(119,131).This is a further indication that the enzyme is a cytosolic orientated, 
membrane integrated protein of the endoplasmic reticulum. 
Leonard and Rosenberg (131) showed an absolute requirement of the renal 
iodothyronine 5'-deiodinase for lipid. On the other hand, these investigators 
found that added phospholipid decreases deiodinating activity.This is in accord-
ance with our· findings on the 1 iver enzyme (see Chapter 6). Therefore, phos-
pholipids may activate the (delipidated) deiodinase via lipid reconstitution 
as well as lead to an apparent inhibition of the enzyme via sequestration of 
the substrate. Iodothyronine 5- and 5'-deiodinase activity, solubilized with 
cholate or deoxycholate from both rat and beef liver, were found to have an 
apparent molecular weight of 60-70 000 (119,131). This is in reasonably good 
agreement with the value (49 900) obtained for the enzyme in rat kidney (131). 
However, the deiodinating activities solubilized with W-1 ether, which is a 
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mixture of the nonionic detergents Brij 56 and 58 (see Fig. 2.1), were shown 
to have an apparent molecular weight of about 200 000 (119). Apparently, the 
calculated molecular weight depends on the type of detergent used for solubili-
zation. The sedimentation coefficient for iodothyronine 5'-deiodinase activity 
of rat liver is 4.3 S (119) and for the renal enzyme 3.5 S (130). The Stokes' 
radii for the liver and kidney enzyme are also similar, viz. 35-37 ~ (119) and 
32 ~ (130), respectively. Isoelectric focusing of the W-1 ether extract gives 
a major activity peak around pH 6.4 and a minor peak at pH 5.2 (see Chapter 6 
and Fig. 2.2.). 
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Fig. 2.2. Isoelectric focusing of the W-1 ether extract. 
Ion exchange chromatography of solubilized liver deiodinase activity yields 
several activity peaks without remarkable increase in specific activity (119, 
131). Affinity chromatography with T4-substituted matrices also proofs useless 
in the purification of enzyme activity (131, Chapter 6).Several other chromato-
graphy media have been tested, but none of these affords a substantial purific-
ation (Chapter 6).The deiodinase activity in the cholate extract is precipitated 
completely with 35% ammonium sulphate. Solubilization of the precipitate with 
W-1 ether yields a preparation (ammonium sulphate extract) with a ten times 
higher specific enzyme activity compared to the cholate extract. It was found 
that ammonium sulphate treatment nearly completely removes phospholipids from 
the deiodinase. This in turn results in increased apparent Km and Vmax values 
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for the enzyme. Moreover, the isoelectric point of iodothyronine deiodinase is 
shifted to a much higher value (pH 9.3) after this treatment (see Chapter 6 and 
compare Fig. 2.3. with Fig. 2.2.). The enzymes catalyzing the 5- and 5'-deiodin-
ation of the iodothyronines could not be resolved by sedimentation, column chro-
matography or isoelectric focusing and showed similar behaviour toward solubil-
ization. Furthermore, the several purification steps employed may have caused 
partial inactivation of the deiodinase activity, which could be a reason for the 
very slight increase in the specific enzyme activities obtained (119,130,131, 
Chapter 6). 
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Fig. 2.3. Isoelectric focusing of the ammonium sulphate extract. 
Colquhoun et al (133) reported on the partial purification of a soluble 
"T4 5'-deiodinase" from rat kidney. These investigators used standard protein 
fractionation techniques combined with affinity chromatography using T4 as the 
bound ligand, yielding a large, cold labile and soluble aggregate with a molec-
ular weight of approximately 1-4 x 106. However, no evidence was presented 
that this preparation catalyzed T3 formation, and I production via a non-enzym-
atic, degradative pathway seems more likely. 
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2.9. Concluding remarks 
Our findings with rat liver microsomes and partially purified enzyme pre-
parations lead to the conclusion that both 5- and 5'-deiodinations of iodothyro-
nines are catalyzed by a single enzyme. Recently,the same conclusion was reached 
by another group of investigators (134). However, these findings have to be in-
terpreted with caution, because both studies ~Jere performed with rat 1 i ver pre-
parations. In rat brain (69,135) and pituitary (79,80) as well as in human (89) 
and rat placenta (136), really specific 5- and 5'-deiodinase activities have 
been shown. These latter findings suggest the existence of deiodinating enzymes 
in other tissues with properties being different from the deiodinase of rat liver .. 
Therefore, our results obtained with rat liver fractions leading to the con-
clusion that a single enzyme is responsible for the 5- as well as the 5'-deiodin-
ation of various iodothyronines, may not simply be extrapolated to the situation 
existing in other tissues or species. 
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CHAPTER 3 
Sequential Deiodination of Thyroxine in Rat Liver Homogenate 
By THEO J. VISSER, DURK FEKKES, ROEL DOCTER and GEORG HENNEMANN 
Department of Internal Medicine III and Clinical Endocrinology, Medical Faculty, 
Erasmus University, Rotterdam, The Netherlands 
(Received 26 October 1977) 
Rat liver homogenate was incubated at 37oC with thyroxine, 3,3',5-tri-iodothyronine, 
3,3',5'-tri-iodothyronine or 3,3'-di-iodothyro:J.ine. The degradation or accumulation of 
these compounds was measured by specific radioimmunoassays. (I) Production of 
3,3',5-tri-iodothyronine from thyroxine was highest at pH6.0-6.5 and was markedly 
stimulated by the addition of dithiothreitol and effectively inhibited in the presence of 
6-propyl-2-thiouracil. (2) Accumulation of 3,3',5'-tri-iodothyronine on incubation of 
thyroxine with homogenate was only observed above pH8.5. Otherwise the product 
was converted into 3,3'-di-iodothyronine too rapidly to allow its measurement. By 
measuring 3,3'-di-iodothyronine it was deduced that 5-deiodination of thyroxine was 
most effective at approx. pH 8.0. Dithiothreitol powerfully stimulated this reaction and 
6-propyl-2-thiouracil strongly inhibited. (3) Monodeiodination of the tyrosine ring of 
3,3',5-tri-iodothyronine was the slowest reaction, was optimal at pH8.0 and was less 
affected by dithiothreitol and 6-propyl-2-thiouracil than the above reactions. (4) 5'-
Deiodination of 3,3',5'-tri-iodothyronine was extremely rapid, with a pH optimum 
probably at about 6.5. Owing to the high reaction rate under the conditions used it was 
not possible to assess the effects of dithiothreitol and 6-propyl-2-thiouracil. 
In recent years several findings have aroused 
new interest in the metabolism of thyroid hormones, 
especially the deiodinative pathways. It has become 
evident that under normal conditions the products of 
the thyroid, 3,3',5,5'-tetraiodothyronine (thyroxine) 
and 3,3',5-tri-iodothyronine (tri-iodothyronine), are 
secreted in a ratio that far exceeds the ratio of their 
turnover rates (Abrams & Larsen, 1973; Chopra & 
Solomon, 1973). This means that most of the 
circulating tri-iodothyronine is of extrathyroidal 
origin, which is in line with previous observations 
on plasma tri-iodothyronine concentrations in 
athyreotic subjects treated with thyroxine (Braver-
man et a!., 1970). Extrapolating from studies on 
thyroxine-supplemented individuals, Surks et a!. 
(1973) calculated that in healthy humans with a 
sufficient iodine intake over 80% of the tri-iodo-
thyronine turnover is derived from peripheral mono-
deiodination of thyroxine. 
The rediscovery of3,3 ',5' -tri-iodothyronine (reverse 
tri-iodothyronine) by Chopra (1974) has also contri-
buted considerably to our understanding of the 
mechanism of regulation of thyroid-hormone activity 
by the peripheral tissues. It is now generally con-
sidered that the metabolism of thyroxine, at least in 
man, proceeds primarily by means of deiodination 
(for a review see Cavalieri & Rapoport, 1977). 
Monodeiodination yields either the principal active 
form of thyroid hormone, tri-iodothyronine (by 
deiodination of the phenolic ring), or the inactive 
metabolite, reverse tri-iodothyronine (by elimination 
of an iodine atom from the tyrosine ring). Both 
products are probably subject to further degradation 
into lower substituted iodothyronines (Wu et a!., 
1976; Rudolph eta!., 1977). It has been shown that 
plasma tri-iodothyronine and reverse tri-iodo-
thyronine vary in a reciprocal fashion in several 
clinical situations: in starvation (Vagenakis et a!., 
1975), systemic illness (Burger et al., 1976), after 
surgical operation (Burr et a!., 1975) or on adminis-
tration of the glucocorticosteroid analogue dexa-
methasone (Chopra eta!., 1975), of the fl-adrenergic 
blocking agent propranolol (Verhoeven et al., 
1977) or of the goitrogenic compound 6-propyl-2-
thiouracil (Westgren et al., 1977). The time course of 
the changes during prolonged caloric restriction in 
the diet seems to indicate that monodeiodination of 
thyroxine involves separate processes (Visser et al., 
1978). 
The development of specific radioimmunoassays 
for the measurement of iodothyronines provides us 
with valuable tools to conduct studies in vitro of 
the monodeiodinative pathways. We previously 
reported on the enzymic production of tri-iodo-
thyronine from thyroxine in rat liver homogenate 
(Visser et al., 1975a) and in the microsomal fraction 
(Visser et al., 1976). We now demonstrate that 
conversion of thyroxine into reverse tri-iodothyronine 
also occurs in this system. This reaction, however, 
cannot be observed directly, owing to the very efficient 
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breakdown of reverse tri-iodothyronine into 3,3'-di-
iodothyronine (di-iodothyronine). Similar findings 
have been reported by Hiifner & Grussendorf (1977). 
Consequently, monodeiodination of thyroxine to 
reverse tri-iodothyronine was determined by measur-
ing the production of di-iodothyronine, since in this 
sequence the first reaction is the rate-limiting step 
and the contribution of the pathway via tri-iodo-
thyronine was found to be negligible. 
Experimental 
Materials 
L-Thyroxine, 3,3',5-tri-iodo-L-thyronine and di-
thiothreitol were purchased from Sigma Chemical 
Co., St. Louis, MO, U.S.A. 3,3',5'-Tri-iodo-L-
thyronine and 3,3'-di-iodo-L-thyronine were ob-
tained by courtesy of Dr. E. Scheiffele, Henning 
G.m.b.H., Berlin, Germany, and 3-iodo-L-thyronine 
was kindly provided by Dr. P. Block, Jr., University 
ofToledo, Toledo, OH, U.S.A. [3',5'-125l]Thyroxine 
(specific radioactivity over 200pCijpg), tri-[3'-1251]-
iodothyronine (specific radioactivity over 1200pCi/ 
pg) and Na125l (approx. 14mCijpg) were from The 
Radiochemical Centre, Amersham, Bucks., U.K. 
Reverse tri-[3',5'-125I]iodothyronine (approx. 
2700pCijpg) was prepared as previously described 
(Visser et a!., 1977) and di-[3' -125l]iodothyronine 
(approx. 3300pCijpg) was prepared similarly starting 
from 3-iodothyronine. Goat anti-(rabbit y-globulin) 
serum was from Antibodies Inc., Davis, CA, U.S.A. 
Preparation of liver homogenate and conversion studies 
The postnuclear supernatant of rat (Wistar) liver 
homogenate was prepared in 0.25M-sucrose in 
5mM-Tris/HCI, pH7.4, as previously described 
(Visser et a!., 1975a). Protein was measured by the 
method of Lowry et a!. (1951), with bovine serum 
albumin as a standard. The iodothyronines were 
dissolved in O.lM-NaOH and diluted in 0.25M-
sucrose in 0.025 M-Tris/HCI, pH7.4, and added in 
200pl quantities for incubation with 1800pl of 
homogenate. In the experiments dealing with possible 
effects of dithiothreitol, EDT A and 6-propyl-2-thio-
uracil (propylthiouracil), 200pl samples of homo-
genate were added to mixtures of I 00 pi of iodo-
thyronine solution and 700pl of 0.25M-sucrose in 
0.025M-Tris/HCI, pH7.4, containing 2.8mM-dithio-
threitol, 2.8mM-EDTA or O.lmM-propylthiouracil. 
In the experiments in which the dependence of the 
several reactions on pH was studied, lOOp! samples 
of homogenate were added to mixtures composed of 
lOOp! of the iodothyronine solution and 800pl of 
0.15M-sodium acetate, 0.15M-sodium phosphate or 
0.15M-sodium borate buffer, containing 4mM-
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dithiothreitol, with a pH range of 4.0-10.0. Control 
experiments were conducted in which homogenate 
was replaced by 0.25M-sucrose in 5mM-Tris/HCl, 
pH7.4. This yielded values for recovery and spon-
taneous deiodination. All experiments were carried 
out in duplicate at 37°C. After various time intervals, 
250 pi portions of the reaction mixture were added 
to 750pl of 95% (v/v) ethanol kept at ooc. The 
precipitates were spun down (1500g, lOmin) and the 
iodothyronine concentrations were measured in 
duplicate directly in 100 pi portions of the super-
natant. 
Measurement of thyroxine, tri-iodothyronine, reverse 
tri-iodothyronine and di-iodothyronine 
The iodothyronines were determined by specific 
radioimmunoassays. Thyroxine (Visser eta!., 1975b), 
tri-iodothyronine (Visser et a!., 1975a) and reverse 
tri-iodothyronine (Visser eta!., 1977) were measured 
as previously reported. Di-iodothyronine was as-
sayed by the method ofT. J. Visser, L. M. Krieger-
Quist, R. Docter & G. Hennemann (unpublisped 
work) as briefly described in the following. 
Di-[125l]iodothyronine (about 12000c.p.m.) was 
made to react with appropriately diluted (1 :200000) 
antiserum in the absence or presence of unlabelled 
di-iodothyronine or other materials to be tested 
(final volume 1 ml). All reagents were dissolved in 
0.06M-sodium barbitone I 0.15M-NaCI containing 
bovine serum albumin, pH8.6. After incubation for 
2-4 days at 8°C antibody-bound di-[125l]iodothyron-
ine was precipitated by addition of goat anti-(rabbit 
immunoglobulin G) antiserum. The lower limit of 
detection is I pg of di-iodothyronine per assay tube. 
The relative affinity of thyroxine for the antiserum 
is less than 0.004 (di-iodothyronine = 100), that of 
tri-iodothyronine 0.6 and that of reverse tri-iodo-
thyronine 0.06. 
The composition of the assay mixtures is shown 
in Table 1. 
Results 
Fig. I shows the accumulation of the various 
iodothyronines when rat liver homogenate was 
incubated with 0.15pM-thyroxine, 0.14pM-tri-iodo-
thyronine or 0.013 pM-reverse tri-iodothyronine. 
Production of tri-iodothyronine and di-iodothyronine 
from thyroxine increased with time. Di-iodothyron-
ine production from tri-iodothyronine appeared to 
slow down after 20min. In contrast, formation of 
reverse tri-iodothyronine from thyroxine was not 
measurable, owing to the very high conversion rate 
of reverse tri-iodothyronine into di-iodothyronine. 
Within 3 min of incubation all reverse tri-iodothyron-
ine added was converted into di-iodothyronine. 
SEQUENTIAL DEIODINATION OF THYROXINE 
Table 1. Composition of radioimmunoassay mixtures 
Standards were made in 0.06M-sodium barbitone/ 
0.15M-NaCI, pH8.6, containing I% bovine serum 
albumin (buffer A). Antiserum was dissolved in 
the same buffer containing 0.1% bovine serum 
albumin (buffer B) and 2.5% normal rabbit serum. 
Extracts of reaction mixtures were made as described 
in the Experimental section. Extracts of homogenate 
for incorporation in the standard curve were 
prepared similarly. 
Standard 
Extract of reaction mixture 
Extract of homogenate 
Buffer A 
[ 1' 5I]Iodothyronine in buffer A 
Antiserum 
Buffer B 
200 
Volume for 
standard 
curve (Jll) 
100 
100 
100 
100 
600 
Volume for 
samples 
(J1]) 
100 
100 
100 
100 
600 
15 ~ 
0 
s 
.8 
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~ 
" .s
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Fig. 1. Deiodination of several iodothyronines in rat liver 
homogenate at pH 7.4 as function of time of incubation 
Accumulation of tri-iodothyronine ( o ), reverse tri-
iodothyronine (e) and di-iodothyronine (II) frorr. 
1.15J1M-thyroxine, of di-iodothyronine from 
0.14J1M-tri-iodothyronine (.t.) and of di-iodothyronine 
from 0.013 JiM-reverse tri-iodothyronine (D) was 
studied. The reaction mixtures contained, in addition 
to the iodothyronines, 2.7mM-dithiothreitol and 
26.8 mg of protein/mi. 
The stability of the iodothyronines in rat liver 
homogenate is shown in Fig. 2. Thyroxine and tri-
iodothyronine were stable under the conditions used. 
Di-iodothyronine was degraded more rapidly; 
during 60min of incubation its concentration de-
creased by over 50%. Reverse tri-iodothyronine was 
broken down very effectively in the homogenate; 
00 
" ·;: 100 
·o;; 
s I ~ 80 I 
" I 
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0 60 ~ ;;, I 
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Fig. 2. Fate of the several iodothyronines during 
incubation with rat liver homogenate at pH7.4 
Rat liver homogenate was incubated with 1.15J1M-
thyroxine(o ), 0.14J1M-tri-iodothyronine (e), 0.013 JiM-
reverse tri-iodothyronine (.t.) and 0.01 JlM-di-iodo-
thyronine (11). After several time intervals the con-
centration of iodothyronine remaining was deter-
mined and expressed in terms of the concentration 
added. For incubation conditions see the legend to 
Fig. 1. 
after 3min all added reverse tri-iodothyronine had 
disappeared. Fig. 1 shows that this rapid dis-
appearance reflects conversion into di-iodothyronine. 
Experiments were conducted in which the effect of 
the addition of dithiothreitol, EDTA and propyl-
thiouracil was studied (Table 2). The presence of 
2.8mM-dithiothreitol resulted in approx. 8-fold 
enhancement of the deiodination of thyroxine into 
tri-iodothyronine and into di-iodothyronine after 
incubation for 60min. The enhancement of the 
conversion of tri-iodothyronine into di-iodothyronine 
and the degradation of added di-iodothyronine was 
approx. 2-fold. The effect of dithiothreitol was 
more pronounced after 60min than after 5min. 
Addition of EDTA further enhanced the conversion 
rates during incubation for 60min. Again, tri-
iodothyronine was stable; even in the presence of 
dithiothreitol and EDTA, loss of tri-iodothyronine 
was less than 20%, as with thyroxine (results 
not shown). Reverse tri-iodothyronine was again 
broken down extremely rapidly. Even in the control 
experiment (without any addition) only 9% of added 
reverse tri-iodothyronine was left after incubation 
for 5min. 
Propylthiouracil inhibited the conversion of 
thyroxine into tri-iodothyronine and di-iodothyron-
ine markedly (80-90% inhibition). However, the 
inhibition of the conversion of tri-iodothyronine 
into di-iodothyronine was only approx. 10%. 
Propylthiouracil seemed to enhance the production 
of di-iodothyronine from reverse tri-iodothyronine. 
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Table 2. Effect of addition of dithiothreitol, EDTA and propylthiouracil on the deiodination of the several iodothyronines in rat liver homogenate at pH7.4 
Incubations were performed as outlined in the Experimental section. Liver protein concentration was 5.8 mg/ml. 
Additions 
0.4pM-Thyroxine (control) 
Control+ 2.8 mM-dithiothreitol 
Control+ 2.8 mM-dithiothreitol + 2.8 mM-EDTA 
Incubation time (min) ... 
Control+ 2.8 mM-dithiothreitol + 2.8 mM-EDTA +0.1 ruM-propylthiouracil 
0.1 /1M-Tri-iodothyronine (control) 
Control+ 2.8 mM-dithiothreitol 
Control+ 2.8 mM-dithiothreitol+ 2.8 mM-EDTA 
Control+ 2.8 mM-dithiothreitol+ 2.8 mM-EDTA +0.1 mM-propylthiouracil 
0.01 /1M-Reverse tri-iodothyronine (control) 
Control+ 2.8 mM-dithiothreitol 
Control+ 2.8 mM-dithiothreitol+ 2.8 mM-EDTA 
Control+ 2.8 mM-dithiothreitol+ 2.8mM-EDTA +0.1 mM-propylthiouracil 
0.01 pM-Di-iodothyronine (control) 
Control+ 2.8 mM-dithiothreitol 
Control+ 2.8 mM-dithiothreitol + 2.8 mM-EDT A 
Control+ 2.8 mM-dithiothreitol + 2.8 mM-EDTA +0.1 mM-propylthiouracil 
Tri-iodothyronine 
5 60 
3.3 6.4 
6.3 57.8 
5.4 80.2 
4.3 9.2 
100.0 99.9 
100.0 89.6 
100.0 84.4 
100.0 87.1 
Iodothyronine measured (nM) 
Reverse tri-iodothyronine 
5 
0.0 
0.0 
0.0 
0.0 
0.9 
0.0 
0.0 
0.0 
60 
0.0 
0.0 
0.0 
0.0 
0.1 
0.0 
0.0 
0.0 
Di-iodothyronine 
5 60 
1.1 2.0 
2.0 14.3 
2.1 19.1 
1.8 3.8 
0.1 0.8 
0.1 1.6 
0.3 1.9 
0.3 1.7 
11.1 10.1 
10.7 4.7 
8.7 3.4 
10.1 7.9 
8.6 6.2 
9.0 3.0 
9.4 4.1 
9.5 5.1 
!""1 
~ 
~ 
(/) 
~ 
~ 
0 
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SEQUENTIAL DEIODINATION OF THYROXINE 
This is probably due to the inhibitory effect of 
propylthiouracil on the degradation of di-iodo-
thyronine, as shown in Table 2. All effects of propyl-
thiouracil were, as with dithiothreitol, more pro-
nounced during prolonged incubation. 
Table 3. Effect of addition of propylthiouracil on the 
deiodination of the various iodothyronines in rat liver 
homogenate at pH 7.4 in the absence and presence of 
dithiothreitol 
For details see legend to Table 2. Incubation time 
was 60 min; liver protein concentration was 6.4mg/ml. 
Concn. of dithio-
Reactions threitol (mM) ... 
Thyroxine -+tri-iodothyronine 
Thyroxine-+ di-iodothyronine 
Tri-iodothyronine-+ di-
iodothyronine 
Reverse tri-iodothyronine -+ 
di-iodothyronine 
Di-iodothyronine -+ ?t 
Inhibition by 
propylthiouracil C:>~) 
0 
60-80 
60-70 
Not 
detectable 
20-40* 
20-30 
2.8 
90 
90 
25 
Not 
detectable 
35 
* Representing an approximate value, since initial 
reaction rates were not measured. 
t The product of this reaction has not been identified. 
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Fig. 3. Dependence of the deiodination of thyroxine and 
tri-iodothyronine in rat liver homogenate on pH 
The incubation mixture contained 3.2mM-dithio-
threitol and 3.6mg of protein/mi. Incubation time 
was 60min. Accumulation of tri-iodothyronine 
( o ), di-iodothyronine ( o) and reverse tri-iodo-
thyronine (.6.) from 1.0 ,uM-thyroxine and of di-
iodothyronine (6) from O.l,uM-tri-iodothyronine was 
studied. The buffers used were acetate (pH 4-6 ), 
phosphate (6-8) and borate (8-10). For details see 
the Experimental section. 
Next, the effects of propylthiouracil on the 
various reactions were studied in the absence as well 
as in the presence of dithiothreitol (Table 3). Owing 
to the slow conversion rate of tri-iodothyronine into 
di-iodothyronine in the absence of dithiothreitol, the 
inhibition by propylthiouracil of this reaction was 
not detectable under these conditions. Since for the 
generation of di-iodothyronine from reverse tri-
iodothyronine initial reaction rates were too high for 
determination, the influence of the addition of propyl-
thiouracil could not properly be measured. Addition 
of dithiothreitol did not alter the inhibitory effect of 
propylthiouracil. In all instances the reaction rates 
in the presence of both dithiothreitol and propyl-
thiouracil were higher than without any addition. 
Fig. 3 shows the pH profile of the various de-
iodination reactions in rat liver homogenate. The 
conversion of thyroxine into tri-iodothyronine was 
optimal at pH6.0-6.5, which has also been found by 
other investigators (Hiifner eta!., 1977; Hiiffken eta!., 
I 977). Production of di-iodothyronine from thyroxine 
or from tri-iodothyronine was optimal at pH8.0. 
In all circumstances less than 20% of added 
thyroxine and tri-iodothyronine was degraded after 
incubation for 60min (results not shown). 
Since the pH -dependence of the conversion of 
reverse tri-iodothyronine into di-iodothyronine and 
10 
3 
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Fig. 4. Dependence of the deivdination of reverse tri-iodo-
thyronine and of the degradation of di-iodothyronine in dilute 
rat liver homogenate on pH 
Incubation mixtures contained 0.015,uM-reverse tri-
iodothyronine or 0.013 ,uM-di-iodothyronine and 
0.025 mg of homogenate protein/mi. The concen-
tration of dithiothreitol was 3.2JIM. After incubation 
for 10 min the production of di-iodothyronine C.) 
and the percentage of added reverse tri-iodothyronine 
( 0) or di-iodothyronine (e) remaining were deter-
mined. The buffers used were acetate (pH4.5-5.5), 
phosphate (5.5-7.5) and borate (7.5-9.5). For details 
see the Experimental section. 
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of the degradation of reverse tri-iodothyronine 
was difficult to interpret, these reactions and the 
breakdown of di-iodothyronine were investigated 
by using dilute homogenate (Fig. 4). Both reverse 
tri-iodothyronine and di-iodothyronine were most 
rapidly degraded at pH6.5. The pH optimum of 
the conversion of reverse tri-iodothyronine into 
di-iodothyronine could not easily be determined, 
because of the lability of the latter around pH 6.5. 
It was also noted that the extent of degradation of 
di-iodothyronine was not linearly dependent on the 
concentration of the homogenate in the reaction 
mixture (results not shown). This is probably the 
result of two counteracting processes; dilution of 
homogenate decreases not only the concentration 
of enzyme but also that of binding sites in the 
medium (Visser et a!., 1975a). Dilution of the 
homogenate therefore increases the availability of the 
substrate for interaction with the enzyme, the 
concentration of which has decreased concomitantly. 
Discussion 
The reactions in Scheme I were studied: reactions I 
and IV represent deiodination of the phenolic (or 
T. J. VISSER AND OTHERS 
outer) ring, whereas in reactions II and III an iodine 
atom is removed from the tyrosine (or inner) ring. 
Under the conditions used reaction II could not 
be investigated directly, owing to the extreme labi-
lity of the product (reverse tri-iodothyronine). The 
rapid disappearance of the latter was virtually 
completely accounted for by reaction IV, since 
addition of reverse tri-iodothyronine to the homo-
genate resulted in a quantitative yield of di-iodo-
thyronine. However, in the cascade thyroxine~ 
reverse tri-iodothyronine ~ di-iodothyronine, at 
least at pH7.4, reaction II is apparently the rate-
limiting step, and conversion of thyroxine into 
reverse tri-iodothyronine can be estimated by 
measuring the production of di-iodothyronine. By 
comparison the production of di-iodothyronine via 
the pathway thyroxine~ tri-iodothyronine~ di-
iodothyronine is negligible under all conditions 
tested. 
Reaction IV is slowed down by increasing the pH to 
9.0, thereby permitting the accumulation of reverse 
tri-iodothyronine (Fig. 3). Thus, since reaction IV 
is much faster than reaction II, except above pH9.0, 
the pH optimum of the production of di-iodothyron-
Thyroxine 
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I I I I 
Tri-iodothyronine Reverse tri-iodothyronine 
n\ /v 
R-<Q(-0-@rOH 
I I 
Di-iodothyronine 
Scheme I. Sequential deiodination of thyroxine as observed in rat liver homogenate R = CH,-CH(NH2)-C02H 
SEQUENTIAL DEIODINATION OF THYROXINE 
ine actually reflects optimal conditions for the 
conversion of thyroxine into reverse tri-iodothyron-
ine. This can also be deduced from the accumulation 
of the· latter as a function of pH and the stability of 
this compound under these conditions (results not 
shown). 
The pH optimum for reaction IV is probably 
about 6.5. This is indicated by the rate of accumu-
lation of di-iodothyronine, taking into account the 
data on the stability of di-iodothyronine in the 
homogenate, which is least at pH6.5 (Fig. 4). This is 
further substantiated by the finding that reverse 
tri-iodothyronine is most rapidly degraded in the 
homogenate at pH6.5 (Fig. 4) and, since this 
compound is quantitatively converted into di-iodo-
thyronine, this must point to a maximal rate of 
reaction IV at approx. pH6.5. Thus it can be 
concluded that conditions for deiodination of the 
phenolic ring (reactions I and IV) are optimal at 
pH6.0-6.5 and for deiodination of the tyrosine ring 
(reactions II and III) at pH8.0. These findings are 
hard to interpret, since in the homogenate optimal 
conditions for the reactions will depend not only 
on the nature of the enzymic reaction but also on the 
availability of the substrates, since pH may be of 
importance in the binding of iodothyronines to cyto-
plasmic proteins (Hoffken et al., 1977). Nevertheless, 
conversion ofthyroxine into tri-iodothyronine by rat 
liver microsomal fraction was also found to be 
maximal at pH 6.0 (Hoffken et al., 1977; T. J. Visser, 
unpublished work). 
In line with our previous observations on the 
conversion of thyroxine into tri-iodothyronine by 
the microsomal fraction of rat liver homogenate 
(Visser et al., 1976), the monodeiodination reactions 
studied are stimulated by the addition of dithio-
threitoL This raises the question whether the 
enhanced reaction rates observed in the presence 
of thiol-group-containing compounds is due to their 
protection of cysteine residues of the enzymes or 
because these compounds act as cofactors or a com-
bination of both effects. As discussed by Visser et al. 
(1976), if the sequential deiodination is accompanied 
by the formation on-, reactions I-IV can be regarded 
as reductions. In that case the reducing equivalents 
may be supplied by thiol-containing-compounds 
(RSH), such as dithiothreitol. The overall reaction 
may then be described by eqns. (I) and (2): 
Thyroxine+ 2RSH -.. tri-iodothyronine 
or reverse tri-iodothyronine+ HI+ RSSR (1) 
Tri-iodothyronine or reverse tri-iodothyronine+ 
2RSH _.. di-iodothyronine+HI+RSSR (2) 
In this respect it is noteworthy that glutathione is 
almost as effective as dithiothreitol in supporting 
the conversion of thyroxine into tri-iodothyronine 
by rat liver microsomal fraction (T. J. Visser, 
unpublished work). It may therefore be postulated 
that glutathione is the endogenous cofactor of the 
monodeiodination reactions. 
All reactions are stimulated in the presence of 
EDT A, which has also been shown to enhance the 
production of tri-iodothyronine in the microsomal 
fraction (Visser et al., 1976). 
Administration of propylthiouracil to humans has 
been shown to result in increased reverse tri-iodo-
thyronine and decreased tri-iodothyronine concen-
trations in plasma (Westgren et al., 1977). This is in 
accordance with previous findings that administration 
of propylthiouracil to rats (Oppenheimer et al., 
1972), as well as to humans (Saberi et al., 1975; 
Geffner et al., 1975), blocks the extrathyroidal 
production of tri-iodothyronine. Our data indicate 
that propylthiouracil decreases markedly the pro-
duction from thyroxine of both tri-iodothyronine 
and reverse tri-iodothyronine (as indicated for the 
latter by the fall in the generation of di-iodo-
thyronine). 
Reaction III was much less affected by propyl-
thiouracil, and its effect on reaction IV is impossible 
to assess, since initial reaction rates were not observed 
under the conditions used. Addition of propyl-
thiouracil affected the reactions to a similar extent 
in both the absence and presence of dithiothreitoL 
This finding excludes the possibility that propyl-
thiouracil interferes with the interaction of the 
cofactor with the enzyme or enzyme-substrate 
complex. It is, however, to be noted that the reaction 
that is least stimulated by dithiothreitol, i.e. 
production of di-iodothyronine from tri-iodothyron-
ine, is also least inhibited by propylthiouraciL 
Data bearing on the mechanism of deiodination 
of the several iodothyronines are scarce. 
Deiodination of iodotyrosines appears to involve 
an NADPH-dependent enzymic reaction (Rosenberg 
& Ahn, 1969). It has also been suggested that 
thyroxine is deiodinated by tyrosine hydroxylase 
(Dratman et al., 1976). On the contrary, Hiifner 
et al. (1977) showed that conversion of thyroxine into 
tri-iodothyronine by rat liver homogenate is not 
influenced by a-methyltyrosine, a specific inhibitor 
of tyrosine hydroxylase. 
For several reasons comparison of the data 
reported here with the mechanism of the enzymic and 
chemical dehalogenation of 5-bromo- and 5-iodo-
2'-deoxyuridylate (Wataya & Santi, 1975, 1977) is of 
interest. First, the structure of 5-iodo-2' -deoxy-
uridylate (1) resembles not only that of iodo-
thyronines, e.g. thyroxine (2), but also that of 
5-propyl-2-thiouracil (3), a strong inhibitor of the 
conversion of thyroxine into tri-iodothyronine 
(Visser et al., 1975a). Secondly, dehalogenation of 
5-bromo- and 5-iodo-2'-deoxyuridylate as catalysed 
by thymidylate synthetase requires thiol-group-
containing compounds, such as dithiothreitol 
(Wataya & Santi, 1975). In analogy with the 
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OH OH OH OH N:rl r,<r J-)CH,-CH,-CH, ''¢£ -:::?' I O~N I ~I ~ X-Enzyme 
~l R2 I H 
(1) (2) 
mechanism of that reaction, we suggest that for 
example in the 5'-deiodination of thyroxine the prim-
ary event is an attack of a nucleophile (X) of the 
enzyme, e.g. a thiol group, at the 2'- or the 
equivalent 6'-position of thyroxine (2) yielding the 
2',3'-dihydro derivative (4). The removal of the 
iodine atom may then take place via different routes, 
in each of which the thiol group of the cofactor is 
oxidized (Wataya & Santi, 1975). 
Two more observations appear to fit remarkably 
well with this model. 
(1) The pH optima of the conversion of thyroxine 
into tri-iodothyronine and of the production of di-
iodothyronine from reverse tri-iodothyronine were 
shown to be somewhat below the pK of the phenolic 
hydroxyl group, which is approx. 6.6 (Handwerger 
eta!., 1975). Dissociation of the phenol would render 
the primary attack of a nucleophile an unlikely event. 
(2) Deiodination of the phenolic ring is much more 
rapid when reverse tri-iodothyronine is the substrate 
than with thyroxine. This may indicate that 
substitution of both the 3- and 5-positions hinders 
the approach of the nucleophile to position 2'. It 
remains, however, to be investigated whether both 
reactions I and IV are catalysed by the same enzyme. 
The resemblance of 5-propyl-2-thiouracil to the 
substrates of the deiodination reactions suggests 
that this compound may act as a competitive inhibitor. 
The resemblance to 6-propyl-2-thiouracil is, however, 
less apparent. Nevertheless this compound is also an 
effective inhibitor of the several monodeiodination 
reactions in the homogenate. 
We have found that iodothyronines are not deio-
dinated by thymidylate synthetase of bacterial 
origin (amethopterin-resistant strain of Lacto-
bacillus casei) (T. J. Visser, unpublished work). We 
suggest, even so, that removal of iodine atoms 
from iodothyronines involves a mechanism that is 
similar to that described for the deiodination of 
5-iodo-2'-deoxyuridylate by thymidylate synthetase 
(Wataya & Santi, 1975) and is mediated by enzymes 
with similar specificities. This can only be tested 
when the reactions are investigated with purified 
enzyme preparations. Such studies will also reveal 
whether reactions I and IV and reactions II and III 
are catalysed by the same enzymes. 
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Summary 
The iodothyronine-deiodinating enzymes (iodothyronine-5- and 5'-deiodi-
nase) of rat liver were found to be located in the parenchymal cells. Differential 
centrifugation of rat liver homogenate revealed that the deiodinases resided 
mainly in the microsomal fraction. The subcellular distribution pattern of these 
enzymes correlated best with glucose-6-phosphatase, a marker enzyme of the 
endoplasmic reticulum. Plasma membranes, prepared by discontinuous sucrose 
gradient centrifugation, were found to contain very little deiodinating activity. 
Analysis of fractions obtained during the course of plasma membrane isolation 
showed that the deiodinases correlated positively with glucose-6-phosphatase 
(r ~ 0.98) and negatively with the plasma membrane marker 5'-nucleotidase 
(r ranging between --D.88 and --D.97). It is concluded that the iodothyronine-
deiodinating enzymes of rat liver are associated with the endoplasmic retic-
ulum. 
Introduction 
It is now generally accepted that peripheral monodeiodination of thyroxine 
is the major source of circulating 3,3',5-triiodothyronine and 3,3',5'-triiodo-
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thyronine in man [1]. In the rat this has been demonstrated only for 3,3 1 ,5-tri-
iodothyronine [2]. However, in vitro conversion of thyroxine into 3,3 1 5-tri-
iodothyronine and 3,3 1,5 1-triiodothyronine has been detected in several extra-
thyroidal tissues ui animals, especially in rat liver [ 3-7]. Several recent studies 
have demonstrated that monodeiodination of thyroxine into 3,3' ,5-triiodo-
thyronine is mainly located in the microsomal fraction of rat liver cells [3,8] 
and Cavalieri et al. [9] found production of 3,3 1 ,5 1-triiodothyronine from 
thyroxine in the cytoplasm of rat liver homogenate. Leonard and Rosenberg 
[10] suggested that the enzymatic activity mediating the formation of 
3,3 1 ,5-triiodothyronine from thyroxine in rat kidney is associated with the 
plasma membrane. Up to now no studies have been reported concerning the 
intracellular location of enzymes converting 3,3 1 ,5-triiodothyronine and 3,3 1 ,5 1 -
triiodothyronine into 3,3 1 -diiodothyronine, reactions known to occur in rat 
liver, too [ 7,11-14]. In this paper we present data on subcellular localization 
of iodothyronine-deiodinating enzymes (iodothyroinine-5- and 5' -deiodinase ). 
It was found that these enzymes are located mainly in the endoplasmic retic-
ulum of rat liver parenchymal cells. 
Materials and Methods 
Materials. L-thyroxine, L-3,3 1 5-triiodothyronine and dithiothreitol were from 
Sigma. L-3,3 1 ,5 1 -triiodothyronine and 3,3 1 -L-diiodothyronine were obtained by 
courtesy of Dr. E. Scheiffele, Henning GmbH, Berlin. 
Isolation of rat parenchymal and non-parenchymal liver cells. Parenchymal 
cells were isolated from rat liver essentially according to the method of Berry 
and Friend [15], using collagenase (0.05%) and Ca2 + (2 mM) in Hank's 
solution. The cells obtained, of which at least 90% excluded trypan blue, were 
not contaminated with non-parenchymal cells or cell fragments as judged by 
light microscopy. The non-parenchymal cells (mainly Kupffer cells) were 
isolated by the second isolation method of Van Berkel et al. [16]. These cells 
were not contaminated with parenchymal cells as judged by light microscopy. 
For conversion studies the freshly prepared liver cells were homogenized in 
Hank's solution using a Potter-Elvehjem homogenizer with a Teflon pestle. 
Preparation of rat liver homogenate and subcellular fractions. Male Wistarrats 
were used after a 24 h period of fasting. The liver was perfused in situ through 
the portal vein (omission of perfursion resulted in decreased enzyme activities), 
minced, washed and homogenized (Potter-Elvehjem) in 4 vols. of medium A, 
consisting of 250 mM sucrose, 3 mM dithiothreitol, 10 mM Tris, pH 7.4. The 
homogenate was filtered through a fine-mesh nylon sieve and partitioned into 
subcellular fractions essentially by the method of De Duve et al. [17]. All steps 
were carried out at 0-5° C. Four particulate fractions and a final supernatant 
were isolated from the homogenate by subsequent centrifugations for 10 min 
at 700 X gmax (nuclear fraction, N), 10 min at 4460 X gmax (mitochondrial frac-
tion, M), 10 min at 25 200 X gmax (lysosomal fraction, L) and 60 min at 
110 000 X gmax (microsomal fraction, P and supernatant, S). The N, M and L 
pellets were washed twice. All pellets were suspended in medium B, consisting 
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of 10 mM Tris, 3 mM dithiothreitol and 3 mM EDTA, pH 7.4. The purity of the 
fractions was evaluated by analysis of several marker enzymes. Acid phos-
phatase (EC 3.1.3.2), glucose-6-phosphatase (EC 3.1.3.9), glutamate dehydro-
genase (EC 1.4.1.2), 5'-nucleotidase (EC 3.1.3.5) and lactate dehydrogenase 
(EC 1.1.1.27) were assayed as described (Refs. 17, 17, 18, 19 and 20, respec-
tively) with minor modifications. DNA [21] and protein [22] were determined 
using calf thymus DNA and bovine serum albumin as standards, respectively. 
Membrane preparations. Liver cell plasma membranes were prepared from a 
nuclear fraction (the pellet obtained after centrifugation of rat liver homo-
genate for 10 min at 1500 X grnax) and from the microsomal fraction. The 
former membranes were isolated using the Neville procedure [23]. The last 
steps in this procedure (steps 13-15) were omitted, because these gave no 
further purification of the membranes. Hardening of the nuclear membrane was 
achieved by adding 0.5 mM CaC12 to the bicarbonate medium [24]. The mem-
branes from the microsomal fraction were isolated by the method of Touster et 
al. [25]. 
Conversion studies and measurement of thyroxine, 3,3',5-triiodothyronine, 
3,3',5'-triiodothyronine and 3,3'-diiodothyronine. To a mixture of 0.8 ml of 
0.15 M sodium phosphate buffer (pH 6.5, 7.0 or 8.0), containing 4 mM 
dithiothreitol and 0.1 ml of tissue preparation, 0.1 ml of 10 11M thyroxine, 
5 11M 3,3' ,5-triiodothyronine or 0.1 11M 3,3' ,5' -triiodothyronine was added. 
Production of 3,3' ,5-triiodothyronine from thyroxine and of 3,3' -diiodo-
thyronine from 3,3' ,5' -triiodothyronine was analysed at pH 6.5 and production 
of 3,3' ,5' -triiodothyronine and 3,3' -diiodothyronine from thyroxine and of 
3,3' -triiodothyronine from 3,3' ,5-triiodothyronine at pH 8.0 [7] unless stated 
otherwise. For the determination of the conversion of thyroxine into 3,3' ,5'-
triiodothyronine, the amount of 3 ,3' ,5' -triiodothyronine degraded into 
3,3' -diiodothyronine was taken into account [7]. After 10 min of incubation at 
37°C 0.2 ml portions of the reaction mixture were added to 0.6 ml of 85% 
(vfv) ice-cold ethanol. Processing of the extracts and measurement of iodo-
thyronines were done as previously described [7]. Recovery estimated with the 
aid of 1251-labelled iodothyronines varied between 92.5 and 99.8%. Under the 
conditions tested less than 10% of added thyroxine, 3,3' ,5-triiodothyronine 
and 3,3' -diiodothyronine was degraded. Where tested degradation of 3,3' ,5' -tri-
iodothyronine was found to be equal to 3,3' -diiodothyronine formation. 
Results 
Iodothyronine-deiodinating activity in homogenates of parenchymal and non-
parenchymal cells 
Table I shows the thyroxine, 3,3' ,5-triiodothyronine and 3,3' ,5' -triiodo-
thyronine-deiodinating activities in homogenates of rat paren~hymal and non-
parenchymal liver cells. The specific activities of all deiodinases in non-
parenchymal homogenates were less than 6% of those in the parenchymal cell 
homogenates. 
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TABLE I 
DEIODINATION OF SEVERAL IODOTHYRONINES IN HOMOGENATES OF RAT PARENCHYMAL 
AND NON-PARENCHYMAL LIVER CELLS 
The reaction mixtures contained 0.14-{).41 mg of liver cell protein/mi. All experiments were done in 
duplicate. 
Reaction Conversion rate (pmol(mg protein per min) in: 
thyroxine-+ 3,3' ,5-triiodothyronine 
thyroxine-+ 3,3' ,5' -triiodothyronine 
3,3' ,5-triiodothyronine-+ 3,3' -diiodothyronine 
3,3' ,5' -triiodothyronine-+ 3,3' -diiodothyronine 
* Below the limits of detection. 
Parenchymal cells 
2.42 
1.72 
1.23 
8.48 ** 
** Representing a minimal value due to exhaustion of the substrate. 
Non-parenchymal cells 
<0.14 * 
0.13 
0.07 
<0.01 * 
Subcellular distribution of iodothyronine-deiodinating enzymes in rat liver cells 
The subcellular distribution of the several deiodinases is shown in Fig. 1 and 
is compared to that of glucose-6-phosphatase and 5'-nucleotidase. All other 
marker enzymes and DNA also showed a characteristic distribution pattern 
(not shown here). Most of the deiodinating activity was recovered in the micro-
somal fraction. Less than 10% was found in the nuclear fraction. There is a 
striking resemblance between the distribution of the deiodinases and that of 
glucose-6-phosphatase. 5'-Nucleotidase activity was distributed somewhat 
differently. This is more obvious if the ratios of the specific activities in the 
microsomal and nuclear fraction are considered (Table II). Table II illustrates 
that the microsomal fraction is more enriched with the deiodinases (6-7-fold) 
and glucose-6-phosphatase (four-fold) than with 5' -nucleotidase (1. 7 -fold), 
whereas compared to whole homogenate, the nuclear fraction contains less 
deiodinases and glucose-6-phosphatase than 5'-nucleotidase. 
TABLE II 
RATIOS OF THE SPECIFIC ENZYME ACTIVITIES IN WHOLE HOMOGENATE (H), NUCLEAR (N) 
AND MICROSOMAL (P) FRACTIONS 
Results shown are the mean ± S.E. of four separate experiments. 
Enzyme of enzymatic reaction 
giucose-6-phosphatase 
5' -nucleotidase 
thyroxine-+ 3,3' ,5-triiodothyronine 
thyroxine-+ 3,3' ,5' -triiodothyronine 
3,3' ,5-triiodothyronine-+ 3,3' -diiodothyronine 
3,3' ,5' -triiodothyronine-+ 3,3' -diiodothyronine 
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Ratio 
N(H 
0.42 ± 0.03 
0.80 ± 0.04 
0.50 ± 0.02 
0.47 ± 0.04 
0.65 ± 0.04 
0.48 ± 0.03 
P/H P(N 
3.88 ± 0.10 9.62 ± 0.54 
1.71 ± 0.13 2.22 ± 0.36 
6.37 ± 0.14 12.76 ± 0.62 
7.02 ± 0.49 15.33 ± 1.64 
7.08 ± 0.54 10.75 ± 1.38 
5.68 ± 0.22 12.00 ± 0.77 
specific 
activity 
0.3 
0.2 
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0.10 
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Reverse tri-iodothyronine-
di-iodothyronine 
Fig. 1. Subcellular distribution pattern of iodothyronine-deiodinating enzymes and marker enzymes. The 
specific activities of the deiodinases are defined as Pmol of deiodinated product formedfmg of protein 
per min and of glucose-6-phosphatase and 5'-nucleotidase as ,umol of inorganic phosphate formedfmg of 
protein per min. For details see Materials and Methods. 
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Activity of deiodinases in the plasma membrane preparations 
Several fractions, more or less enr~ched in the plasma membrane marker 
5' -nucleotidase were isolated from the nuclear fraction. Among these were the 
floating layer and a dense layer, obtained according to Neville [23]. In Table 
III the specific activities of glucose-6-phosphatase, 5' -nucleotidase and some 
deiodinases of these three fractions are shown. From the microsomal fraction 
(P) we obb:cined a fraction (P2), which was enriched in plasma membranes and 
two fractions (P5 and P6) enriched in endoplasmic reticulum, according to 
Touster et al. [ 25]. The specific activities of glucose-6-phosphatase, 5 '-nucleo-
tidase and the deiodinases of these fractions and of P are also shown in Table 
III. From these data it is obvious that the deiodinases correlate positively with 
glucose-6-phosphatase (r = 0.98--D.99). On the other, a negative correlation 
between the deiodinases and 5' -nucleotidase is shown, with r ranging between 
--D.88 and -0.97. 
TABLE III 
COMPARISON OF SPECIFIC ACTIVITIES OF GLUCOSE-6-PHOSPHATASE AND 5'-NUCLEOTIDASE 
WITH DEIODINASE ACTIVITIES 
For definition of specific activities see Fig. 1. Conversion studies were done at pH 7 .0. The concentrations 
of thyroxine and 3,3' ,5' -triiodothyronine were 5.0 and 0.5 }lM, respectively. Further conditions are 
described in Materials and Methods. 
Fraction glucose-6-phosphatase 5' -nucleotidase Converting activity 
thyroxine____.. thyroxine --+ 3,3' 5' -tri-
3,3' ,5-tri- 3,3' ,5' -tri- iodothyro-
iodethyro- iodothyro- nine__.. 3.3'-
nine nine diiodo-
thyronine 
Nuclear fraction 0.167 0.133 2.84 1.70 7.6 
Floating layer 0.090 0.680 2.28 1.14 5.0 
Dense layer 0.246 0.034 3.62 2.52 9.6 
p 0.387 0.085 8.38 4.66 53.8 
P2 0.180 0.344 2.12 2.52 23.2 
P5 0.507 0.070 13.88 5.78 76.2 
P6 0.611 0.007 16.96 6.02 82.0 
Discussion 
Our results demonstrate in which rat liver cells the thyroxine-deiodinating 
enzymes are located and their subcellular location. It was found that the 
specific activities of the deiodinases in non-parenchymal cells are less than 6% of 
those in parenchymal cells. However, if we consider the whole rat liver, con-
sisting of about 90% of parenchymal cell protein and 10% of non-parenchymal 
cell protein [26], it can be concluded that the parenchymal cells are responsi-
54 
ble for at least 99% of the deiodination of thyroxine into 3,3' -diiodothyronine 
via 3,3' ,5-triiodothyronine and 3,3' ,5' -triiodothyronine. 
The subcellular fractionation studies revealed that both thyroxine-mono-
deiodinating enzymes and the enzymes converting 3,3' ,5-triiodothyronine and 
3,3',5'-triiodothyronine into 3,3'-diiodothyronine are mainly located in the 
microsomal fraction of rat liver homogenate. These results are in conformity 
with those of Hesch et al. [3] and Visser et al. [8], who have shown thyroxine-
5' -deiodinase to be located in the same fraction. However, Maciel et al. [27] 
reported about integration of the enzyme in the plasma membrane and 
Leonard and Rosenberg [10] also showed a plasma membrane location in rat 
kidney. On the other hand Cavalieri et al. [9] found the enzyme converting 
thyroxine into 3,3' ,5' -triiodothyronine in the soluble fraction of rat liver 
homogenate. These results are based on very smal conversion rates, being of the 
same order of magnitude we found in cytosol. Conversion rates in microsomes 
are at least 50 times higher than in cytosol (Fig. 1). 
Because of cofractionation of 5' -nucleotidase with the deiodinases in the 
microsomal fraction, we tried to separate endoplasmic reticulum (glucose-6-
phosphatase activity) from plasma membranes (5' -nucleotidase activity) by 
means of discontinuous sucrose gradient centrifugation. We obtained relatively 
pure plasma membranes and fractions enriched in glucose-6-phosphatase 
activity. From the data in Tables II and III it is obvious that the above-
mentioned deiodinases are all associated with the endoplasmic reticulum of rat 
liver cells. These observations are in contrast with those of Maciel et al. [27], 
who found a plasma membrane location of thyroxine- and 3,3' ,5' -triiodothyro-
nine-5' -deiodinase activities. 
The specific activities of the deiodinating enzymes mentioned in this paper 
have to be interpreted with caution, because these values are, among others, 
dependent on the concentration of substrate. Ideally, for estimation of specific 
activities saturating concentrations of substrate should have been used. Because 
of the very high concentrations of thyroxine and 3,3' ,5-triiodothyronine 
needed and the insolubility of these compounds under these conditions [28], 
this was not possible. Also under these circumstances, due to cross-reaction of 
substrate in the assay of the products, estimation of the conversion rate is less 
accurate. However, except for the 5' -deiodination of 3,3' ,5' -triiodothyronine 
in Table I, it was assessed that conversion rates were proportional to the 
protein concentration in the incubation mixture. Therefore, although not 
representing maximal velocities, the reported figures on enzyme activities in the 
several preparations may be interpreted as specific activities. 
Subcellular fractionation does not result in separation of the deiodinating 
enzymes. However, it has also been found that thyroxine~ 3,3 ',5-triiodo-
thyronine and 3,3' ,5' -triiodothyronine~ 3,3' -diiodothyronine converting activ-
ities are more sensitive to omission of dithiothreitol during preparation of rat 
liver microsomes than the thyroxine--+ 3,3' ,5' -triiodothyronine and 3,3' ,5-tri-
iodothyronine ~ 3,3' -diiodothyronine converting activities (not detailed here). 
These findings are compatible with the concept that the sequential deiodina-
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tion of thyroxine is mediated by two enzymes, viz. iodothyronine-5-deiodinase 
catalyzing conversion of thyroxine into 3,3' ,5' -triiodothyronine and 3,3' ,5-tri-
iodothyronine into 3,3' -diiodothyronine and iodothyronine-5' -deiodinase 
catalyzing conversion of thyroxine into 3,3' ,5-triiodothyronine and 3,3' ,5' -tri-
iodothyronine into 3,3' -diiodothyronine [29]. However, confirmation of this 
hypothesis must await the final purification of these enzymes. 
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Summary 
Rat liver cells contain iodothyronine deiodinating enzymes (iodothyronine-5 
and 5' -deiodinases), which are associated with the endoplasmic reticulum. In 
the present study, the iodothyronine deiodinases have been solubilized from 
the microsomal fraction of rat liver with 1.0% cholate and 0.25% of the poly-
oxyethylene ether W-1. Cholate can be effectively removed from the cholate 
extract with a mixture of the polystyrene beads XAD-2 and XAD-7. However, 
after some time, aggregation of proteins occurred. 
Cholate solubilized iodothyronine-5' -deiodinase has an apparent molecular 
weight of 65 000 and a Stokes radius of 36-37 A. The sedimentation 
coefficient is 4.3 S in 0.4-0.6% cholate, 7.6 S in 0.05% W-1 ether and 12.8 S 
in the absence of detergent. The enzyme solubilized with W-1 ether has an 
apparent molecular weight of approx. 200 000 and a Stokes radius of 52-56 A 
in 0.025% W-1 ether. In the latter extract, the sedimentation coefficient of 
the deiodinase is 4.3-5.2 Sunder different conditions. 
On DEAE-Sepharose chromatography, 70% of the bound deiodinases eluted 
with 0.1 M NaCl. The purification of this fraction was only 2-fold. Covalent 
chromatography, using activated thiol-Sepharose, resulted in approximately 
3-fold purification of the deiodinases solubilized with W-1 ether, whereas in 
case of the cholate extract, no purification at all was obtained. Glutathione-
Sepharose affinity chromatography resulted in no enrichment of the 
deiodinases. 
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Introduction 
The parenchymal cell of rat liver can deiodinate thyroxine to 3,3'-diiodo-
thyronine via 3,3' ,5-triiodothyronine and 3,3' ,5'-triiodothyronine [1,2]. This 
deiodination pathway is composed of four reactions, which are catalyzed by 
enzymes. Several reports favour the concept that these reactions are catalyzed 
by two enzymes, viz. an iodothyronine-5'-deiodinase, responsible for the 
5'-deiodination of thyroxine and 3,3',5'-triiodothyronine, and an iodothy-
ronine-5-deiodinase, catalyzing the 5-deiodination of thyroxine and 3,3' ,5-
triiodothyronine [1,3-5]. Upon subcellular fractionation, all deiodinase 
activities were found to be associated with the endoplasmic reticulum of the 
rat liver cell [2,6] and, at the present, no separation of deiodinase activities has 
been obtained. 
In the present study, we have solubilized the iodothyronine deiodinases from 
the microsomal fraction, determined some of their physico-chemical properties 
and made preliminary attempts at purification. 
Materials and Methods 
Materials. L-Thyroxine, L-3,3' ,5-triiodothyronine, dithiothreitol, Triton 
X-405, cholate, deoxycholate, Brij 35, polyoxyethylene ether W-1 (W-1 ether), 
trypsin (bovine pancreas, crystallized twice) and trypsin inhibitor (soya bean) 
were obtained from Sigma. L-3,3' ,5'-Triiodothyronine was obtained by 
courtesy of Dr. E. Scheiffele (Henning GmbH, Berlin). Triton X-100 and 
digitonin were purchased from B.D.H. Lubrol PX was from I.C.I. and tauro-
cholate from Calbiochem. Sephadex G-25 (Fine), DEAE-Sepharose CL-6B, 
activated thiol-Sepharose 4B, Sepharose 6B, Sephacryl S-200 SF, Sephadex 
G-150, and the marker proteins ribonuclease A, chymotrypsinogen A, oval-
bumin, albumin aldolase, catalase, ferritin and thyroglobulin were obtained 
from Pharmacia, Uppsala, Sweden. Glutathione-Sepharose was obtained by elu-
tion of an activated thiol-Sepharose column with dithiothreitol. The resins 
XAD-2 and XAD-7 were purchased from Serva, Heidelberg, F.R.G. 
Assay of iodothyronine deiodinase activity. Iodothyronine deiodinase 
activity was determined by incubating 5 JLM thyroxine, 2.5 JLM 3,3' ,5-triiodo-
thyronine or 0.5 JLM 3,3' ,5'-triiodothyronin~ with appropriate dilutions of the 
fraction to be tested in the presence of 0.08 M sodium phosphate (pH 7.0) and 
2.5 mM dithiothreitol in a total volume of 0.2 ml. After incubation at 37° C 
for 10 min with shaking, the reaction was stopped by addition of 0.8 ml 
0.06 M barbitone buffer, (pH 8.6), 0.1% bovine serum albumin, 0.1% SDS. The 
amounts of iodothyronine produced were measured directly in 50 JLl of the 
extract with specific radioimmunoassays [1]. For the determination of the 
conversion of thyroxine into 3,3' ,5'-triiodothyronine, the amount of 3,3' ,5'-
triidothyronine degraded into 3,3' -diiodothyronine was taken into account. 
Solubilization of enzymes. Microsomes vvere prepared as described previously 
[2]. Solubilization was carried out using various procedures, viz. solvent 
extraction, treatment with detergents, high salt concentrations, trypsin or 
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EDTA. For solvent extraction, acetone [7] and n-butanol [8] were used. The 
detergents used were Triton X-100 and X-405, Lubrol, cholate, deoxycholate, 
taurocholate, Brij 35, digitonin and W-1 ether. W-1 ether is a 1-1.78 mixture 
of cetyl 10 ether (Brij 56) and cetyl 20 ether (Brij 58). Detergent (in Tris-HCl/ 
dithiothreitol buffer, consisting of 10 mM Tris-HCl (pH 7.4), 3 mM dithio-
threitol) and an equal volume of microsomal fraction (containing approx. 15 mg 
protein/ml) were mixed and incubated for 45 min at 0° C. Final detergent con-
centrations ranged between 0.05 and 1.3% (w/v). Deiodinase activity was deter-
mined in the suspension and, following centrifugation (1 h at 110 000 X g), in 
the supernatant and in the pellet which was suspended in Tris-HCl/dithiothrei-
tol buffer. Salt extraction with 0.2-4.0 M KCl (final concentration) [9] and 
treatment with 3--50 mM EDT A were carried out similarly. Solubilization with 
trypsin was attempted by incubating approx. 6 mg microsomal protein with 
25-100 J.lg trypsin in a total volume of 0.9 ml (in Tris-HCl/dithiothreitol 
buffer). After incubation at 20° C for 2.5 h, or at 37° C for 1 h, the reaction was 
stopped by the addition of a 3-fold excess of trypsin inhibitor. Determination 
of deiodinases was carried out as described above. 
Protein determinations. Protein was estimated by a modification of the 
Bradford method [ 10] using bovine serum albumin as standard [ 11]. This 
method is not influenced by several laboratory reagents, especially by dithio-
threitol, which is used throughout all procedures. In preparations containing 
detergent, a modification [12] of the method of Lowry et al. [13] was used. 
Removal of cholate. Cholate was removed from solubilized microsomal 
proteins by using a mixture of the polystyrene beads XAD-2 and XAD-7 
(4: 1, w/w) [14]. The column (1.0 X 19.5 em) was equilibrated and eluted 
with 15 mM Tris-HCl (pH 9.0), 3 mM dithiothreitol (flow rate, 18 ml/h). 
Cholate was determined by liquid scintillation counting of [14 C]cholic acid 
(New England Nuclear, Boston, MA) of which a tracer quantity had been added 
to 1% sodium cholate. 
Gel filtration. Gel filtration was carried out at 8° C on columns of Sepharose 
6B (1.5 X 26 em), Sephacryl S-200 (1.6 X 30 em) and Sephadex G-150 (1.5 X 
25 em). The elution buffer contained 0.05 M Tris-HCl (pH 7.2), 0.1 M NaCl, 
2 mM dithiothreitol with or without detergent (flow rates, 14, 28 and 9.5 ml/h, 
respectively). The molecular weight and the Stokes radius, R 5 , were calculated 
from the plot of Ka v vs. log molecular weight and of y -log (Ka v) vs. R 5 , 
respectively, using marker proteins from Pharmacia calibration kits. 
Sucrose gradient centrifugation. Linear sucrose gradients ( 4-24%, w jw) 
contained 20 mM Tris-HCl (pH 7.4), 2 mM dithiothreitol and in some experi-
ments 0.6% cholate or 0.05% W-1 ether. A Beckman SW41 rotor was used for 
16 h at 5° C and 153 000 X g. The sedimentation coefficients were determined 
by comparison with several marker proteins. 
Chromatography on DEAE-Sepharose. The microsomal proteins solubilized 
with W-1 ether (approx. 15 mg protein) were loaded on a colum (1.6 X 8 em) 
of DEAE-Sepharose CL-6B, which had been equilibrated with 20 mM Tris-HCl 
(pH 8.0)/2 mM dithiothreitol. The column was then eluted (flow rate, 20 ml/h) 
with 35 ml buffer and, subsequently, with similar volumes of buffer con-
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taining 0.1, 0.2 and 0.4 M NaCL 
Chromatography on thiol-Sepharose 4B. Approximately 20 mg of solubilized 
microsomal protein was added to the top of a Sephadex G-25 column (1 X 12 
em), which had been equilibrated with 40 mM Tris-HCl buffer (pH 7.4), 1 mM 
EDTA, 0.15 M NaCl. The fractions containing deiodinase activity were pooled 
and this solution was then added to the top of a column (0.7 X 9 em) activated 
thiol-Sepharose 4B, which had been equilibrated with the Tris-HCl buffer. The 
column was washed with the same buffer (flow rate, 6 ml/h) until the 
absorbance at 277 nm of the effluent was approx. zero. Elution was achieved 
with the equilibration buffer containing 8 mM dithiothreitol. Conditions for 
chromatography on glutathione-Sepharose were the same as for activated thiol-
Sepharose. 
Results 
Solubilization 
In the control experiment (treatment with Tris-HCl/dithiothreitol only) the 
supernatant contained less than 10% of deiodinase ,activity (Table I). Treat-
ment with Lubrol, Triton X-100, Triton X-405, deoxycholate, KCl, EDTA, 
acetone, n-butanol or trypsin yielded a soluble preparation displaying less than 
15% of the activity of untreated microsomes. Taurocholate, digitonin and Brij 
35 were able to solubilize 20-40% of the deiodinases. Of these detergents 
Brij 35 inactivated the deiodinases most strongly. In Table I are summarized 
results obtained with the detergents cholate and W-1 ether, which were most 
successful in solubilizing microsomes. 
As demonstrated in Table I, cholate and W-1 ether are most effective at a 
final concentration of 1.0 and 0.25% (wjv), respectively. However, the apparent 
yield of solubilized enzyme was low. It was found that cholate or W-1 ether, 
added directly to the assay, caused a concentration-dependent decrease in 
microsomal deiodinase activity (Fig. 1). Therefore, the low yield of enzymatic 
activity after solubilization is at least partly due to a direct inhibitory effect 
of the detergent. Indeed, when the solubilized microsomes were assayed in a 
TABLE I 
DEIODINASE ACTIVITY AFTER SOLUBILIZATION OF MICROSOMES 
Conversion studies were done at pH 7.0 using thyroxine as the substrate. Values for the supernatant are 
indicated as a percent of those for the mixture of microsomes and detergent before centrifugation and 
represent the mean of three experiments. 
Detergent 
0.25% Cholate 
0.50% Cholate 
1.00% Cholate 
1.30% Cholate 
0.10% W-1 ether 
0.25% W-1 ether 
0.50% W-1 ether 
1.00% W-1 ether 
60 
Protein 
(% of initial) 
24 
44 
66 
80 
86 
49 
68 
85 
90 
5' -Deiodinase activity 
(% of initial) 
8 
20 
58 
80 
82 
22 
78 
82 
84 
5-Deiodinase activity 
(% of initial) 
8 
19 
52 
78 
81 
26 
81 
84 
86 
specific activity 
(percent of control) 
100 
80 
60 
40 
20 
0 0.05 0.10 0.15 
specific activity 
(percent of control) 
100 
80 
60 
40 
20 
0 0.01 0.02 0.03 
Chelate in assay (%) W-1 in assay (%) 
Fig. 1. Effects of cholate and~ W-1 ether on the specific activities of iodothyronine-5'- (D-O) and 
5-deiodinase <•---•). Thyroxine was used as a substrate. Values are indicated as a percent of untreated 
microsomes. 
suitable dilution (yielding 0.005-0.025% cholate and 0.0025% W-1 ether, final 
concentrations), most of the deleterious action of cholate and W-1 ether was 
prevented (see specific activities in Table II). The data in Fig. 1 suggest that the 
5-deiodinase activity is more affected by cholate than the activity of 5'-
deiodinase, whereas with W-1 ether the reverse appears to be the case. Table II 
summarizes the isolation and solubilization of the 5'- and 5-deiodinase. It can 
be seen that cholate decreases the specific activity of the deiodinases by approx. 
30%, whereas the decrease in case of W-1 ether is less than 20%. 
TABLE II 
ISOLATION AND SOLUBILIZATION OF RAT LIVER MICROSOMAL IODOTHYRONINE-5'- AND 
5-DEIODINASE 
The conversion studies were performed at pH 7.0, with thyroxine as the substrate. 
Fraction 
Homogenate 
Microsomes 
Supernatant fluid after solubilization 
with cholate 
Supernatant fluid after solubilization 
with W-1 ether 
Total 
protein 
(mg) 
1544 
284 
222 
173 
Specific activity 
(pmol{mg protein per 
min) 
5'-De- 5-De-
iodinase iodinase 
1.32 0.76 
7.65 4.24 
5.62 2.73 
6.23 3.63 
Recovery (%) 
5'-De-
iodinase 
106 
61 
53 
5-De-
iodinase 
102 
53 
55 
61 
Removal of cholate 
Elution of microsomal proteins solubilized with 1.0% cholate on a mixture 
of the polystyrene beads XAD-2 and XAD-7 resulted in a more than 99% 
removal of cholate. Recovery of protein was approx. 95% and that of 5'-
deiodinase activity (measured with 3,3',5'-triiodothyronine as the substrate) 
was 190%. This is probably due to stripping of cholate from the enzyme. In 
this manner a crude soluble enzyme preparation was obtained essentially free 
of detergent. However, after some time aggregation occurred. 
Gel filtration 
Microsomal proteins solubilized with cholate or W-1 ether were applied to 
columns of Sepharose 6B, Sephacryl S-200 and Sephadex G-150. Apparent 
molecular weights and Stokes radii of the 5' -deiodinase after gel filtration on 
Sepharose 6B and Sephacryl S-200 are shown in Table III. In the absence of 
cholate in the solvent, the actual. cholate concentration in the fractions con-
taining deiodinase activity after chromatography on Sephacryl S-200 was 
approx. 0.05 mM (measured by using 14C-labeled cholate). Apparently, this 
amount is sufficient to keep the protein in a soluble state. No cholate was 
measured in deiodinase containing fractions after Sepharose 6B chromatog-
raphy. The results obtained with Sephadex G-150 are not included in this 
table, because the molecular weight of the deiodinase was, under all condi-
tions, higher than 200 000 on this column. It is evident that the molecular 
weight and Stokes radius of the 5' -deiodinase are not only dependent on the 
solubilizing agent, but also on the type of gel filtration and the presence of 
detergent in the elution buffer. The apparent molecular weight and the Stokes 
radius of the 5' -deiodinase in the cholate extract are approx. 65 000 and 
36-37 A, respectively. For the W-1 ether extract, these values are 160 000-
230 000 and 52-56 A, respectively. 
TABLE III 
SEPHAROSE 6B AND SEPHACRYL 8·200 GEL FILTRATION DATA OF MICROSOMAL 5'-DE-
IODINASE 
The molecular weight and Stokes radius (Rs) of the 5' -<leiodinase solubilized with cholate and W-1 ether 
are given. 3,3' ,5' -Triiodothyronine was used as a substrate. n.d ., not determined. 
Sample 
Cholate extract 
Cholate extract 
(0.4% cholate in eluent) 
W-1 Ether extract 
W-1 Ether extract 
(0.025% W-1 ether in eluent) 
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Sepharose 6B 
chromatography 
Molecular 
weight 
>700000 
60 000-70 000 
160 000 
n.d. 
Sephacryl S-200 
chromatography 
Rs(A) Molecular Rs(A) 
weight 
>100 60 000-70 000 34-37 
36-39 6 5 000-7 5 000 35-38 
53 >300 000 >60 
n.d. 200 000-230 000 52-56 
TABLE IV 
SEDIMENTATION COEFFICIENTS (s2o,w) OF SOLUBILIZED 5'-DEIODINASE 
3,3' ,5' -Triidothyronine was used as substrate. 
Sample 
Cholate extract 
Cholate extract 
Cholate extract 
Cholate extract after removal of cholate 
W-1 Ether extract 
W-1 Ether extract 
W-1 Ether extract 
Sucrose gradient centrifugation 
Detergent in gradient 
none 
0.6% cholate 
0.05% W-1 ether 
none 
none 
0.6% cholate 
0.05% W-1 ether 
12.8 
4.3 
7.6 
12.8 
4.3 
5.2 
5.2 
In Table IV, the sedimentation coefficients of the 5' -deiodinase under 
several conditions are shown. The deiodinase solubilized with W-1 ether had a 
sedimentation coefficient ( 4.3-5.2 S), which was almost independent of the 
presence of detergent in the gradient. However, in the cholate extract the 
enzyme had a high sedimentation coefficient (12.8 S) in the absence of any 
detergent in the gradient, pointing to aggregation. This also appeared to be the 
case after removal of cholate with the XAD-resin. In the presence of 0.05% 
W -1 ether, the sedimentation coefficient was 7.6 S and in the presence of 
0.6% cholate it was 4.3 S. 
DEAE-Sepharose chromatography 
The DEAE-Sepharose column bound approx. 80% of added 5'-deiodinase at 
pH 8.0 (Fig. 2). Nearly 70% of this bound enzyme could be eluted with 0.1 M 
NaCl. At concentrations higher than 0.2 M NaCl, no deiodinase activity was 
100 
50 
0 
5'-deiodinase activity 
(pmol/min/ml) 
-
0.1 M 
' NoCI I 
I 
t I 
/A.~---
0 10 
0.2 M 
NaCI 
t 
20 30 
0.4 M 
NaCI 
t 
,, 
I I 
o' 1¢ 
I I 
I I 
I I 
I I 
I I 
' ' q 1 I 
protein 
(mg/ml) 
o----o 
I ¢>_._ ~-..rt... 
'---------o-• ,...__. -----o 
40 50 
fraction no. 
1.0 
0.5 
0.0 
Fig. 2. DEAE.Sepharose chromatography, pH 8.0, of microsomes solubilized with W-1 ether. The column 
was developed with a discontinuous gradient of KCl in column buffer. 3,3 1,51-Triiodothyronine was used 
as t~1e substrate. 
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bound to the column, whereas protein was still present. The 5-deiodinase 
showed a similar profile. Recovery of total deiodinase activity was approx. 50% 
(protein recovery 100%) and enrichment of the enzyme in the fraction eluted 
with 0.1 M NaCl was only 2-fold. 
Chromatography on thiol-Sepharose 4B 
After removal of dithiothreitol from W-1 ether-solubilized microsomal 
proteins by Sephadex G-25, the sample was applied to activated thiol-
Sepharose. The elution pattern is seen in Fig. 3. About 25% of the deiodinase 
activity appeared in the column volume, whereas the remainder could be 
eluted with 8 mM dithiothreitol. However, many other proteins were bound 
to thiol-Sepharose too, resulting in little purification of the 5' -deiodinase 
(approx. 3-fold). 5-Deiodinase showed a similar profile. Protein and deiodinase 
recoveries were higher than 75%. After application of microsomes solubilized 
with cholate and prechromatographed on Sephadex G-25, about 90% of the 
deiodinase activity (together with approx. 7 5% protein) appeared in the 
column volume. The deiodinases were not adsorbed onto glutathione-Sepharose 
using microsomes solubilized with W-1 ether as well as with cholate. 
Discussion 
Effective solubilization of the microsomes was obtained with the detergents 
cholate and W-1 ether. The results with cholate are in agreement with those of 
Kohrle et al. [9] and Leonard and Rosenberg [15], although the latter studied 
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Fig. 3. Chromatography of W-1 ether-solubilized microsomes on thiol-Sepharose 4B. Elution of the bound 
enzyme was performed with buffer containing 8 mM dithiothreitol. 3,3 1,51-Triiodothyronine was used as 
a substrate. DTT, dithiothreitol. 
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rat kidney microsomes. In the presence of 1.0% cholate, 58 and 52% of the 
active form of iodothyronine-5'- and 5-deiodinase, respectively, could be 
solubilized. For 0.25% W-1 ether, these values are 50 and 54%, respectively. 
From our observations, it can be concluded that the thyroxine-deiodinating 
enzymes are integral (intrinsic) and not peripheral (extrinsic) membrane pro-
teins because the enzymes cannot be dislodged from the membrane by the 
chelating agent EDT A nor by increasing the ionic strength (salt extraction) 
with KCL However, Kohrle et al. [9] reported the solubilization of the deiodin-
ase from microsomal fractions with 4 M KCl. We repeated the experiments and 
indeed we found deiodinating activity in the supernatant after centrifugation. 
But this turbid supernatant apparently had a similar density as the microsomes. 
Upon dilution, all deiodinating activity could be pelleted. Therefore, no actual 
solubilization had occurred. Although solubilization does not result in separa-
tion of the deiodinating enzymes, the detergents cholate and W-1 ether affect 
the specific activity of iodothyronine-5'- and 5-deiodinase in a different manner 
(Fig. 1). 
In many cases it is desirable to have a soluble enzyme preparation which is 
essentially free of detergent, especially in case of an ionic detergent. Therefore, 
we attempted to remove cholate from the soluble microsomal proteins. A 
mixture of the polystyrene beads XAD-2 and XAD-7 (4: 1, w/w) appeared to 
be very successful for this purpose. However, after storage for a few days at 
4°C, the proteins obtained in this manner aggregated visibly. Probably, aggrega-
tion occurred immediately after stripping of cholate from the proteins. In 
almost all chromatography procedures described in this paper, the applied 
cholate extract aggregated during elution, which was accompanied by consider-
able loss of activity of the deiodinases. The latter fact remained even in the 
presence of cholate during chromatography. For this reason, most column 
chromatography was carried out with microsomes solubilized with the non-
ionic detergent, W-1 ether. Even in the absence of W-1 ether during chromatog-
raphy, no observable aggregation occurred. 
The apparent molecular weight of the 5' -deiodinase as determined by gel 
filtration turned out to be dependent on the presence and type of detergent 
and surprisingly, also on the gel filtration support. The results suggest that 
aggregation took place during chromatography of the cholate extract on the 
Sepharose 6B column in the absence of detergent in the eluent. Measurement 
of cholate in the deiodinase-containing fractions revealed that these were 
devoid of the detergent. On the other hand, some cholate was present in the 
deiodinase-containing fractions after chromatography on Sephacryl S-200, 
which, apparently, was sufficient to keep the deiodinase in a soluble form. 
Also, in case of the W-1 ether extract, differences in apparent molecular 
weights were observed to be dependent on the gel filtration support. Since we 
were not able to measure the amount of W-1 ether in the fractions containing 
deiodinase activity, we cannot conclude whether this was due to loss of deter-
gent during chromatography. 
The molecular weight of the deiodinase as determined by Sephadex G-150 
chromatography was in all cases higher than 200 000. An explanation for this 
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finding cannot be given at the moment. Nevertheless, from the gel filtration 
experiments on Sepharose 6B and Sephacryl S-200, it can be concluded that 
the apparent molecular weight of the 5' -deiodinase in the cholate extract is 
lower than in the W-1 ether extract. This may be explained by the fact that the 
deiodinase has more binding sites for W"1 ether than for cholate. Another 
possibility is that the enzyme binds to a whole micelle. In the latter case, the 
protein-detergent complex formed with W-1 ether is larger than that formed 
with cholate, because cholate has a micellar weight of only 900-1800, whereas 
for W-1 ether, having a similar structure as Lubrol and Brij, this value is higher 
than 50 000 [16]. 
The sedimentation coefficient of the 5'-deiodinase in the cholate extract in 
the presence of 0.6% cholate was 4.3 S. Similar values were obtained by 
centrifugation of the W-1 ether extract under various conditions. This value is 
near the sedimentation coefficient of bovine serum albumin, which is 4.4. S. 
The approximate molecular weight of the enzyme is therefore similar to the 
one determined by gel filtration. Omission of cholate in the sucrose gradient 
resulted in aggregation, whereas exchange of cholate for a low concentration of 
W-1 ether, yielded partial aggregation of the deiodinase. The sedimentation 
coefficients of the 5'-deiodinase in the cholate and W-1 ether extract show only 
a slight difference, whereas their apparent molecular weights as determined by 
gel filtration show a much greater difference. This may be explained by their 
different hydrodynamic properties. Protein-W-1 ether complexes have a low 
sedimentation coefficient and a high Stokes radius, whereas protein-cholate 
complexes lack a similar combination [16]. 
DEAE-Sepharose chromatography of the W-1 ether-solubilized deiodinases 
at pH 8.0 yielded essentially three activity peaks. A minor peak eluted with 
buffer, a major peak with 0.1 M NaCl and a minor peak with 0.2 M NaCl. How-
ever, purification was very modest (approx. 2-fold). This is also true for 
chromatography on activated thiol-Sepharose. Since it is known that iodo-
thyronine deiodinases contain essential sulfhydryl groups [ 17], it seemed 
worthwile trying to purify these enzymes by chromatography on thiol-
Sepharose. It appeared that approx. 75% of the enzymes solubilized with W-1 
ether, were absorbed onto this column. The bo1fnd deiodinases could be eluted 
from the column with the activating sulfhydryl reagent dithiothreitol [1,17]. 
However, many other proteins were bound to thiol-Sepharose too, resulting in 
very little purification of the deiodinases. The deiodinases were neither resolved 
by DEAE- nor by thiol-Sepharose. Unexpectedly, no binding occurred on a 
glutathione-Sepharose column, whereas glutathione is thought to be the 
endogenous cofactor of iodothyronine deiodinases [ 1,4]. 
In conclusion, iodothyronine deiodinases of the endoplasmic reticulum of 
rat liver cells can be solubilized with cholate and W-1 ether, and these enzymes 
are integral and not peripheral membrane proteins. The 5' -deiodinase has a 
molecular weight of about 65 000 in cholate and of approx. 200 000 in W-1 
ether, a Stokes radius of 36-37 A in cholate and of 52-56 A in W-1 ether, a 
sedimentation coefficient of 4.3 Sin cholate and 5.2 Sin W-1 ether; it contains 
accessible sulfhydryl groups and has negligible affinity for glutathione under 
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the conditions used. Up to now, no molecular evidence has been obtained for 
the existence of two deiodinating enzymes. This is not surprising, because the 
purification of 5' -deiodinase activity after column chromatography was only 
very modest. 
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CHAPTERS 
PROPERTIES OF DETERGENT-DISPERSED IODOTHYRONINE 5- and 5'-DEIODINASE ACTIVITIES 
FROM RAT LIVER 
EVIDENCE FOR A COMMON ENZYME 
Durk Fekkes, Georg Hennemann and Thea J. Visser 
Biochimica et Biophysica Acta, submitted for publication 
ABSTRACT 
In order to obtain more knowledge about the regulation and mechanism of 
thyroid hormone deiodination, some properties of detergent-solubilised iodothyro-
nine deiodinase have been studied. Moreover, a starting point for its purific-
ation has been made. Several chromatography media were tested for their ability 
to purify the deiodinases. In some instances, a 4-fold purification was obtained. 
Treatment of cholate-solubilised microsomes with 35% ammonium sulphate resulted 
in quantitative precipitation of the deiodinase activities and concomitant re-
moval of phospholipid. The pellet could be solubilised with 0.3% W-1 ether and 
the deiodinase in this ammonium sulphate extract exhibited approximately 10-fold 
higher apparent Km and Vmax values for its substrate compared with the cholate 
extract. Readdition of some phospholipids was shown to decrease enzyme activity. 
Isoelectric focusing of W-1 ether-solubilised microsomes resulted in a major 
activity peak around pH 6.4 and a minor peak at pH 5.2, while in the ammonium 
sulphate extract the deiodinase had an isoelectric point at pH 9.3. Refocusing 
of this activity peak yielded a preparation with a specific activity being only 
3 times higher than in the ammonium sulphate extract. However, after sodium 
dodecyl sulphate gel electrophoresis only 5 bands could be detected. 
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The elevated kinetic parameters as well as the higher isoelectric point of 
the deiodinase after ammonium sulphate treatment were caused by delipidation of 
the enzyme. Both the change in isoelectric point and the behaviour on several 
column materials were found to be similar for the 5- and 5'-deiodinase activi-
ties. These results suggest that a single enzyme is operative in the deiodin-
ation of iodothyronines in rat liver and that its activity may be regulated by 
phospholipids. 
INTRODUCTION 
Deiodination is an important route in the metabolism of thyroid hormone in 
humans as well as in rats (1-3). At least one half of circulating thyroxine (T4) 
undergoes deiodination, where 3,3',5-triiodothyronine (T3) and3,3' ,5'-triiodo-
thyronine (rT3) are the immediate products. In normal humans, 80% of T3 and an 
even greater fraction of rT3 are derived from deiodination of T4 in peripheral 
tissues, the remainder being secreted by the thyroid (2,4). The biological ef-
fects of thyroid hormone are only exerted after conversion of T4 to T3, while 
rT3 is devoid of thyromimetic activity (5-7). 
T3 is produced from T4 by deiodination of the phenolic ring, a process term-
ed 5'~eiodination. Via the same type of reaction rT3 is converted to 3,3'-diiodo-
thyronine (3,3'-T2). Deiodination of the tyrosyl ring (5-deiodination) of T4 
yields rT3, and 5-deiodination of T3 is another way to generate 3,3'-T2• In 
several clinical situations, commonly referred to as the low T3 syndrome, charac-
teristic changes in the metabolism of thyroid hormone are observed, leading to 
low serum T3 and elevated rT3, while, usually, T4 concentrations are normal (2). 
Studies of the plasma disappearance curves of injected tracers are compatible 
with a decreased production but normal clearance of T3, and a normal production 
but decreased clearance of rT3 (2). These findings have led several investigat-
ors to imply the involvement of distinct enzymes, i.e. iodothyronine 5- and 5'-
deiodinase, in the sequential breakdown of T4 (2,3,8). A reduction in the 5'-
deiodination of T4 and rT3 by a selective decrease in the activity of the latter 
enzyme could then explain the abnormal metabolism of thyroid hormone in the low 
T3 syndrome. 
Iodothyronine deiodinase activities are most abundant in the liver and the 
kidneys of the rat (2,3,8)o The enzyme activities of rat liver are associated 
with the endoplasmic reticulum (9-11) and are thought to be intrinsic membrane 
proteins (12,13). Soluble deiodinase preparations have been obtained with re-
tention of activity by treatment of microsomes with detergents (12-14) and some 
of the physicochemical properties have been determined (13). 
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Here we report a starting point for the purification of a hepatic iodothyro-
nine deiodinase. All techniques employed sofar have not resulted in a dissociation 
of 5- and 5'-deiodinase activities. This is compatible with previous, circumstan-
tial evidence that, at least in rat liver, both types of deiodination are catalyse 
by a single enzyme (15). 
MATERIALS AND METHODS 
Materials 
T3, rT3 and 3,3'-T2 were purchased from Henning GmbH. (Berlin, FRG). 
[3' ,5•- 125 ~ rT3 was from the Radiochemical Centre (Amersham, UK). Minicon B15 
units and Matrex gel red A were products from Amicon Co. (Lexington, USA). All 
other chromatography media and Pharmalytes were from Pharmacia Fine Chemicals 
(Uppsala, Sweden). Ultrodex and Ampholines were obtained from LKB Produkter 
(Bromma, Sweden). Dithiothreitol (OTT), sodium cholate, polyoxyethylene ether 
W-1 (W-1 ether), N-ethyl- N'-(3-dimethylaminopropyl) carbodiimide hydrochloride, 
Coomassie brilliant blue R 250 and G 250, phosphatidylcholine, -ethanolamine, -
inositol and - serine were products from Sigma Chemical Co. (St. Louis, MO, USA). 
Sphingomyelin was purchased from Supelco Inc. (Bellafonte, USA) and 2- thiouracil-
6-propionic acid was a gift from Dr. D.S. Cooper, Massachusetts General Hospital 
and Harvard Medical School, Boston, ~1A, USA. Ammonium sulphate (for enzyme work) 
and sodium dodecyl sulphate (specially pure) were obtained from BDH Chemical 
Co, (Poole, UK). All other chemicals were of analytical grade. 
Assays of Iodothyronine Deiodinase Activities 
Iodothyronine deiodinase activities were determined at pH 7.2 and 37° C 
using T3 (5 pM) or rT3 (0.5 pM) as substrate in the presence of 3 mM OTT by the 
method described previously (16). One unit of activity is defined as the amount 
which produces 1 pmol 3,3'-T2/min from T3 (5-deiodination) or rT3 (5'-deiodinatior 
under the standard assay conditions. The product 3,3'-T2 was measured by a speci-
fic radioimmunoassay (16). Specific activity is expressed as enzyme units/mg 
protein. 
In later experiments, rT3 5'-deiodinase activity was assayed by a rapid 
procedure based on the measurement of radioactive iodide released from [3',5'-
125I]rT 3" 
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Reaction mixtures consisted of 0.06 M sodium phosphate, pH 7.2, 3 m~1 EOTA, 3 mM 
OTT, 0.4 ~M [125 I]rT3 and the enzyme preparation to be tested in a final volume 
of 0.12 ml. The reaction was allowed to proceed for 20 min at 37°C and was stop-
ped by the addition of 0.5 ml human serum. After 30 min at 0°C the iodothyronine 
substrate (rT3) and product (3,3'-T2), bound to serum proteins, were precipitated 
with 0.5 ml 10% trichloroacetic acid. After centrifugation for 10 min at 1500 x g, 
the radioiodide liberated was quantitated by counting 0.4 ml of the supernatant 
using a Nuclear Enterprise NE 1600 gamma spectrometer. In control experiments 
the enzyme preparation was added only after the serum. Net enzymatic deiodin-
ation was calculated by subtraction of the 125 I- in the control experiment from 
that produced in the complete reaction mixture, and multiplication of the differ-
ence by 2 as the radioactivity is equally distributed among the products 3,3'-T2 
and I-. This procedure yields the same value for the rT3 5'-deiodinase activity 
as that based on the determination of 3,3'-T2 by radioimmunoassay. 
Preparation of solubilised enzymes 
Microsomes were prepared as described previously (9). For solubilisation, 
the microsomal fraction was treated with detergent in reaction mixtures contain-
ing (at final concentrations): 7-8 mg microsomal protein/ml, 40 mM Tris/HCl (pH 
7 .5), 3 mM EDTA, 3 mM OTT and 1% (w/v) sodium chol ate or 0.25% (w/v) \H ether. 
The suspension was stirred at 0° C for 1 h and centrifuged at 110 000 x g for 1 h. 
The clear yellow supernatants are designated as the cholate orW-1 ether extracts, 
respectively. 
Ammonium sulphate fractionation 
Solid ammonium sulphate was added with stirring to the cholate extract at 
0° C to give a 35% saturated solution. After gentle stirring for 1 h, the sus-
pension was centrifuged at 20 000 x g for 20 min. The supernatant was discarded 
and the pellet was solubilised in a minimum volume of 50 mM Tris/HCl buffer (pH 
7.4), 0.1 M NaCl, 1 mM EOTA, 2.5 mM OTT and 0.3% W-1 ether. After 1 h incubation 
at 0° C and centrifugation (110 000 x g, 1 h), the supernatant (designated as 
ammonium sulphate extract) retained most of the deiodinase activity. 
Analytical Methods 
Protein was measured by the Bradford method (17) as modified (18), using 
bovine serum albumin as the standard. When determinations were done in the 
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presence of detergent, the protein standards were prepared in a solvent contain-
ing an equal concentration of the detergent. 
The phospholipid contents of protein fractions and phospholipid dispersions 
were quantitated by measurement of lipid phosphorus (19). 
Gel electrophoresis in presence of sodium dodecyl sulphate (0.2%) was per-
formed using 5% polyacrylamide gels (20). The protein bands were stained with 
0.25% Coomassie brilliant blueR 250 in 45% methanol and 9% acetic acid. 
Chromatographies 
Ion exchange chromatographies ( DEAE-Sephace l and CM-Sepharose CL-68) were per-
formed on 1.6 x 5 em (5 ml) columns and all other chromatographies on 0.7 x 8 em 
( "'3 ml ) columns at 4-8° C. In most instances the crude W-1 ether extract was 
applied to the several columns, but on some occasions the cholate or the ammonium 
sulphate extracts were chromatographed as well. The chromatography media and 
buffer systems used, are reported in the Results section. 
Preparation of affinity columns 
T4- and T3-Sepharose were prepared by coupling T4 or T3 to activated CH-
Sepharose 48 at pH 8.3 and room temperature according to the procedure described 
[125 125 by the manufacturers ( 21). The use of tracer amounts of I] T 4 or [ I] T 3 
allowed for the estimation of the degree of coupling. This was found to be 7-8 
~molT4 or T3/ml gel. 
Thiouracil~epharose was prepared by coupling of 2-thiouracil-6-propionic 
acid to AH-Sepharose 48 using N-ethyl-N'-(3-dimethyl-aminopropyl) carbodiimide 
hydrochloride. The coupling procedure was performed around pH 5 at room tempe-
rature as described by the manufacturers (21). This affinity adsorbent contained 
approximately 10 ~mol ligand/ml gel, as determined spectrophotometrically (mea-
surement of absorbance of reaction mixture and wash fluids at 285 nm). 
Isoelectric focussing 
Preparative flat-bed electrofocusing was performed at 1° C with the LK8 
2117 Multiphor system (LK8, 8romma, Sweden), according to manufacturers' instruct-
ions. As solid support Ultrodex was used, which was equilibrated with 10% ethyl-
ene glycol containing 2% of carrier ampholytes and W-1 ether at a final concen-
tration of 0.25%. Ampholine or Pharmalyte gradients were used as supplied, or 
by appropriate mixing of commercially available products. Samples were concen-
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trated with a Minicon B-15 unit before loading on the gel. Focusing was carried 
out for 16 h at 12 W and 1200 V constant. The initial amperage was 18 rnA and 
this decreased steadily to about 3 rnA. 
After the run the gel w'as fraction a ted using the grid provided and the pH 
gradient was measured with 'the aid of a surface glass electrode (type 10403 3005, 
Ingold AG, Urdorf, Switzerland). Thereafter the gel of each fraction was trans-
ferred to small plastic columns and the proteins were eluted with 2.5 ml 0.05 M 
sodium phosphate (pH 7.3) containing 2.5 mM EOTA, 2mM OTT and 15% ethylene glycol. 
Effects of phospholipids on deiodinase activity 
Phospholipid dispersions were prepared by the addition of buffer (50 mM 
Tris/HCl, 0.1 M NaCl,1 mM EOTA, 3 mM OTT, pH 7.3) to a dry lipid film (rotary 
evaporation) and shaking of the suspension for 3 h at 37° C. Various concentrat-
ions of phospholipid were added to the ammonium sulphate extract (1.2 pg protein) 
and after preincubation for 1 hat 37° C rT3 or T3 was added to a final concen-
tration of 0.1 or 5 p~1, respectively. Incubation (at 37° C) was performed for 
20 min at pH 7.3 (using rT3 as substrate) or for 60 min at pH 8.0 (using T3 as 
substrate) in a total volume of 0.25 ml. The reaction was stopped and the 3,3'-T2 
produced was measured as described previously (16). 
Treatment of kinetic data 
Kinetic constants were determined by drawing the straight lines of double-
reciprocal (Linev1eaver-Burk) plots by the least-squares method applied to un-
weighted means. 
RESULTS 
Ammonium sulphate fractionation 
The supernatant, obtained after treatment of the cholate extract with 35% 
ammonium sulphate, contained negligible deiodinase activity (Table 1). The pellet 
could be solubilised best with 0.3% W-1 ether, yielding a soluble preparation 
with approximately ten times higher specific activity than the cholate extract. 
The overall recovery of 5'-deiodinase activity was 310%. The W-1 ether extract 
could not succesfully be fractionated with ammonium sulphate. 
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Table 1. AMMONIUM SULPHATE FRACTIONATION AND SUBSEQUENT SOLUBILISATION OF RT3 
5'-DEIODINASE ACTIVITY FROM CHOLATE SOLUBILISED RAT LIVER MICROSOMES 
Fraction 
cholate extract 
(5.0ml) 
supernatant after 
35% (NH4)2 so4 
treatment (5.0 ml) 
supernatant after 
solubilisation of 
(NH4)2 so4-pellet 
(3.3 ml) 
pellet after solu-
bilisation of 
(NH4)2 so4-pellet 
Chromatographies 
Protein 
mg 
25.0 
7.0 
6.6 
rT3 5'-deiodinase Specific activity 
activity 
units units/mg protein 
1412 56.5 
2 0.3 
3804 576.4 
578 54.5 
Results of several chromatographies are summarized in Table 2. Ionexchange 
chromatography on DEAE-Sephacel at pH 8.0 resulted in elution of 3% of activity 
in the void volume vlith the W-1 ether extract, whereas with the ammonium sulphate 
extract this was 11%, representing virtually all activity recovered. With the 
former sample 30% of activity was eluted with 0.1 M NaCl and with the latter 
this was only 1%. The behaviour of these two extracts on CM-Sepharose was the 
reverse of that on DEAE-Sepharose; i.e. with the W-1 ether extract most of the 
activity recovered from this column appeared in the void volume (Table 2). Total 
enzyme recoveries were in case of the ammonium sulphate extract very low. 
Deiodinase activity was strongly retained on octyl-Sepharose and could not 
be eluted with ethylene glycol. Results with phenyl-Sepharose were similar. 
However, Sephadex LH-60, a gel possessing both hydrophilic and lipophilic pro-
perties, did neither retain activity nor protein (results not shown). 
Con A-Sepharose and heparin-Sepharose retained very little activity (Table 
2), while 2',5'-ADP-Sepharose retained no activity at all and less than 5% of 
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(j) TABLE 2. CHROMATOGRAPHIES OF IOOOTHYRONINE OEIOOINASE ACTIVITY SOLUBILISEO FROM RAT LIVER MICROSOMES. 
The samples applied on the columns were the cholate extract (a), the ammonium sulphate (b) and in all other 
cases the W-1 ether extract. Pi, phosphate buffer n.d., not determined -
Column material 
OEAE-Sephacel 
II 
CM~Sepharose CL-68 
II 
Octyl-Sepharose CL-48 
II 
Con A-Sepharose 48 
Heparin-Sepharose 
CL-68 
Thiopropyl-Sepharose 
68 
Thiol-Sepharose 48 
Blue-Sepharose CL-68 
II 
Matrex gel red A 
T 4-sepharose 48 II 
T3-Sepharose 48 
Thiouracil-Sepharose 
48 
Equilibration buffer 
30 mM Pi, 2 mM OTT, pH 8.0 
II 
30 mM Pi, 2 mM OTT, pH 5.6 
II 
15 mM Pi, 2 mM OTT, pH 7.0 
II + 0,8 M (NH4)2 S04 
15 mM Pi, 2 mM OTT, pH 7.0 
II + o.6 M (NH4)2 so4 
40 mM Pi, 150 mM NaCl, 2mM 
OTT, pH 7.2 
30 mM Tris, 150mM NaCl,2mM 
EOTA, 2 mM OTT, pH 7.2 
50 mM Tris, 100 mM NaCl, 
1M EOTA, pH 7.3 
40 mM Tris,150 mM NaCl,1mM 
EOTA, pH 7.4 
40 mM Pi, 100 m~1 NaCl, 2mM 
EOTA, 2mM OTT, pH 6.5 
40 mM Pi, 100 mM NaCl, 1mM 
EOTA, 2 mM·OTT, 0.1% W-1 
ether, pH 6.7 
40mM Tri s ,500mM NaCl, pH 8.0 
40 mM Tris, 100 mM NaCl, 
2 mM EOTA, pH 7.0 
40 mM Tris, 150 mM NaCl, 
2 mM EOTA, 0.015 mM 
3' ,5'-T2, pH 7.4 
Fraction eluted 
with 
Activity/protein (%) 
0.1 M NaCl, pH 7.0 
II 
0.1 M NaCl, pH 6.5 
II 
0-50% ethylene glycol, 
pH 7.8 
0-50% ethylene glycol, 
pH 7.8 
0.2 M a-0-methyl-
glucopyranoside 
0-1.5 M NaCl 
8 mM OTT 
8 mM OTT 
1M NaCl, pH 7.7 
1M NaCl, pH 7.9 
50% ethylene glycol 
11 + 5 mM T4 
50% ethylene glycol+ 
4 mM OTT 
50% ethylene glycol+ 
12 mM OTT 
30/18 
1/3 
12/4 
6/11 
1/8 
< 1/n. d. 
<1/4 
< 1/2 
3/5 
5/18 
30/40 
33/43 
58/32 
56/41 
97/62 
2/30 
2/n.d. 
71/35 
7/10 
Recovery of activity/ 
protein (%) 
58/68 
13/53 b 
50/99 
12/48 b 
10/65 
<1/n .d. 
7/50 a 
2;1o a 
64/76 
94/83 
49/75 
84/83 
68/74 
57/59 b 
107/88 
3/35 
3/n.d. 
72/50 
47/59 
protein (not shown). Covalent chromatography using thiopropyl-Sepharose or act-
ivated thiol-Sepharose did not result in enrichment of enzyme activity (Table 2). 
Blue-Sepharose and Matrex gel red A both retained most of the enzyme activity 
applied to the column. Elution could be achieved with 1M NaCl. Some of these 
eluted fractions exhibited a three-fold increase in specific activity compared 
with the original sample. The ammonium sulphate extract was adsorbed almost com-
pletely onto the blue-Sepharose column and eluted with 1 M NaCl with 60% recovery 
of both protein and enzyme activity. 
Both T4- and T3-Sepharose strongly bound deiodinase activity (see Table 2). 
However, enzyme could not be eluted from the T4-sepharose column, whereas more 
than 70% of activity, together with 35% of protein, could be eluted from T3-
Sepharose using 50% ethylene glycol. Thiouracil-Sepharose retained very little en-
zyme and only some of the eluted fractions showed an increase in specific activit) 
There was no difference in behaviour between the 5- and 5'-deiodinase activit 
on the column materials tested. 
Isoelectric focusing 
Electrofocusing of the W-1 ether extract revealed that the enzyme activity we 
resolved into two peaks, a major one around pH 6.4 and a minor one at pH 5.2 (Fig. 
1). Overall recovery of deiodinase activity was more than 90%. 
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Fig. 1. Preparative isoelectric focusing of iodothyronine deiodinase activity. 
'[he \i-1 ether extract (50 mg protein in 0. 6 ml) was applied to the gel at the po-
sition indicated by the arrow. Focusing was carried out for 16 h at 1° C. An ali-
quot of the 2.5 ml fraction was used to determine deiodinase activity as describec 
in Materials and Methods. (o--o) r'J3 5'-deiodinase activity ; ( _ __.) T3 5-deiodin-
ase acti vi'ty ; (--) pH ampholyte gradient. 
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In the absence of detergents, the isoelectric focusing profile was diffuse and 
exhibited maximum activity between pH 5.7 and 6.3. Focusing of the ammonium sul-
phate extract resulted in one major peak of deiodinase activity around pH 9.3 
(Fig. 2A). Overall recoveries after focusing of this extract were between 50 
and 60%. Refocusing of the latter activity peak again showed a single dominant 
species with an isoelectric point of 9.1 (Fig. 2B). There was no dissociation 
between the 5- and 5'- deiodinase activities by isoelectric focusing of both 
the W-1 ether extract and the ammonium sulphate extract. Peak fractions after 
electrofocusing showed only a three-fold increase in specific activity. Refocus-
ing of the material around pH 9.3 did not result in a higher specific deiodinase 
activity. Despite its low specific activity, the latter preparation consisted 
of only 5 protein bands as demonstrated by sodium dodecyl sulphate gel electro-
phoresis. In the crude W-1 ether extract of the microsomal fraction, containing 
the same amount of protein, about 30 protein bands could be detected (not shown). 
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Fig. 2A. Preparative isoelectric focusing of iodothyronine deiodinase activity in 
the ammonium sulphate extract (17 mg protein in 0.3 ml was applied). The arrow 
indicates the position of sample application. Focusing experiments were performed 
for 16 h at 1° C. An aliquot of the fraction (2.5 ml) was assayed for deiodinase 
a~tivity as described in Materials and Methods. (o---o) rT3 5'-deiodinase activity 
(•---•) T3 5-deiodinase activity;(---) pH ampholyte gradient. The bar above the 
activity peak indicates the fraction which was combined and used in the refocusing 
experiment (see Fig. 2B). 
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Fig. 2B. Preparative isoelectric refocusing of iodothyronine deiodinase activity 
the peak fraction (0.6 mg protein in 0.3 ml) obtained after isoelectric focusing c 
the ammonium sulphate extract. See legend to Fig. 2A. 
Isoelectric focusing of the desalted and concentrated eluate, obtained after 
chromatography of the W-1 ether extract on 1•1atrex gel red A, resulted in a major 
activity peak around pH 9 (not shown). 
Characteristics of solubilised iodothyronine deiodinase activity 
Table 3 presents the Km and Vmax values for rT3 of membrane-bound and solubi. 
ised iodothyronine deiodinase activity. The kinetic parameters were not greatly 
altered by solubilisation with cholate or W-1 ether. However, solubilisation of 
the ammonium sulphate precipitate with W-1 ether greatly increased both kinetic 
constants. In addition, the phospholipid content of the several preparations is 
shown in Table 3. It is obvious that treatment with ammonium sulphate results 
in nearly complete depletion of phospholipid from the deiodinase. After ammonium 
sulphate fractionation approximately 97% of phospholipid remained in solution. 
The supernatant contained 49 ~g lipid phosphorus per mg protein. 
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Table 3. K~1 AND VMAX VALUES FOR RT3 AND PHOSPHOLIPID CONTENT OF MEMBRANE-BOUND 
AND SOLUBILISED RAT LIVER IODOTHYRONINE DEIODINASE ACTIVITY. Values are 
average of three separate. experiments. 
Origin of enzyme Apparent Km Vmax Phospholipid content 
!lM units/mg Jlg lipid phosphorus/mg 
protein protein 
microsomal fraction 0.10 0.36 21.8 
W-1 ether extract 0.09 0.26 12.3 
cholate extract 0.11 0.29 11.8 
ammonium sulphate 0.69 4.09 1.0 
extract 
Storage of the W-1 ether extract for 23 weeks at 4° C resulted in a 97% 
loss of deiodinase activity (Table 4). Ethylene glycol in concentrations of 20-50% 
(v/v) partially prevented this loss. After storage under the same conditions in 
50% ethylene glycol, remaining activity was 25%. Storage in the frozen state at 
-25° C proved to be a better means to keep enzyme activity, with only 15 and 20% 
loss after 15 and 25 weeks, respectively. However, after 15 weeks at -25° C de-
iodinase activities of the cholate and ammonium extracts had fallen to 20 and 
30%, respectively. At -25° C no protection was provided by ethylene glycol. 
Table 4. EFFECT OF ETHYLENE GLYCOL ON THE STABILITY OF vJ-1 ETHER SOLUBILISED 
IODOTHYRONINE DEIODINASE ACTIVITY. 
Ethylene glyco 1 Activity after Activity after 
23 weeks at 4°C 25 weeks at -25°C 
% % of original 
3 80 
20 8 81 
30 14 77 
40 20 78 
50 25 78 
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Effects of phospholipids 
Treatment of the delipidated deiodinase in the ammonium sulphate extract 
with several classes of phospholipid showed that phosphatidylserine inhibited 
the 5'-deiodinase activity strongest (Fig. 3). Phosphatidylcholine and -ethanol-
amine inhibited the enzyme to a lesser extent, while phosphatidylinositol was 
without effect. On the other hand, sphingomyelin stimulated 5'-deiodinase activity. 
Similar effects of these phospholipids were observed on T3 5-deiodinase activity 
(not shown). 
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Fig. 3. Effect of phospholipids on rT3 5'-deiodinase activity. ~e ammonium sulphate extract was treated with various concentrations of phospha-
tidylcholine(o), phosphatidylethanolamine (e), phosphatidylserine (~), phospha-
tidylinositol (a) and sphingomyeline (D) as described in the Materials and Methods. 
Enzyme activity was assayed by the standard method and the values were expressed 
as a percentage of the activity of untreated enzyme. 
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DISCUSSION 
None of the chromatographic methods tested resulted in a significant purific-
ation of iodothyronine deiodinase activity. Even affinity chromatography on T4-
and T3-sepharose failed to separate this activity from other proteins. In case 
of T4-Sepharose, enzyme activity as well as the bulk of protein were bound very 
strongly. After elution with 50% ethylene glycol only 3% of the enzyme and 35% 
of protein could be recovered. In this regard T4-Sepharose behaved similarly as 
octyl-Sepharose. On the other hand, 71% of activity and 35% of protein could be 
eluted from T3-sepharose with 50% ethylene glycol. This may reflect the higher 
affinity of the enzyme for T4 than for T3, which is in accordance with the Km 
values of these substrates for the deiodinase (16). 
The results of the chromatography on DEAE-Sephacel are similar to those 
obtained previously with DEAE-Sepharose (13). Chromatography on activated thiol-
Sepharose did not result in an appreciable enrichment of deiodinase activity, 
somewhat in contrast to the meagre 3-fold purification previously reported (13). 
The reason for this is unclear, but slight differences in sample preparation 
cannot be excluded. The strong adsorption of the deiodinase to phenyl- and 
octyl-Sepharose suggests that the enzyme is a hydrophobic membrane protein. 
Since 2-thiouracil and 6-propyl-2-thiouracil are strong inhibitors of en-
zymatic deiodination (22), we decided to prepare an affinity column by coupling 
2-thiouracil-6-propionic acid to Sepharose. As it is known that substrate is 
required for the inhibition of iodothyronine deiodinase by thiouracil (23,24), 
3',5'-T2 was incorporated in the equilibration buffer. However, approximately 
50% of the enzyme was adsorbed to this column and only 7% could be eluted with 
high OTT concentrations. Even after batchwise incubation of the W-1 ether extract 
for 1 h at 37° C, less than 50% of the activity was bound to thiouracil-Sepharose 
of which only a few percent could be recovered after incubation for 1 h at 20° C 
with 20 mM OTT to reduce the enzyme-thiouracil mixed disulphide. 
Only the chromatographies on DEAE-Sephacel, CM-Sepharose, Blue-Sepharose, 
Matrex gel red A and T3-Sepharose yielded 2- or 3-fold purification of deiodinase 
activity. However, these findings should be interpreted with caution, because 
removal of any inhibiting substance during chromatography leading to an apparent 
purification cannot be ruled out. The 10-fold purification of the enzyme in the 
ammonium sulphate extract over the chelate extract is not only due to loss of 
non-enzyme protein, but also to loss of some inhibitor, because the overall re-
covery of deiodinase activity was over 300%. 
An indication for the kind of inhibitor removed by ammonium sulphate fract-
ionation came from the isoelectric focusing experiments. Focusing of the W-1 
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ether extract yielded two activity peaks with relatively low isoelectric points 
(Fig. 1). However, most of the activity in the ammonium sulphate extract was 
focused around pH 9.3 (Fig. 2). This rise in isoelectric point indicates that 
ammonium sulphate treatment results in removal of some acidic inhibitor. As most 
phospholipids are acidic substances which may influence the activity of membrane-
bound enzymes, we decided to determine total phospholipid in the several preparat-
ions. Indeed, most of the phospholipid was found in the supernatant after ammonium 
sulphate fractionation and the phospholipid: protein ratio was 12 times higher in 
the W-1 ether extract than in the ammonium sulphate extract (Table 3). The Km and 
Vmax of rT3 5'-deiodination in the delipidated ammonium extract were also greatly 
altered. Thus, delipidation results in increases of the isoelectric point and the 
maximal deiodination rate, but, unfortunately, in a less stable enzyme preparation. 
Addition of some phospholipids to the ammonium sulphate extract leads to an 
inhibition of deiodinase activity (Fig. 3). Of these lipids phosphatidylserine 
appeared to be the strongest inhibitor. However, no significant difference in 
inhibitory activity between phosphatidylcholine, -ethanolamine and -serine was 
observed when these compounds were tested at a phospholipid: protein ratio equi-
valent to that in the microsomal membrane of rat liver (25). Phosphatidylinositol 
and sphingomyelin showed under these circumstances no effect. On the other hand, 
the phospholipid composition of the solubilised preparations needs not be similar 
to that of the microsomal fraction as exposure to mild detergents may release 
proteins in association with specific phospholipids not representative of the 
total membrane lipid. Consequently, the activity of the deiodinase in the mem-
brane of the endoplasmic reticulum may be regulated in part by its association 
with different phospholipids. 
Our stability studies suggest that phospholipids also have a stabilising 
effect on deiodinase activity, whereas Leonard and Rosenberg (26) found that 
iodothyronine 5'-deiodinase showed an absolute requirement for phospholipid. 
Apparently, the W-1 ether we used for solubilisation of the enzyme in the ammo-
nium sulphate pellet can substitute in part for phospholipid to provide a suit-
able matrix for deiodinase activity. Clearly, this does not hold for both deoxy-
cholate, the detergent used by Leonard and Rosenberg (26) and cholate, which we 
also employed. 
Studying the effects of soybean phospholipid, Leonard and Rosenberg (26) 
obtained evidence that besides an absolute dependence of deiodinase activity on 
phospholipids, these substances may also apparently inhibit deiodination by the 
sequestration of substrate. This latter effect may have contributed to the de-
creased deiodination rates we observed after addition of some phospholipids. 
The enrichment in deiodinase activity after chromatography of the W-1 ether 
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extract on Matrex gel red A may also be due to removal of phospholipids, as the 
isoelectric point of this preparation was approximately 9. The differences in 
behaviour on DEAE-Sephacel and CM-Sepharose between the deiodinase activity in 
the W-1 ether extract and in the ammonium sulphate extract square completely 
with the higher isoelectric point of the enzyme in the latter preparation. 
The ultimate enzyme preparation obtained after repeated isoelectric focus-
ing of the ammonium sulphate extract appeared to be relatively pure as judged by 
electrophoresis in the presence of sodium dodecyl sulphate. However, the specific 
activity was increased only 3-fold, which may be owing to the lability of the 
enzyme. 
Under all conditions used in the present study iodothyronine 5- and 5'-
deiodinase activities appeared to be affected in identical fashions. Neither 
chromatography on various columns nor isoelectric focusing of the different en-
zyme preparations resulted in a dissociation of the two activities. This is 
strong support of previous, circumstantial evidence that both deiodinations 
are mediated by a single enzyme entity (15). Thus, among other things, both S-
and 5'-deiodinase activities have been localized in the same subcellular fraction 
of rat liver (endo~lasmic reticulum) (9,10,27), have very similar cofactor re-
quirements (thiols) (3), are inhibited in the same way by thiouracil (uncompet-
itive with substrate, competitive with cofactor) (2,3) and are inhibited to 
the same extents by a number of competitive inhibitors (radiographic contrast 
agents and iodothyronine analogues) (15). The latter point is further substan-
tiated by the finding that the~ values for substrates undergoing 5'-deiodin-
ation are equal to the Ki values in their inhibition of the 5-deiodination of 
other substrates and vice versa. 
It should be emphasized that the above conclusion only applies to rat 
liver. Recently, Chopra et al (28) arrived at the same conclusion on the basis 
of similar, indirect evidence. These findings make it implausible to explain 
the low T3 syndrome (see Introduction) solely on the basis of changes in the 
deiodinase activity of the liver and, perhaps, the kidneys. 
It has, however, been demonstrated that in other tissues such as rat ante-
rior pituitary (29,30), rat brain (31) and rat and human placenta (32,33), en-
zymes specific for the inner or the outer ring of iodothyronines do exist. It 
is not excluded that the 5-deiodinase activity of the liver enzyme is not ex-
pressed in vivo and that most 5-deiodinations occur in extrahepatic tissues. 
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CHAPTER 7 
ONE ENZYME FOR THE 5'-DEIODINATION OF 3,3',5'-
TRIIODOTHYRONINE AND 3',5'-DIIODOTHYRONINE IN 
RAT LIVER 
DuRK fEKKEs,* GEORG HENNEMANN and THEO J. VISSER 
Department of Internal Medicine III and Clinical Endocrinology, Medical Faculty, Erasmus 
University Rotterdam, The Netherlands 
(Received 11 Seprember 1981: accepred 7 December 1981) 
Abstract-Many studies suggest that one enzyme is involved in the phenolic ring deiodination of 
iodothyronines in rat liver and kidney and another one in the tyrosyl ring deiodination. This study 
describes some characteristics of the phenolic ring (5'-) deiodination of rT,. and 3' .5' -T2 by rat liver 
microsomes. At pH 7.2 the Km values of the 5' -deiodination of rT.1 and 3' S -T2 were 0.103 and 0. 77 fiM, 
respectively. 3' .5' -T, and rT, inhibited the respective 5' -deiodination reactions competitively, the K, 
values being 1.05 and 0.134 fiM. respectively. Several radiographic contrast agents markedly inhibit the 
5' -monodeiodination of rT, and 3' ,5' -T,, the type of inhibition being competitive. Of these compounds 
iopanoic acid, ipodic acid and iophenoxic acid are the most potent inhibitors with K, values of 
approximately 2 fiM for both reactions. The non-iodine containing compound 8-anilino-1-naphthalene 
sulphonic acid (ANS) appeared to be a very strong competitive inhibitor of both 5'-deiodinations (K, 
4.3-4. 7 11M), whereas salicylic acid, which as ANS inhibits the binding of iodothyronines to T,-binding 
globulin, inhibited these reactions to a much lesser extent (K, 30(}...500 11M). On the other hand, 
diiodosalicylic acid was a very strong inhibitor. The /)-adrenergic blocker D,L-propranolol was a weak 
noncompetitive inhibitor of both 5' -deiodinations (K, 0.4--0.7 mM). These reactions were also inhibited 
by various 2.6-diiodophenol derivatives, triiodophenol being the strongest and diiodotyrosine the 
weakest inhibitor tested. Comparing the K, values of various inhibitors for the 5'-deiodination of rT, 
and 3',5'-T2 , a positive correlation between these values was found (r = 0.97). It was concluded that 
rT, (to 3,3'-T,) and 3',5'-T, (to 3'-Tt) monodeiodinating activities are very similar to each other and 
that there may just be one monodeiodinase catalyzing the 5' -deiodination of iodothyronines in rat liver. 
Deiodination of T4t is an important pathway for the 
production of T 3, rT3 and lower substituted iodothy-
ronines [1-3]. The deiodination reactions in rat liver 
are catalyzed by iodothyronine deiodinase activity, 
which is associated with the endoplasmic reticulum 
[4-6]. Since the deiodination is a reductive process 
and is enhanced by thiol compounds, reduced 
glutathione is thought to be the endogenous cofactor 
for this reaction [7-9]. 
did not result in separation of the 5- and 5 '-deiodi-
nating activities. In this study, the 5-deiodination of 
rT3 and 3' ,5' -T2 by rat liver microsomes has been 
studied to establish whether the effect of various 
inhibitors is similar by comparing the inhibitor con-
stants on these reactions. The results in the present 
paper suggest that in rat liver one iodothyronine 
deiodinase catalyzes the 5'-monodeiodination ofrT3 
and 3',5'-T2• 
Two types of deiodination reactions may be dis-
tinguished, viz. deiodination of the phenolic ring 
(5'- or 3' -deiodination) and deiodination of the 
tyrosyl ring (5- or 3-deiodination). Many investiga-
tors suggest that 5- and 5' -deiodinations in rat liver 
and kidney are mediated by separate enzymes, viz. 
an iodothyronine 5- and 5'- deiodinase, respectively 
[8, 10, 11]. However, subcellular fractionation [4], 
as well as solubilization and partial purification [12]t 
* To whom correspondence should be sent. 
t Abbreviations: T4, thyroxine; T3, 3,5,3' -triiodothyron-
ine; rT3 (reverse T3), 3,3' ,5'triiodothyronine; 3' ,5' -T,, 
3' ,5' -diiodothyronine; 3,3' -T2, 3,3' -diiodothyror;ine; 3,5-
T2, 3,5-diiodothyronine; 3'-T, 3'-monoiodothyronine; 3-
T, 3-monoiodothyronine; DTT. dithiothreitol; ANS, 8-
anilino-1-naphthalene sulphonic acid. 
:j: Fekkes, Hennemann and Visser, in preparation. 
MATERIALS AND METHODS 
Materials. All iodothyronines and thyronine 
except for 3-T 1 were purchased from Henning GmbH 
(Berlin, F.R.G.). 3-T1 was obtained by courtesy of 
Dr. P. Block, Jr. (University of Toledo, OH, 
U.S.A.). Iopanoic acid (Telepaque) and sodium 
tyropanoate (Bilopaque) were kindly provided by 
Sterling Winthrop Laboratories (New York, NY). 
Sodium ipodate (Oragrafin), amidotrizoic acid 
(Urografin), iotroxic acid (Biliscopin), ioglycamic 
acid (Bilivistan) and iodipamide (Biligrafin) were a 
gift from Schering (Berlin, F.R.G.). Diatrizoic acid 
(Angiografin), iocetamic acid (Cholebrin), iodamide 
(Urombrin), metrizoic acid (Isopaque), acetrizoic 
acid (Plexombrine) and iophenoxic acid (Trilom-
brine) were kindly supplied by the Research Lab-
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_.ratories ofDagra (Diemen, Holland). Salicylic acid 
was purchased from B.D.H. (Poole, U.K.), sulfos-
alicylic acid from Pierce Chemical Company (Rock-
ford, IL) and D,L-propranolol from I.C.I. (Maccles-
field, U.K.). The following substances were obtained 
from Sigma (St. Louis, MO): 3,5-diiodotyrosine, 
3,5-diiodosalicylic acid, DTT and ANS. 2,4,6-Triio-
dophenol, 2,6-diisopropylphenol and 3,5-diiodo-4-
hydroxybenzoic acid were purchased from I.C.N. 
Pharmaceuticals (Plainview, NY) and 2,6-diiohydro-
quinone and 2,6-diiodo-4-nitrophenol were from 
Pfaltz & Bauer (Stamford, CT). 
Preparation of rat liver microsomes. Male Wistar 
rats weighing approx. 200 g were used. Preparation 
of rat liver microsomal fraction in 25 mM Tris/ 
HCl-3 mM EDTA-3 mM DTT (pH 7.4) was done 
essentially as described before [7]. The protein con-
tent of this fraction was measured after solubilization 
in 0.5 M NaOH, by using the method of Spector [13] 
with bovine serum albumin as a standard. 
Deiodination studies. Conversion of rT3 and T3 
into 3,3'-T, and of 3',5'-T, into 3'-T1 by rat liver 
microsomal fraction were studied essentially as by 
Visser et a!. [11]. In short, the iodothyronine was 
reacted with microsomes (5-15 .ug protein/ml) and 
various substances to be tested for 10-20 min at 37° 
in 0.1 M sodium phosphate-3 mM EDTA-3 mM 
DTT (pH 6.5 or 7.2), unless stated otherwise. The 
reaction was stopped by the addition of 4 vol. 0.06 M 
barbitone buffer (pH 8.6 at 20°) containing 0.1% 
(w/v) sodium dodecyl sulphate (SDS) and 0.1% 
(w/v) bovine serum albumin. The amounts of 3,3'-
T2 and 3'-T1 produced were measured in duplicate 
with a specific radioimmunoassay in 50 .ul of the 
extract [14, 15]. The amounts of 3,3'-T2 and 3'-T1 
measured varied between 2 and 200 pg/tube (detec-
tion limit for both iodothyronines is 1 pg/tube). 
Cross-reactivities of the precursors and of the various 
agents tested with the products in the radioimmuno-
assay were in most instances negligible [14, 15]. Only 
in the case of the effect of rT3 on the 5'-deiodination 
of 3' ,S'-T2, the amount of 3,3'-T2 produced from rT3 
cross-reacted considerably in the radioimmunoassay 
of 3'-T1• In this special case, different amounts of 
3,3'-T2 were included in the 3'-T1 standards (this 
resulted in a modified 3'-T1 standard curve), both 
the amounts of 3,3'-T2 generated from rT3 and of 
3'-T1 from 3',5'-T2 were measured and the actual 
amount of 3' -T1 formed was gathered from the modi-
fied 3'-TI standard curve. In control experiments 
substrate was added only after the addition of the 
barbitone-SDS buffer. The amounts of 3,3'-T2 and 
3'-T1 measured in the control experiments were less 
than 5 and 20%, respectively of those produced in 
the complete reaction mixture and were subtracted 
from these latter values. Under all conditions tested, 
both 3,3'-T2 and 3'-T1 were degraded for less than 
5% during the incubation period. 
Treatment of data. For the determination of Km 
and Vmax values the straight lines of double reciprocal 
plots were drawn by the method of least squares 
applied to unweighted means. In case of competitive 
inhibition K values were estimated by using the 
equation: apparent Km = Km (1 + [I]IK1), where the 
apparent Km is -1/intercept on the abscissa in the 
Lineweaver-Burk plot and [I] the concentration of 
the inhibitor. In case of noncompetitive inhibition 
K; values were determined by using the equation: 
1/apparent Vmax = l!Vmax (1 + [I]IK1), where the 
apparent V max is 1/intercept on the ordinate in the 
Lineweaver-Burk plot. 
RESULTS 
Deiodination studies of rT3 and 3' ,5 '- T2 • Table 1 
shows the Km, V max and K; values of the 5' -deiodi-
nation of rT3 and 3',5'-T2 at pH 6.5 and 7.2. The 
results demonstrate that at both pH values 3' ,5 '-T2 
inhibits the 5 '-deiodination of rT3 competitively with 
a K1 value being close to its Km value in the 5'-
deiodination to 3'-TJ. rT3 also inhibits the 5'-deiod-
ination of 3',5'-T2 competitively with a K; value 
similar to the Km value of the rT3 5' -deiodination. 
The data shown in Table 1 were obtained in the 
presence of 3 mM DTT. Repetition of these experi-
ments with varying concentrations of DTT yielded 
2-3-fold higher Km and Vmax values after extrapolat-
ing the data to infinite DTT concentrations. The Km 
values of DTT varied between 2 and 4 mM for both 
5'-deiodinations (results not shown). 
Effects ofiodothyronines. In Table 2 the K, values 
of various iodothyronines for the 5'-deiodination of 
rT3 and 3' ,S'-T2 are shown. All inhibitions are com-
petitive and K values of these analogs are similar 
Table 1. Km. Vmax and K, values for rT3 and 3',5'-T2 5'-deiodinations catalyzed by rat liver microsomal fraction 
Substrate Inhibitor pH Km (,uM) K,(!'M) Vm" (nmoles/min/mg protein) 
rT3 6.5 0.063 ± 0.011 0.271 ± 0.113 
3' ,S'-T2 0.42 ± 0.14 
3',5'-T2 6.5 0.36 ± O.G7 0.155 ± 0.040 
rT3 0.033 ± 0.007 
rT3 7.2 0.103 ± 0.046 0.380 ± 0.107 
3' ,5' -T2 1.05 ± 0.21 
3' ,5' -Tz 7.2 0. 77 ± 0.41 0.270 ± 0.055 
rT3 0.134 ± 0.040 
Values are means ± S.E. (n = 6). 
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Table 2. K, values of various competitive inhibitors for the 5' -deiodination of rT, and 
3'.5'-T3 by rat liver microsomal fraction 
K, of inhibitor (.uM) 
Inhibitor rT3-5' -deiodination 3' .5' -T2-5' -deiodination 
rT3 
3',5'-T2 
T4 (V) 
T, 
3.5-T2 
3-Tt 
Thyronine 
Diiodotyrosine 
ANS 
Salicylic acid 
Sulfosalicylic acid 
Diiodosalicylic acid 
Iopanoic acid (0) 
Ipodic acid (8) 
Iophenoxic acid (D) 
Tyropanoic acid (A) 
Ioglycamic acid (D) 
Iodipamide (1111) 
1.0 ± 0.3 
2.7 ± 1.0 
17.3 ± 9.5 
9.6 ± 1.0 
-* 
103 ± 46 
191 ± 107 
4.7±1.1 
476 ± 191 
114 ± 16 
0.3 ± 0.1 
1.8 ± 0.5 
2.2 ± 0.8 
2.1±0.5 
27.9 ± 6.4 
107 ± 26 
25.2 ± 5.6 
Conversion studies were done at pH 7 .2. 
Values are means ± S.E. (n = 4). 
Symbols refer to Fig. 1. 
* Could not be determined due to experimental problems. 
0.13 ± 0.04 
2.4 ± 0.6 
19.6 ± 6.1 
10.1 ± 2.3 
12.3 ± 2.3 
90 ± 16 
177 ± 29 
4.3 ± 1.2 
302 ±54 
142 ± 30 
0.4 ± 0.2 
1.5 ± 0.4 
2.0 ± 0.3 
1.8±0.7 
21.5 ± 14.2 
24.9 ± 9.2 
16.2 ± 3.1 
for both deiodinations. In addition diiodotyrosine 
was tested. It can be seen (Table 2) that this corn-
pound is about 100 times less active than T4 and 
even two times less active than thyronine. 
graphic agents and T4 on the conversion of rT3 into 
3,3 '-Tz. The K, values of these compounds, except 
for diatrizoic acid, are given in Table 2. At the same 
time the K;values for the 5'-deiodination of 3' ,5'-T2 
are shown. All inhibitions with these agents are 
competitive with respect to substrate. An exarnpll: 
of the type of inhibition of iopanoic acid and ipodic 
acid is shown in Fig. 2. As can be extracted from 
Fig. 1 and Table 2, 5'-deiodination of rT3 and 
3' ,5'-Tz were inhibited best by iopanoic acid, ipodic 
acid and iophenoxic acid and to a somewhat lesser 
Effects of radiographic agents. Figure 1 shows the 
effect of increasing concentrations of various radio-
roo r:::::-..... =-,=s:Z:::-------
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Fig. 1. Inhibition of the conversion of rT3 into 3,3'-T2 by 
increasing concentrations of radiographic agents and T, 
('V). For explanation of symbols see Table 2; in addition, 
the effect of diatrizoic acid is shown (D). Conversion 
studies were done with 0.1/lM rT3 at pH 7.2. Data are 
mean of two closely agreeing experiments performed in 
duplicate. 
M 
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Fig. 2. Lineweaver-Burk plot of the conversion of rT1 into 
3,3'-T2 at pH 7.2 in the absence (0) and presence of 10 !lM 
iopanoic acid (8) and 10 I'M ipodic acid (D). Results are 
mean of two experiments performed in duplicate. 
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Fig. 3. Inhibition of the conversion of rT3 into 3,3'-T2 by increasing concentrations of 2,6-diiodophenol 
derivatives. Deiodination studies were performed at pH 6.5 using O.l,uM rT3• 0, 2,4,6-Triiodophenol: 
e. 2,6-diisopropylphenol; 'V, 3.5-diiodosalicylic acid; D., 3.5-diiodo-4-hydroxybenzoic acid; &. , 3.5-
diiodotyrosine; D. 2,6-diiodohydroquinone; Ill, 2,6-diiodo-4-nitrophenol. All points represent the mean 
of three separate determinations. 
extent by T •. There was no significant difference 
between the inhibitory potency of these three radio-
graphic agents. The radiographic agents amidotrizoic 
acid, iotroxic acid, iodamide, metrizoic acid and 
acetrizoic acid inhibited the 5'-deiodination of rT3 
and 3' ,5'-T2 for less than 20% at a concentration of 
100 ,uM, while iocetamic acid at this concentration 
inhibited these reactions for approximately 50% 
(results not shown). 
Effects of other inhibitors. Salicylic acid and ANS. 
agents known to displace T4 from serum binding 
proteins, were competitive inhibitors. the latter 
being about 100 times more active than salicylic acid 
(see Table 2). Two derivatives of salicylic acid, viz. 
sulfosalicylic acid and especially diiodosalicylic acid, 
have a greater inhibitory activity than salicylic acid 
(Table 2). Addition of D,L-propranolol, a {3-adre-
nergic blocker commonly used in treating hyperthy-
roid patients, was found to inhibit both 5'-deiodi-
nations noncompetitively with K; values of 0.4-
0.7mM. 
From the data in Table 2 it can be deduced that 
the K, values of the various inhibitors for the 5'-
deiodination of rTJ correlate positively with those 
for the 5'-deiodination of 3',5'-Tl (r = 0.97). 
Figure 3 shows the effect of increasing concentra-
tions of 2,6-diiodophenol derivatives on the conver-
sion of rTJ into 3,3'-T2 . The inhibitory activity is 
strongly dependent on the substituent at C4, iodine 
being the best of the substituents tested. The order 
of activity was I~ OH > N02 > COOH ~alanine. 
Unfortunately, 2,6-diiodophenol was not available. 
Instead, 2,6-diisopropylphenol was tested, the 
activity of which was found to be similar to that of 
diiodotyrosine (see Fig. 3). 
DISCUSSION 
In vitro studies of the enzymatic reductive deiod-
ination of iodothyronines in rat liver and kidney have 
led to the hypothesis that T4 is sequentially deiodi-
nated by two enzymes, viz. an iodothyronine 5- and 
A_ C2Hs 
l-x-CH2-C~-COOH I&IH I&IH 
VNH-C-(CH2)4-C-NH¥ 
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Fig. 4. Structures of some radiographic contrast agents. 
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5'-deiodinase [8, 10, 11]. The fact that T4 and rT3 are 
5'-monodeiodinated by the same enzyme has been 
confirmed by several investigators [10, 11, 16, 17]. 
Recently, Chopra [18] showed that 3',5'-T2 and 
3,3'-Tz are similarly substrates for a common 5'-
deiodinase, and the involvement of a single enzyme 
in the 5'-deiodination of rT3 and 3',5'-T2 has also 
been suggested by Visser [15]. In this study a simi-
larity of the Km and Kdor rT3, and the Km and K; for 
3' ,5'-Tz at two pH values was found. This is a strong 
indication that a single hepatic enzyme catalyzes 
5'-monodeiodination of both rT3 and 3' ,5'-Tz. When 
taking these data together one could conclude that 
the 5'- (or 3'-) monodeiodinations of T,, rT3, 
3',5'-Tz and of 3,3'-Tz in rat liver are all mediated 
by one enzyme. This is strengthened by the fact that 
the 5'-monodeiodination of rT3 and 3',5'-T2 are 
inhibited in a similar manner by a number of iodothy-
ronines, several radiographic agents and various 
other substances as tested in this study. We have 
chosen radiographic agents, because these iodine-
containing compounds have been reported to influ-
ence thyroid hormone deiodination in vivo [19] and, 
in addition, some of these agents are potent inhibi-
tors of the liver system convertir T4 to T3 [2, 10]. 
We found that iopanoic aci. .podic acid and 
iophenoxic acid are very strong competitive inhibi-
tors of the 5'-deiodination of rT3 and 3',5'-Tz with 
K; values of approx. 2 ,uM irrespective of the agent 
or reaction tested. The inhibitory activity of these 
compounds was similar to that of T4 (Table 2). The 
structure of iophenoxic acid differs from that of 
iopanoic acid (Fig. 4) in that it contains an amino 
instead of a hydroxyl group in the meta position to 
the side chain. Clearly this does not affect inhibitory 
potency. The structural differences between iopanoic 
acid and iopdic acid are much more pronounced, 
though this is not reflected by their activity (Fig. 4 
and Table 2). Comparing the structures of iopanoic 
acid, tyropanoic acid and ipodic acid (Fig. 4), one 
should expect tyropanoic acid to be about as active 
as the other compounds. However, tyropanoic acid 
appeared to have less than a tenth of the activity of 
iopanoic acid and ipodic acid (Table 2). As can be 
gathered from Fig. 4 this difference is situated in the 
acyl group of tyropanoic acid, which strongly dimin-
ishes the electron-donating properties of the amino 
group. The activities of iodipamide and ioglycamic 
acid are comparable to that of tyropanoic acid (Table 
2). These compounds are also structurally related to 
tyropanoic acid as they contain two N-acyl triiodo-
benzoic acid groups (Fig. 4). Addition of a second 
N-acetyl amino group to such a ring as in diatrizoate 
(Fig. 4) results in a virtually inactive structure (Fig. 
1). As can be concluded from Table 2 all inhibitors, 
except for ioglycamic acid, have similar activity 
towards the 5'-deiodination of rT3 and 3',5'-Tz. An 
explanation for the difference in inhibitory activity 
of ioglycamic acid cannot be given. Deletion of the 
side-chain of iophenoxic acid yields 2,4,6-triiodo-
phenol, a compound which is even more inhibitory 
to the 5'-deiodinase than the most potent radio-
graphic agent (see Figs. 1 and 3). Replacement of 
the 4-iodine atom by a nitro group, a carboxyl group 
or by an alanine side-chain (yielding diiodotyrosine) 
strongly reduces inhibitor activity. Replacement by 
a hydroxyl group (yielding diiodohydroquinone) 
affects the inhibitory potency least (Fig. 3). Very 
interesting is the difference in inhibitory activity 
between 3,5-diiodo-4-hydroxybenzoic acid and 3,5-
diiodosalicylic acid (3,5-diiodo-2-hydroxybenzoic 
acid), as shown in Fig. 3. The only difference in 
structure is the position of the hydroxyl group. The 
reason for the high activity of diiodosalicylic acid is 
unclear. It does, however, closely resemble the 
highly potent triiodophenol from which it is derived 
by substituting COOH for I in one of the ortho 
positions to the OH group. 
We found that ANS is a very strong competitive 
inhibitor (K; -4 ,uM) of iodothyronine 5' -deiodina-
tion. This is in discordance with previous reports 
[20, 21] on 100-1000-fold higher values for the K; of 
ANS. However, these studies were performed with 
homogenate containing an abundance of ANS bind-
ing proteins [3], whereas we used low amount of 
microsomal fraction. On the other hand, our data 
concerning salicylic acid are in agreement with these 
other studies [20, 21]. The effects of D,L-propranolol 
on the 5'-deiodination are contradictory [20, 22, 23]. 
We found that this compound is a weak noncom-
petitive inhibitor (K; 0.4--0.7 mM) of the 5'-deiodi-
nation .of rT3 and 3',5'-T2 and is therefore of no 
importance for the in vivo inhibition of the deiodi-
nation, because the plasma levels of D,L-propranolol 
during treatment of hyperthyroid patients never 
exceed a concentration of 0.6 ,uM [25]. 
In conclusion, our results strongly suggest that a 
single hepatic enzyme catalyzes the 5' -deiodination 
of rT3 and 3' ,5' -Tz. Consequently, all iodothyronines 
may be 5'-monodeiodinated by one enzyme in rat 
liver. 
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Structure-activity relationship 
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1. Introduction 
It has been found that several iodine-containing 
radiographic contrast agents are potent inhibitors of 
the 5'-deiodination of thyroxine (T4 ) to 3,3',5-tri-
iodothyronine (T 3 ) in peripheral tissues in vivo [1] 
as wellas in vitro [2,3]. In rat liver microsomes the 
5 '-deiodination of 3,3' ,5' -triiodothyronine (rT 3) to 
3,3'-diiodothyronine (3,3'-T2 ) and of 3',5'-diiodo-
thyronine to 3 '-monoiodothyronine as well as the 
5-deiodination ofT3 to 3,3'-T2 are also inhibited by 
these radiographic agents [4,5]. It is still uncertain 
whether a single enzyme mediates both types of de-
iodination or that two separate enzymes are involved, 
i.e., iodothyronine 5- and 5'-deiodinase [5,6]. 
During attempts to purify the enzyme(s) from rat 
liver by electrophoresis, it was noted that the tracking 
dye bromophenol blue strongly inhibited deiodination. 
This compound is structurally related to iodothyron-
ines and several X-ray contrast agents in that it also 
contains two halogen substituents in the ortho posi-
tions to an electron-donating group (OH or NH2 ). It 
was therefore thought of interest to study the struc-
ture-activity relationship of phenolphthalein deriva-
tives as inhibitors of iodothyronine 5 '-deiodination. 
Another point of consideration for this study was the 
wide use of these compounds as acid-base indicators. 
It was found that bromophenol blue is a very strong 
competitive inhibitor of iodothyronine 5 '-deiodinase 
activity. At the same time sulfobromophthalein (BSP) 
and bilirubin, both compounds known to displace T4 
and T 3 from cytosol binding proteins [7], were found 
to inhibit the 5 '-deiodination of rT 3• 
2. Materials and methods 
2 .1 . Materials 
Phenolphthalein, chlorophenol red, thymol blue, 
cresol red, bromocresol-purple, 2-bromophenol, 
2-iodophenol and BSP were purchased from Merck, 
Darmstadt; bromophenol blue, bromothymol blue and 
bromocresol green from BDH Chemicals, Poole; bili-
rubin from Fluka AG, Buchs; 2,4,6-tribromophenol 
and 2,4,6-triiodophenol from ICN Pharmaceuticals 
Inc., Piainview, NY; phenol red from Serva, Heidelberg; 
2,6-dibromophenol from Eastman Kodak Co., 
Rochester, NY; rT 3 and 3,3'-T2 from Henning GmbH, 
Berlin. 
2.2.Methods 
Deiodination ofrT 3 to 3,3'-T2 by rat liver microsomal 
fraction was studied essentially as in [8]. In short, 
0.1 ,uM rT 3 was reacted with 2-5 ,ug microsomal pro-
tein and various substances to be tested in 0.25 ml 
0.06 M phosphate, 3 mM EDTA and 1 mM dithio-
threitol (pH 6.5). After incubation for 10-20 min at 
37° C, the reaction was stopped by the addition of 
1 ml 0.06 M barbitone buffer containing OJ% bovine 
serum albumin and OJ% SDS (pH 8.6). The amount 
of 3,3'-T2 produced was measured with a specific 
radioimmunoassay in 50 ,ul of the extract [9]. All 
values were corrected for non-enzymatically formed 
3,3'-T2 by incorporating appropriate controls, as pre-
viously described [8]. Under all conditions tested, less 
than 5% of added 3,3'-T2 was degraded during the 
incubation period. Moreover, it was found that in all 
experiments the amount of3,3'-T2 formed is equiv-
alent to the amount of rT 3 disappearing from the sys-
tem. Consequently, nonenzymatic deiodination was 
not promoted by the various phenolphthalein dyes 
tested. 
Published by Elsevier/North-Holland Biomedical Press 
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For the determination of Ki values, conversion 
studies were done at pH 7.2 in the presence of 3 mM 
dithiothreitol and the straight lines of double-reciprocal 
(Lineweaver-Burk) plots were drawn by the method 
of least squares applied to unweighted means. Estima-
tion of the Ki value was done by using the equation: 
apparent Km = Km (1 + [I]/K;), where the apparent 
Km is -!/intercept on the abscissa in the Lineweaver-
Burk plot and [I] the concentration of the inhibitor. 
3. Results 
Figure 1 shows the effect of increasing concentra-
tions of various phenolphthalein derivatives on the 
conversion of rT 3 into 3,3'-T2 . The inhibitory activ-
ities and the structures of these compounds are given 
in table 1. Replacement of the carboxyl group in 
phenolphthalein by sulfonic acid, yielding phenol red, 
does not alter inhibitory activity. Addition of methyl 
(Me) groups to the 5' and 5" positions of phenol red, 
yielding cresol red, does not affect inhibitory activity, 
whereas addition of Cl, yielding chlorophenol red, 
enhances activity sixfold. Addition of Br to the 3' 
and 3" positions of cresol red, yielding bromocresol 
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purple, stwngly increases activity, and so does further 
substitution of Br for Me in bromocresol purple as 
well as for isopropyl (iPr) in bromothymol blue, yield-
ing bromophenol blue and bromocresol green, respec-
tively. Comparing the latter compounds, it is obvious 
that Me in the 2' and 2" positions has a deleterious 
effect. Despite the presence of this Me group in thymol 
blue its activity is similar to chlorophenol red and 
tenfold higher than phenol red, demonstrating the 
favourable effect of iPr in the 5' and 5" positions. (It 
should be noted that in the absence of 2' and 2" sub-
stituents, positions 3' and 3" are equivalent with 5' 
and 5"). The negative logarithm of the ID50 (piD50 ) 
of the phenolphthalein derivatives was inversely cor-
related with their pK values (r = -0.84; p < 0.005). In 
fig.2 the effect of three bromine-containing phenol-
phthalein derivatives on the 5 '-deiodination of rT 3 is 
shown. The results demonstrate that all three com-
pounds inhibit this reaction competitively with rT 3. 
From the change in apparent Km for rT 3 the Ki values 
were calculated (table 2). In addition, BSP and bili-
rubin were found to be inhibitory to the 5 '-deiodina-
tion of rT 3, the type of inhibition being competitive. 
The K; values for these agents are shown in table 2. 
To find out whether bromine attached to a rela-
10-6 10-5 10-4 
MOLAR CONCENTRATION OF TEST AGENT IN INCUBATION MIXTURE 
Fig.l. Inhibition of the conversion of rT 3 into 3,3' -T 2 by increasing concentrations of phenolphthalein derivatives. For detalls see 
section 2 and for explanation of symbols see table 1. Results are mean of 3 closely agreeing experiments performed in duplicate. 
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Table I 
Inhibitory activity of phenolphthalein derivatives 
Ra R3 HO~' ' R4 R::¢" " 0 I --.:::2, 7 4" 
' 1' 
Rz 71' O;c R ~5 Rz 
6 1 
5 
4 
R, R, R, R. p!D 50 pK 
0 phenolphthalein coo- H H H 4.3 9.6 
• phenol red so,- H H H 4.2 7.9 
v chlorophenol red so,- Cl H H 5.1 6.0 
"' 
cresol red so,- CH, H H 4.3 8.3 
D bromocresol purple so,- CH, Br H 6.4 6.3 
II thymol blue so,- CH(CH3 ) 2 H CH 3 5.2 8.9 
"" 
bromothymol blue so,- CH(CH,)2 Br CH 3 5.9 7.0 
A bromophenol blue so,- Br Br H 7.0 4.0 
:a: bromocresol green so,- Br Br CH 3 6.5 4.7 
piD 50 : the negative logarithm of the concentration giving 50% inhibition of deiodinase activity. Sym-
bols refer to fig.l. 
30 
Fig.2. Lineweaver-Burk plot of the conversion of rT 3 into 
3,3' -T 2 at pH 7.2 in the absence ( o) and presence of 0.2 ,uM 
bromophenol blue (•), 0.4 ,uM bromothymol blue("') or 
0.2 ,uM bromocresol green (o). For details see section 2. 
Results are means of 3 -experiments performed in dup!ica.te. 
tively simple aromatic ring is also inhibitory or that a 
more complicated structure is required, 2-bromo-
phenol, 2,6-dibromophenol and 2,4,6-tribromophenol 
were tested. The results are shown in fig.3 and are 
compared with the effect of 2-iodophenol, 2,6-diiso-
propylphenol (unfortunately, 2,6-diiodophenol was 
not available) and 2,4,6-triiodophenol. This last men-
tioned agent appeared to be a very strong inhibitor [4). 
Table 2 
Ki values of bromine-containing phenolphthalein derivatives 
and bilirubin in the 5' -deiodination of rT 3 
Inhibitor 
bromophenol blue 
bromothymol blue 
bromocresol green 
BSP 
bilirubin 
Ki of inhibitor (,uM) 
0.04 ± 0.01 
1.36 ± 0.49 
0.11 ± 0.01 
1.33 ± 0.48 
2.12 ± 0.94 
The Km of the 5'-deiodination ofrT3 was 0.10 ± 0.04 ,uM. 
The type of inhibition is competitive. Values are means ± SE 
(n;4) 
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MOLAR CONCENTRATION OF TEST AGENT IN INCUBATION MIXTURE 
Fig.3. Inhibition of the conversion of rT 3 into 3,3' -T, by increasing concentrations of 2-bromophenol (o), 2-iodophenol ( •), 
2,6-dibromophenol ("-), 2,6-diisopropylphenol ( .. ), 2,4,6-tribromophenol (o) and 2,4,6-triiodophenol (•). For details see section 
2. Results are mean of 2 closely agreeing experiments performed in duplicate. 
4. Discussion 
The present study indicates that 5'-monodeiodina-
tion of rT 3 is strongly inhibited by phenolphthalein 
derivatives. Inhibitory potency of the various dyes is 
enhanced, in this order, by Me, Cl, iPr and Br substi-
tuents in the ortho positions of either phenolic ring. 
The most active compound tested is the tetra-bromo 
derivative bromophenol blue. The presence of a 
methyl group in the meta position has a deleterious 
effect. All bromine-containing phenolphthalein deriv-
atives are competitive inhibitors of the rT 3 5 '-deiodi-
nation (fig.2, table 2). 
The reason why bromophenol blue is such a strong 
competitive inhibitor of iodothyronine 5 '-deiodination 
is unclear. Part of the structure of this dye is similar 
to that ofT4 and rT 3, viz. the 3,5-dihalogen-4-hydroxy-
phenol group. However, comparing the activity of 
2,4,6-tribromophenol with that of2,4,6-triiodophenol, 
it is clear that for a proper fit on the enzyme I is a 
better substituent than Br. This is in agreement with 
the finding that iodothyronines are better substrates 
for the deiodinase than bromoiodothyronines [10]. 
Yet, the Ki for bromophenol blue (0.04 pM) is less 
than the Km for rT 3 (0.1 pM). The structure shown in 
96 
table 1 for phenolphthalein derivatives is that present 
in solution below the pK of these compounds. Above 
the pK the rings equilibrate between the quinoid and 
phenolate resonance structures. Our finding of a nega-
tive relationship between the dissociation and inhibi-
tion constants for these compounds suggests that the 
phenolate anion is the preferred form for interaction 
with the enzyme. This may also explain the increased 
activity of 2,4,6-tribromophenol compared with 2,6-
dibromophenol considering the higher acidity of the 
OH in the former. An important implication of these 
findings is that one should be careful with the use of 
these dyes in deiodination studies. A well known 
example is the application of bromophenol blue as a 
marker in protein separation studies. The concentra-
tion used in these experiments often amounts to 
0.1 mM, which lies far beyond the K; value (0.04 pM) 
of this dye. One should also keep in mind the use of 
phenol red as an indicator in various growth media. 
This latter compound is mostly present in a concen-
tration of about 0.3 mM, which amount results in 
more than 80% inhibition of deiodinase activity as 
can be gathered from fig. I. 
BSP, which is used for liver function test and bili-
rubin, an intermediate in the degradation of hemoglo-
Volume 137, number 1 FEBS LETTERS January 1982 
bin, were also tested. It has been shown that BSP and 
bilirubin can displace both T 4 and T 3 from the cytosol 
binding proteins Y (ligandin) and Z [7]. However, the 
affinity of these binding proteins for T4 and T 3 was 
much (~104-times)higher than for BSP_ Furthermore, 
BSP and bilirubin are able to inhibit uptake ofT 4 and 
T 3 by rat liver slices [ 11] and BSP can displace T 4 
from the liver in vivo [12]. BSP is a bromine-contain-
ing phenolphthalein derivative with only one bromine-
containing phenyl ring, which is substituted with four 
bromine atoms, while the two remaining positions in 
this ring are also occupied. Nevertheless, we found 
BSP to be a relatively strong competitive inhibitor 
(Ki 1.33 )1M) of the 5 '-deiodination of rT 3• Bilirubin 
also inhibited this reaction, though less effectively 
than BSP (table 2). A reason for the inhibitory activ-
ity of the seemingly structurally unrelated bilirubin 
cannot be given at the moment. The finding that bili-
rubin inhibits the 5 '-deiodination of rT 3 could be of 
clinical importance. If we take the line that one 
enzyme is responsible for the 5'-deiodination of all 
iodothyronines, bilirubin would also be inhibitory to 
the 5'-monodeiodination ofT4 [4,6]. In hepatic cir-
rhosis serum T3 is unusually low relative to T4 , which 
is probably due to a reduction in peripheral conversion 
ofT4 to T3 [3]. This inhibition of the 5'-monodeiodi-
nation of T4 may be caused in part by the increased 
bilirubin levels. 
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CHAPTER 9 
Evidence for a single enzyme in rat liver catalysing the deiodination of the 
tyrosyl and the phenolic ring of iodothyronines 
Durk FEKKES. Georg HENNEMANN and Theo J. VISSER 
Department of Internal Medicine III and Clinical Endocrinology, Medical Facul(v, Erasmus University, 
Rotterdam, The Netherlands 
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The enzymic 5'-deiodination of 3'.5'-di-iodothyronine and 5-deiodination of 3.3'.5-
tri-iodothyronine by rat liver microsomal fractions were found to be characterized by 
apparent Km values of 0.77 and 17.4J1M respectively. 3'.5'-Di-iodothyronine was a 
competitive inhibitor of 3.3' .5-tri-iodothyronine 5-deiodination (K; 0.65 JIM) and 
3.3'.5-tri-iodothyronine was a competitive inhibitor of 3'.5'-di-iodothyronine 5'-
deiodination (K; I 9.6 JIM). In addition, several radiographic contrast agents and 
iodothyronine analogues inhibited both reactions competitively and with equal potencies 
(r = 0.999). These results strongly suggest the existence of a single hepatic deiodinase 
acting on both the tyrosyl and phenolic ring of iodothyronines. 
The biologically active form of thyroid hormone. 
3.3' .5-tri-iodothyronine (tri-iodothyronine), is pro-
duced predominantly by enzymic phenolic-ring- or 
5'-deiodination of thyroxine in peripheral tissues like 
the liver and the kidney. whereas the inactive isomer, 
3.3' .5' -tri-iodothyronine (reverse tri-iodothyronine). 
is formed by tyrosyl-ring- or 5-deiodination of 
thyroxine. Both tri-iodothyronines are further de-
graded by a cascade of deiodinations. with 5 '-
deiodination to 3.3'-di-iodothyronine as the main 
initial step in the metabolism of reverse tri-iodo-
thyronine (Visser. 1980). 
In a variety of clinical settings a concomitant 
decrease in tri-iodothyronine production and reverse 
tri-iodothyronine clearance has been observed. pre-
sumably owing to a specific decrease in the 
5'-deiodinase activity of the tissues (Braverman & 
Vagenakis. 1979). This has led to the hypothesis that 
the sequential deiodination of thyroxine is catalysed 
by two distinct enzymes. i.e. an iodothyronine 
5-deiodinase and an iodothyronine 5'-deiodinase 
(Schimmel & Utiger. I 977: Visser. I 978). However. 
subcellular fractionation of rat liver homogenate 
(Fekkes et a!.. I 979) and partial purification of 
detergent extracts of microsomal fractions thereof 
(Fekkes et a!.. 1980). have not resulted in a 
separation of these two activities. 
In the present paper we describe the effect of 
various inhibitors on the 5-deiodination of tri-
iodothyronine and the 5'-deiodination of 3'.5'-di-
iodothyronine by rat liver microsomal fractions. 
Evidence is obtained that a single enzyme is 
responsible for both deiodination reactions in rat 
liver. 
Materials and methods 
Materials 
All iodothyronines and thyronine were from 
Henning G.m.b.H .. Berlin. Germany. Iopanoic acid 
(Telepaque) and sodium tyropanoate (Bilopaque) 
were kindly supplied by Sterling-Winthrop Labora-
tories (Amsterdam, The Netherlands) and iophen-
oxic acid (Trilombrine) was a gift from the Research 
Laboratories of Dagra, Diem en. The Netherlands. 
Deiodination studies 
Rat liver microsomal fraction was prepared as 
previously described (Fekkes et a/.. 1979). The 
protein content of this fraction was mesured after 
solubilization in 0.5 M-NaOH. by a modification of 
the method of Bradford (1976). with bovine serum 
albumin as the standard (Spector. 1978). Reaction 
mixtures contained 0.1 M-sodium phosphate/3 mM-
EDT A/3 mM-dithiothreitol. pH 7.2. 1-10 JIM-tri-
iodothyronine or 0.4-3.2J1M-3' .5'-di-iodothyronine. 
2-4 Jig of microsomal protein and various inhibitors 
to be tested. all in a volume of 0.25 ml. The reaction 
was initiated by addition of microsomal fraction and 
incubation was carried out for 15min at 37°C. The 
reaction was stopped by the addition of 1 ml of 
0.06 M-barbitone/0.15 M-NaCl/0.1% (w/v) sodium 
dodecyl sulphate/0.1% (w /v) bovine serum albumin. 
pH 8.6. In control experiments. microsomal fraction 
0306-3275/82/0306 73-04$0 !.50/ I © 1982 The Biochemical Society 
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was added after the detergent solution. Each 
experimental point was determined in duplicate. The 
amounts of 3,3 '-di-iodothyronine (5-deiodination 
product of tri-iodothyronine) and 3'-iodothyronine 
(5 '-deiodination product of 3 '.5' -di-iodothyronine) 
were measured in duplicate by specific radio-
immunoassays in 50 ,ul of the extract (Visser et al .• 
1978; Visser & van Overmeeren-Kaptein, 1980). 
Data analysis 
The amount of product formed was corrected for 
non-enzymic deiodination by subtraction of the 
respective control value, which was always less than 
1 Oo/o of enzymic deiodination. Regression lines of the 
double-reciprocal plots were calculated by un-
weighted least-squares analysis. K, values for com-
petitive inhibitors were estimated by using the 
equation: 
K:n=Km(l+[IlK;) 
where Km and K;, are -!/intercept on the abscissa 
in the absence or presence of inhibitor respectively, 
and I I I is the concentration of inhibitor. 
Results 
The enzymic 5-deiodination of tri-iodothyronine 
was characterized by a mean apparent Km value of 
17.4,uM, and the 5'-deiodination of 3',5'-di-iodo-
thyronine by a mean apparent Km value of 0. 77 ,uM 
(Table 1). Tri-iodothyronine was a competitive 
inhibitor of the 5 '-deiodination of 3 ',5 '-di-iodo-
thyronine (Fig. !), with a mean apparent K; of 
19.6,uM (Table 1). Similarly, 3'.5'-di-iodothyronine 
was a competitive inhibitor of tri-iodothyronine 
5-deiodination (Fig. 2) with a mean apparent K, of 
0.65 ,UM (Table 1 ). 
As potential inhibitors of enzymic 5- and 5'-
deiodination were tested 3,5-di-iodothyronine. thy-
ronine and the radiographic contrast agents iophen-
oxic acid, iopanoic acid and tyropanoic acid. All 
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these compounds inhibited both tri-iodothyronine 
5-deiodination and 3 ',5 '-di-iodothyronine 5' -de-
iodination competitively with respect to the sub-
strates (see tyropanoic acid as an example in Figs. 1 
and 2). Spanning over two orders of magnitude, 
inhibitor constants of the different compounds were 
very similar for the two types of deiodination 
(Table 1). Among the inhibitors. the 2,4,6-tri-iodo-
phenol derivatives, iophenoxic acid. and the 
20 
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1/[3',5'-Di-iodothyronine] (,u~ 1 ) 
Fig. I. Lineweaver-Burk plot of the 5'-deiodination of 
3' .5'-di-iodothyronine to 3' -mono-iodothyronine in the 
absence (O) or presence of 20 ,UM-tri-iodothyronine (8) 
or 30 ,UM-tyropanoic acid (6) 
For experimental details. see the text. Results shown 
are means of two closely agreeing values obtained 
from experiments performed in duplicate. 
Table I. Km values for substrates and K1 values for competitive inhibitors of tri-iodothyronine 5-deiodination and 
3', 5' -di-iodothyronine 5' -deiodination (mean± s.o., n = 4) 
100 
Compound 
Tri-iodothyronine 
3',5' -Di-iodothyronine 
3.5-Di-iodothyronine 
Thyronine 
Iopanoic acid 
Iophenoxic acid 
Tyropanoic acid 
Km *or K 1 value (,uM) 
Tri-iodothyronine 
5-deiodination 
17.4± 4.2* 
0.65±0.16 
11.5 ± 3.1 
125 ± 29 
1.9 ± 0.6 
1.9 ± 0.8 
27.2± 11.6 
3' .5'-Di-iodothyronine 
5 '-deiodination 
19.6± 6.1 
0.77±0.41* 
10.1 ±2.3 
90± 16 
1.5± 0.4 
1.8 ± 0.7 
21.5± 14.2 
Rapid Papers 
400 
300 
200 
100 
-0.25 0.25 0.5 0.75 1.0 
1/[Tri-iodothyronine] (,u.r-1) 
Fig. 2. Lineweaver-Burk plot of the 5-deiodination of 
tri-iodothyronine to 3,3'-di-iodothyronine in the absence 
(O) or presence of0.5J1M·3',5'-di-iodothyronine (O) or 
20 J1M-tyropanoic acid (6) 
For experimental details, see the text. Results are 
means for three experiments performed in duplicate. 
analogous 2,4,6-tri-iodoaniline derivative, iopanoic 
acid, were the most potent, with apparent K; value of 
1.5-1. 9 p.M. Thyronine was at least effective, with an 
apparent K; of approx. 100 p.M. 
As a corollary of these findings, Fig. 3 shows the 
highly significant (r = 0.999) correlation between the 
mean Km and K; values for the substrate and 
competitive inhibitors of tri-iodothyronine 5-de-
iodination and the corresponding values for 3',5'-
di-iodothyronine 5'-deiodination. A similar rela-
tionship (r = 0.996) was observed when we studied 
the 5' -deiodination of reverse tri-iodothyronine 
instead of 3 '.5' -di-iodothyronine (results not shown). 
Discussion 
Investigations in vitro involving rat liver pre-
parations have revealed striking similarities between 
enzymic 5- and 5 '-deiodination of iodothyronines. 
(1) Both 5- and 5 '-deiodinase activities have been 
localized in the endoplasmic reticulum (Fekkes 
etal., 1979; Aufdem Brinke etal., 1979, 1980). 
(2) Both types of deiodination are reductive 
processes, and are driven by thiols like dithiothreitol 
(Visser et al., 1978). 
(3) Enzymic 5- as well as 5'-deiodinations are 
00 
0 
'T 
0 
4 
-log [ Ki(ml of 3 '.5 '-di-iodothyronine 5 '-deiodination I 
Fig. 3. Correlation between the negative logarithms of 
mean apparent Km and K1 values for substrates and 
competitive inhibitors of tri-iodothyronine 5 -deiodination 
and 3 ',5 '-di-iodothyronine 5 '-deiodination 
For details. see Table I. 
inhibited by derivatives of 2-thiouracil (Visser et al., 
1978), and in both cases this inhibition is un-
competltive with the iodothyronine substrate 
(Chopra et al., 1978). Thiouracil is a mechanism-
based inhibitor, since it reacts, under formation of a 1 
mixed disulphide, with an enzyme-sulphenyl iodide 
('E-SI') complex that is an intermediate in the 
deiodination process (Leonard & Rosenberg, 1978: 
Visser, 1979). These findings therefore indicate that 
5- and 5'-deiodination follow the same reaction 
mechanism. 
(4) Reaction ofrat liver microsomal fractions with 
3,5-di-iodothyronine, a substrate of which only the 
tyrosyl ring can be deiodinated, yields the sulphenyl 
iodide complex of the enzyme catalysing the 
phenolic-ring deiodination of other iodothyronines 
as evidenced by the persistent inactivation of 
5 '-deiodinase activity in the presence of thiouracil 
(Visser & Van Overmeeren-Kaptein. 1981). 
(5) Iodothyronine 5- and 5'-deiodinase activities 
in detergent -treated rat liver microsomal fractions 
have very similar chromatographic and sedimen-
tation properties, although, admittedly, none of the 
methods used has resulted in a considerable in-
crease in specific enzyme activity (Fekkes et al., 
1980). 
(6) However, a major improvement in enzyme 
purification has recently been achieved applying the 
technique of isoelectric focusing to W-1 ether fa 
1:1.78 (v/v) mixture of cetyl 10 ether (Brij 56) 
and cetyl 20 ether (Brij 58)] extracts of rat liver 
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microsomal fractions. Both before and after removal 
of phospholipids, 5~ and 5'~deiodinase activities were 
found to co~migrate, indicating identical isoelectric 
points (Fekkes & Visser, 1981). 
(7) We demonstrate here that rat liver 5~ and 
5 '~deiodinase activities are equally affected by 
several competitive substances covering a wide 
range of inhibitory potencies. Furthermore. the K; 
value for tri~iodothyronine as a competitive inhibi~ 
tor of 3 ',5 '~di~iodothyronine 5 '~deiodination is equal 
to its Km value in the 5~deiodination to 3,3'~ 
di~iodothyronine. Conversely, the K; value for 
3',5'~di~iodothyronine as a competitive inhibitor of 
the 5~deiodination of tri~iodothyronine is equal to the 
apparent Km for 3',5'~di~iodothyronine in its 5'~ 
deiodination to 3 '~iodothyronine. 
In conclusion, the present study in conjunction 
with previously presented findings seriously chal~ 
lenges the generalization of two specific enzymes, i.e. 
iodothyronine 5~ and 5'~deiodinase. being involved 
in the sequential deiodination of thyroxine in 
peripheral tissues (Schimmel & Utiger. 1977: Visser. 
1978). Evidence is now compelling that. at least in 
rat liver, a single enzyme is capable of carrying out 
both phenolic~ and tyrosyl~ring deiodination. If the 
same holds true for human liver and if this organ 
plays an important role in the extra~thyroidal 
conversion of thyroid hormone, then our results 
imply causes other than changes in deiodinase 
activity for the regulation of this process. 
The present investigations have been carried out with 
financial aid from the Netherlands Organisation for the 
Advancement of Pure Research (ZWO). We thank Mr. 
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Ruud Ramakers for his technical aid and Ms. Corry 
Boot and Ms. Ankie Bos for expert secretarial assist· 
ance. 
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SUMMARY 
Chapter 1 is an introduction on sources and metabolism of thyroid hormone 
in humans and defines the scope of the study. Secretion by the thyroid gland 
is probably the only source of circulating thyroxine (T4), while the biologic-
ally active 3,3',5-triiodothyronine (T3) and the metabolically inactive 3,3',5'-
triiodothyronine (reverse T3, rT3) are released from this gland in small and 
negligible amounts, respectively. These triiodothyronines are produced mainly 
by enzymatic deiodination of T4 in peripheral tissues, which process is a major 
pathway in the degradation of T4• Two types of deiodination reactions can be 
distinguished, viz. deiodination of the tyrosyl ring (3- or 5-deiodination) 
and deiodination of the phenolic ring (3'- or 5'-deiodination). The reactions 
are thought to be catalyzed by two separate enzyme activities, viz. iodothyro-
nine 5- and 5'-deiodinase. These enzyme activities also mediate the further 
deiodination of both T3 and rT3 to thyronine via the di- and monoiodothyronines. 
The reciprocal changes in serum T3 and rT3 levels observed in several situat-
ions indicate that the enzymatic deiodination is subject to a certain regulat-
ory mechanism. The aim of my study was to obtain more knowledge about the regul-
ation and mechanism of thyroid hormone deiodination. This has been attempted 
by the determination of some of the characteristics of the deiodination react-
ions with partially purified enzyme activities. 
In Chapter 2, in vitro observations from others and ourselves on the mono-
deiodination of iodothyronines are described. Nearly all possible deiodination 
reactions have been demonstrated in a variety of tissues. Liver and kidney are 
the most important sites for the metabolism of thyroid hormone by deiodination. 
The deiodinating activity is enzymatic in nature and requires thiols as cofactor. 
The enzyme activities of rat liver are located in the endoplasmic reticulum, 
while those of rat kidney appear to be associated with the plasma membrane. All 
deiodinations, except for the 5'-monodeiodination of T4, proceed maximally at 
slightly alkaline pH, when high substrate concentrations are used. From the 
kinetics of stimulation by thiols and inhibition by thiouracil derivatives, it 
is concluded that enzymatic deiodination follows a ping-pong mechanism. Iodo-
thyronine deiodinating enzymes are intrinsic membrane proteins, which can be 
solubilized in an active form with several detergents. 
Chapter 3 deals with the conversion of T4 into 3,3'-diiodothyronine (3,3'-
T2) via T3 and rT3, using rat liver homogenate. It was found that the formation 
of rT3 from T4 is difficult to quantitate, because of the very rapid conversion 
of rT3 into 3,3'-T2• The 5-deiodinatiori of T3 was found to be the slowest reaction 
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At low substrate concentrations, the 5'-deiodinations of T4 and rT3 were highest 
between pH 6 and 6.5, while the 5-deiodinations of T4 and T3 were most effective 
at pH 8. All deiodination reactions studied were stimulated by dithiothreitol 
and inhibited by 6-propyl-2-thiouracil. 
Chapter 4 concerns the localization of the iodothyronine deiodinating en-
zyme(s). Activity was found solely in the parenchymal cells of rat liver. Further-
more, these enzymes appeared to be associated with the endoplasmic reticulum of 
these cells. 
In Chapter 5, the solubilization of the membrane-bound iodothyronine de-
iodinase(s) in an active form is described. In addition, several characteristics 
such as the sedimentation coefficient, apparent molecular weight and Stokes' 
radius are determined. At the same time, preliminary attempts at purification 
are presented. 
In Chapter 6, further investigations of the purification and characteriz-
ation of solubilized deiodinase activities are reported. It was found that 
treatment of a solubilized extract with ammonium sulphate removes phospholipids 
from the enzyme, which results in a marked change in its kinetic parameters. 
Moreover, the isoelectric point of the deiodinase was shifted towards pH 9.3. 
Both this change in isoelectric point and the behaviour on several column ma-
terials were found to be similar for the 5'- and the 5-deiodinating activities. 
Chapter 7 deals with the 5'-deiodination of rT3 and 3',5'-diiodothyronine 
(3',5'-T2). Both reactions are inhibited competitively and to the same extent 
by several iodothyronine analogues, radiographic contrast agents and some non-
iodine containing compounds. 
Phenolphthalein dyes, such as bromophenol blue, appeared to be competitive 
inhibitors of the 5'-deiodination of rT3• These dyes are structurally related 
to iodothyronines. Therefore, the structure-activity relationship of phenol-
phthalein derivatives was investigated. The results of this study are presented 
in Chapter 8. 
In the last chapter, a study concerning the 5-monodeiodination of T3 and 
the 5'-monodeiodination of 3',5'-T2 is described. Comparison of the type and 
magnitude of inhibition of both reactions by various iodothyronine analogues 
and radiographic contrast agents led to the conclusion that both 5- and 5'-
deiodinations of iodothyronines in rat liver are catalyzed by a single en~e. 
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SAMENVATTING IN OMGANGSTAAL 
De schildklier is een orgaan dat een bepaalde stof, schildklierhormoon of 
thyroxine (T4) genaamd, maakt en vervolgens in de bloedbaan afscheidt. Dit thy-
roxine wordt wel eens afgekort tot T4,omdat het een molekuul is wat vier jodium-
atomen bevat. Een van de voornaamste werkingen (biologische aktiviteit) van 
schildklierhormoon is de stimulering van het energieverbruik van de lichaams-
cellen. De schildklier kan ook nog een hormoon met drie jodiumatomen maken, het 
zgn. 3,3',5-trijodothyronine, kortweg T3 genoemd (zie figuur 1.2.). Dit hormoon 
wordt in veel kleinere hoeveelheden aan de bloedbaan afgegeven dan T4. De bio-
logische aktiviteit van T3 is echter vele mal en groter dan die van r4 en sommige 
onderzoekers denken zelfs dat T4 helemaal geen aktiviteit bezit. Het lijkt dus 
in eerste instantie zinloos dat de schildklier r4 maakt. Als we echter eens 
kijken naar water met T4 gebeurt in het lichaam, dan wordt al gauw duidelijk 
dat dit laatste toch niet het geval is. Het is namelijk gebleken dat veel or-
ganen in staat zijn om T4 om te zetten in het aktieve r3• Dit omzettingsproces 
(reaktie) is niets anders dan het verwijderen van een jodiumatoom uit het T4 
molekuul en wordt daarom dejodering genoemd. Deze dejodering wordt bewerkstel-
ligd en versneld (gekatalyseerd) door een enzym (dit is een eiwit met een be-
paalde werking), dat 5'-dejodase is genoemd. Het voorvoegsel 5' slaat op de 
plaats van het jodiumatoom, dat door dit enzym van T4 wordt afgeplukt. 
Zo kan er ook een jodiumatoom van een andere plaats in het T4-molekuul 
worden afgehaald. Dit leidt tot een stof met verwaarloosbare biologische akti-
viteit, het zgn. 3,3' ,5'-trijodothyronine, kortweg "reverse" (omgekeerd) T3 of 
rT3 genoemd, omdat het jodiumatoom van de 5-plaats wordt verwijderd (zie figuur 
1.2.). De enzymaktiviteit die deze reaktie katalyseert heet 5-dejodase. Beide 
T3-molekulen kunnen aldus in verscheidene organen uit T4 worden gevormd en komen 
ondermeer in de bloedbaan terecht. Nu is in een aantal omstandigheden, zoals na 
operaties en tijdens vasten, gevonden dat de hoeveelheid T3 in het bloed ver-
laagd is, terwijl de hoeveelheid rT3 juist verhoogd is. Kennelijk heeft het 
lichaam tijdens deze gebeurtenissen minder behoefte aan het biologisch aktieve 
hormoon r3• Met het vermogen minder van dit hormoon te maken zorgt het lichaam 
er dus zelf voor dat het energieverbruik van de weefsels wordt verminderd. Dit 
vermogen wordt regulatie genoemd. Aldus heeft men deze veranderingen vertaald 
in een verschuiving van de vorming van T3 uit T4 ten gunste van de vorming van 
rT3 uit r4• De zaak ligt echter iets minder simpel dan nu is voorgesteld. Het 
is namelijk gebleken dat de vorming van rT3 uit T4 niet is veranderd, maar dat 
de afbraak van rT3 verlaagd is. Deze afbraak wordt voornamelijk gekatalyseerd 
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door de eerdergenoemde 5'-dejodase aktiviteit. De bovenstaande bevindingenhebben 
daarom geleid tot de veronderstelling dat het enzym wat T4 omzet in T3 (het 5'-
dejodase) niet hetzelfde is als het enzym wat de omzetting van T4 in rT3 kata-
lyseert (het 5-dejodase). De eerdergenoemde omstandigheden leiden kennelijk tot 
een lagere aktiviteit van het 5'-dejodase, terwijl het 5-dejodase hiervan geen 
hinder ondervindt. 
Om meer te weten te komen omtrent de regulering van de dejoderingsreakties 
in het lichaam, is het noodzakelijk een dieper inzicht te krijgen in de werking 
en eigenschappen van de daarbij betrokken enzymen. Hiervoor is het nodig om deze 
enzymen te isoleren (scheiden van andere stoffen) uit een orgaan dat het vermo-
gen bezit om T4 te dejoderen. Bovendien kunnen we dan te weten komen of er inder-
daad twee enzymen (een 5- en 5'-dejodase) zijn, zoals door klinische waarnemingen 
wordt gesuggereerd. Aangezien het verkrijgen van menselijk weefsel niet eenvoudig 
is, heb ik mijn toevlucht genomen tot de lever van een rat. Dit dier wordt erg 
veel gebruikt in laboratoria. 
Allereerst heb ik onderzocht welke dejoderingen er in rattelever plaats-
vinden en of deze omzettingen gevoelig zijn voor bijvoorbeeld veranderingen in 
de zuurgraad. Hiertoe werd gebruik gemaakt van zgn. homogenaten, die verkregen 
waren door fijnwrijven van stukjes lever. Deze bewerking maakt de celstruktuur 
kapot,maar laat de subcellulaire deeltjes (onderdeeltjes van de eel), zoals de 
kern, grotendeels intakt. Er werd gevonden dat, behalve de dejoderingen van T4 
in T3 en rT3, ook de 5'-dejodering van rT3 en de 5-dejodering van T3 (beide om-
zettingen leiden tot de vorming van het 3,3'-dijodothyronine) plaatsvinden in 
dit homogenaat (zie figuur 1.4.). De 5'-dejodering van rT3 bleek de snelste 
reaktie te zijn. Voor de 5'-dejodering van T4 en rT3 was een iets hoger dan 
normale zuurgraad het meest gunstig, terwijl de 5-dejoderingen van T4 en r3 juist het beste bij een wat lagere zuurgraad verliepen. Alle dejoderingen konden 
worden gestimuleerd door stoffen met een SH-groep, die mogelijk een ondersteu-
nende funktie (als cofaktor) hebben in de enzymatische reaktie. Deze experimen-
ten zijn beschreven in Hoofdstuk 3. 
Vervolgens werd onderzocht waar in de rattelever de dejoderende enzymen 
zitten. Hiertoe werden de subcellulaire deeltjes in het homogenaat van elkaar 
gescheiden met behulp van een centrifuge. Het bleek dat alle eerdergenoemde 
dejodases in de zgn. microsomen zitten. Deze microsomen komen niet als zodanig 
in de eel voor maar worden gevormd tijdens het maken van een homogenaat. Het 
zijn voornamelijk fragmenten van het endoplasmatische reticulum (dit is een 
soort samenhangend buizenstelsel van zgn. membranen met vertakkingen in de ge-
hele eel) en van de celmembraan. Nader onderzoek wees uit dat de dejoderende 
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enzymen verankerd ZlJn in het endoplasmatische reticulum en niet in de plasma-
of celmembraan (zie Hoofdstuk 4). 
Voor de zuivering van enzymen is het nodig deze in een oplosbare vorm te 
hebben. Daarom werden de dejodases als het ware uit de membraan geweekt met 
zgn. detergentia (een soort zeep). Vervolgens werd met een aantal chemische 
technieken getracht de dejoderende enzymen te scheiden van andere eiwitten. 
Ik kon echter hooguit 70% van die andere eiwitten kwijtraken. Met een andere 
techniek, behandeling met het zout ammoniumsulfaat, raakte ik niet alleen on-
geveer 70% van die andere eiwitten kwijt, maar tevens een aantal zure stoffen 
die de dejodase-aktiviteit remmen. Deze remmende stoffen bleken zgn. fosfolipi-
den te zijn. Dit zijn vetachtige stoffen met een hydrofiele (water aantrekkende) 
kop en twee hydrofobe (waterafstotende) staarten, die samen met eiwitten membra-
nen kunnen vormen, zoals bijvoorbeeld het endoplasmatische reticulum waarin het 
dejoderende enzym zit. Een schematische voorstelling van zo'n membraan is weer-
gegeven in de figuur. 
q' hydrofi e l e kop 
j ), hydrofobe staart 
Fosfolipide 
0 
Eiwit of enzym 
Nu lijkt het een beetje tegenstrijdig dat een enzym, als we dit uit zijn natuur-
lijke omgeving (membraan) halen en fosfolipiden verwijderen een reaktie sneller 
kan laten verlopen. Echter de manier waarop het schildklierhormoon door het 
dejodase wordt omgezet gebeurt met een lagere affiniteit voor dit hormoon, d.w.z. 
schildklierhormoon past slechter op het enzym na verwijdering van de fosfolipi-
den. Het bleek dat alle hierboven b~schreven bewerkingen dezelfde invloed hebben 
op de 5- en de 5'-dejodaseaktiviteit; met andere woorden, de toegepaste tech-
nieken resulteerden niet in een scheiding tussen de 5- en de 5'-dejoderende 
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enzymaktiviteiten (zie de Hoofdstukken 5 en 6). Dit gegeven zou erop kunnen 
wijzen dat er niet twee maar een enzym is dat beide dejoderingsreakties kan 
katalyseren. 
In Hoofdstuk 7 is de invloed van een aantal rontgenkontrastmiddelen 
(rontgenkontrastmiddelen zijn stoffen die worden toegepast bij het maken van 
een rontgenfoto van bepaalde organen en wat struktuur betreft een beetje lijken 
op schildklierhormoon) op de aktiviteit van het dejoderende enzym bekeken. Het 
bleek dat het merendeel van deze stoffen de dejodering remmen. Ook een aantal 
kleurstoffen, de zgn. fenolftaleine kleurstoffen, bleken de dejodases te rerrrnen 
(zie Hoofdstuk 8). Ik heb naar de remming van bovengenoemde stoffen gekeken om 
meer te weten te komen over de manier waarop schildklierhormoon wordt omgezet. 
In Hoofdstuk 9 zijn nag een aantal experimenten beschreven die ook leiden 
tot de konklusie, dater in rattelever kennelijk een enzym is dat zowel de 5-
als de 5'-dejodering van schildklierhormoon katalyseert. Als dit laatste ook 
het geval is voor de lever van de mens en als dit orgaan tevens belangrijk is 
voor de vorming van T3 en rT3 uit T4, dan is het onwaarschijnlijk dat de regu-
lering van de dejoderingsreakties in het lichaam plaatsvindt door middel van 
veranderingen in de aktiviteit van het dejodase. 
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